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Glossary of Technical Terms 
Chromatography physical method of separation in which the components are distributed 
between the stationary and mobile phases that moves in a definite direction. 
Chromatogram 
 
a graphical presentation of detector response depicting concentration of 
analyte in the sample on a paper or layer with separated zones as in planar 
chromatography. 
Effluent  aqueous sample in mobile phase leaving the column or treatment plant 
Influent aqueous sample in mobile phase entering the column or treatment plant 
Sample mixture consisting of a number of components/analytes. 
Sample components the chemically pure constituents of the sample 
Gas chromatography a separation technique in which the mobile phase is a gas 
Adsorption separation based mainly on differences between the adsorption affinities 
between the sample components  and active solid. 
Sewage treatment 
work 
convectional site where wastes are treated and the most significant routes 
through which the drugs inadvertently enter the environment via sewage 
treatment systems 
Aquatic environment domestic, industrial influents and effluents which include rivers, surface 
waters, underground waters and ecosystems. 
Pollutants chemical substances that have potential toxicological consequences on the 
environment beyond a particular threshold. 
Residual analyte bio-transformed compound arising from degradation of residues that 
generates toxic by-products 
Metabolite the active ingredients of medicinal products with a wide range of chemical 
structures that are excreted from humans and animals after metabolism of 
dosed user producing more polar degradation products of which many 
complex modes of biochemical pathways are poorly understood. 
Matrix sample media where compounds can be extracted for chemical analysis. 
Pharmaceuticals drugs procured legally for medicinal or therapeutic use with or without 
prescription 
Illicit drugs drugs procured illegally for illicit use without prescription 
Sewage sludge complex association of wastes of industrial chemicals and human excreta 
containing mixtures of residues with several valuable properties which are 
agriculturally relevant. 
Drug stability conditions of temperature and pH that minimize degradation of drug 
Degradation pathways a typical interplay of complex physical, biochemical and transformational 
routes of pollutants in sewage treatment works 
Solid Phase Extraction multi-step extraction procedures of different protocols for improved 
recovery, and ability of delivering clean extracts using several adsorbents. 
Batch test 
Partition coefficient 
 
octanol/water partition 
coefficient 
 
experiment to monitor bio-degradation of compounds  
distribution ratio of a compound between two partially miscible solvents in 
intimate contact (Kd). 
the (Kow) is a chemical concentration ratio in the octanol/aqueous phases. 
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Abstract 
Sewage treatment works (STWs) are routes through which treated wastewater effluents often 
containing myriads of chemicals are passed into receiving waters due to incomplete removal 
processes as have been identified in several studies. The current work aimed to determine the levels of 
these chemicals in the effluents from Stoke Bardolph STW, Nottingham and to determine the fate and 
behaviour of compounds by conducting degradation batch studies under different treatment 
conditions. The selection of representative illicit compounds; cocaine and its metabolite 
benzoylecgonine, heroin and its metabolites 6-monoacetylmorphine and morphine and a 
pharmaceutical (diazepam) was based on their presence in the STW effluent. 
 
The results obtained using solid phase extraction gas-chromatography technique (SPE-GCMS) 
showed thirteen compounds detected at concentrations between 1.9 and 3147 ng L
-1
 in effluents from 
Stoke Bardolph STW. Procaine, bromacil, codeine, lidocaine, ibruprofen, caffeine, nicotine and 
diazepam were the most abundant compounds in the final effluent with concentrations of 99.2, 
1806.8, 33.5, 71.8, 3147, 213.4, 252.5 and 105.2 ng L
-1
, respectively. The percentage recoveries 
ranged from 74.5 – 109.6%, with the instrumental limits of detection (LODs) ranges of 0.2 – 12.7 ng 
L
-1
, and relative standard deviation (RSD) values of 0.6 – 4.7% were achieved for all the compounds. 
 
The batch tests enabled determination of the degradation of the compounds at different temperatures 
and times, using various sludge types after characterization. Removal rates of cocaine (91.0%), 
benzoylecgonine (90.6%), heroin (97.9%), morphine (99.7%), 6 monoacetylmorphine (93.3%) and 
diazepam (99.7%) were measured after 3 hours equilibration; partition coefficients (Kd) for these six 
substances ranged from 1.2 – 68.1 Kg L-1. The degradation of compounds at 19 ± 0.5o C was            
relatively greater but it still occurred slowly at 4 ± 0.5
o 
C, at between 5 and 10%.   
 
Mass balances for two STW (Molesworth, Cambridgeshire, U.K. and Stoke Bardolph) were 
constructed using the removal rate data from these batch studies. Final effluent concentrations of 
110.0 ng L
-1
 (cocaine), 690.0 ng L
-1
 (benzoylecgonine), 10.0 ng L
-1
 (morphine), 80.0 ng L
-1
 (6-
monoacetylmorphine), and 0.7 ng L
-1
 (diazepam) were found in effluents after a total of 8 hour 
hydraulic  times (8 HRT) from an initial influent concentration of 50 mg L
-1
. Projected influent 
concentrations of cocaine (14, 471 ng L
-1
) and benzoylecgonine (23, 907.1 ng L
-1
) at Stoke Bardolph 
were derived from back-calculating measured final effluent concentrations using this same mass 
balance approach.  
 
Work encompassed in this study directly measures illicit drug removal rates in laboratory studies for 
the first time. The application of removal rates in calculating mass balances in sewage works is an 
improvement over prior studies where assumptions on removal rates at STW were made. 
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CHAPTER 1: Introduction & Literature review  
 
Environmental occurrence of organic pollutants through interconnectedness of human actions and 
activities impacts the environment in many ways. These impacts arising from the potential of global 
warming, deforestation and deposition of drugs comprising myriads of chemical and therapeutic 
classes harbours risks to our daily lives. The individual use of these pharmacologically active 
substances generates great but underappreciated levels of other toxicologically potent and associated 
bioactive metabolites through purposeful and inadvertent discharge to the environment via excreta 
and by illegal disposal.   
This work reviews aspects of drugs occurrence, metabolism, transport routes, stability, analysis and 
environmental distribution of these emerging contaminants and highlights current developments in 
investigating and monitoring their fate and potential effects in aquatic environments. Gas 
chromatography-mass spectrometry (GCMS) is the preferred method for trace drugs analysis in 
wastewaters as their measurements depend largely on successful application of a fast and reliable 
method for qualitative and quantitative determination. The application of this method to the actual 
influents, effluents, sludge and environmental sediments from sewage treatment works (STWs) allows 
the assessment of drugs content and  the extent at which STW helps in the transport of these 
pollutants (via different media) into the environment. Use of sewage and wastewater in batch studies 
to investigate partitioning/degradation of selected drugs in such media are investigated because of the 
current insufficient information on their biodegradability and persistence after their disposal to lands 
or receiving waters. As a result, decisions and policy thrusts regarding the future practices of safe 
sewage-sludge disposal as well as complete removal of these contaminants from STWs effluent-
waters becomes difficult.  
Batch tests using sewage sludge grab samples obtained from two sewage treatment works have been 
conducted to determine the effects of the compounds physico-chemical properties and biological 
sludge characteristics on biodegradation. Degradation of selected illicit drugs such as cocaine and its 
active metabolite benzoylecgonine, heroin with 6-monoacetylmorphine and morphine and diazepam 
with nordiazepam (NorD) as metabolites respectively is examined together with the concomitant 
production of some other metabolites and other compounds. Degradation has been determined to 
involve both biotic and abiotic processes with the mixed liquor solids concentration involving both 
intracellular and extracellular enzyme activities which influenced compounds degradation. However, 
increased degradation of the drugs led to the accumulation of the related metabolites which were in 
turn degraded, but some showed possibilities of conjugation of residues that may result in their escape 
from complete removal from the sewage treatment processes to the receiving waters in a complex-
interplay of interactions. The capability is also outlined of furthering our understanding of fate and 
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behaviour of drugs with particular reference to illicit drugs, abused pharmaceutical and environmental 
processes in our quest to understand the overall issues of drugs and make available exposure data for 
the aquatic realm.  
Mass balance calculations to assess amount of drug degradation in the STWs is addressed as limited 
calculations have been carried out in the literature. To improve upon erroneous calculation of drug 
consumption based on analytes found in surface water, assessment of the existing reports in the 
literature can be compared to our typical design studies of drug degradation at four sampling points 
through the process at RAF Molesworth sewage treatment works (STW).  The Molesworth base is 
manned 24hrs a day; the flow arrives to the works at a reasonably consistent rate (78 m
3
/d). Possible 
applications of mass balance with respect to mass transfer in each sewage sample (processing unit) 
and to evaluate degradation-sorption variables in the overall removal efficiency of compounds are 
presented as more work is required in this area. 
1.1 Sources of chemical substances in the aquatic environment. 
Heavy metals, solvents, dyes, pesticides etc. are some of the chemicals that enter the aquatic 
environment in several ways causing chemical pollution. Some are either from sewage treatment 
works (STWs) or are dumped directly from industrial effluents. Other sources include the use of 
herbicides and fertilizers in agriculture. Apart from phytoestrogens that come from plants; humans 
and animals also excrete natural hormones which are disrupting chemicals in the environment [1]. In 
effluents, bisphenol A (BPA), nonylphenol, nitrates found in fertilizers as well as animal excrements 
and industrial chemicals occur [2]. Figure 1, shows also the presence of polycyclic-aromatic hydro 
carbons (PAHs), heavy metals and phthalates are shown. 
Metals
PAHs
Semivolatile organics
Inorganic anions
PBDEs 
Antibiotics
Other drugs
Steroids
Hormones
 
Figure 1:  Chemical components in sewage sludge. Data from The U. S. Environmental Protection Agency. 
(Renewable Energy Venture, Austin, Texas) [4] 
 
Other classes of endocrine disrupting compounds (EDCs), which includes multitudes of chemicals are 
considered in the studies of accumulation of potential toxic elements exposed to sheep grazed on 
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grassland with repeated applications of sewage sludge and its exposure effects on sheep foetal testis 
development at different gestation periods [3, 4] have been reported. The chemicals used in the plastic 
industry includes phthalate esters and other major environmental pollutants [5] and Koppe et al [6] 
studied the metabolism of the parent phthalate and argued that a very active glucuronidated metabolite 
(monoester) was excreted, while in the digestive system their higher monomers has been detected [7].  
Table 1 shows most of the reported data of pollutants and residual analytes in sewage samples 
showing the sources and the analytes found. In foetus studies, high bioaccumulation of phthalates due 
to easy placental transfer [8] has been observed and the effects of high doses of phthalates on male’s 
reproductive organs have been shown but in most organ systems, they are relatively non-toxic. A 
reduction in testosterone production in rats exposed to phthalates confirmed extensive studies of 
phthalates with the increased high levels of human exposure in human spermatozoa increased damage 
to DNA [9-14]. Activity effects of dibutyl phthalate (DBP) [62], di-ethylhexyl phthalate (DEHP) 
induced ‘anti-androgenic’ on humans testicular dysgenesis syndrome [63], multinucleate gonocytes in 
rats [64-66] and occurrence of weak oestrogens on breast cancer cells have all been linked to 
phthalate exposures [67].  
 
Polychlorinated biphenyls (PCBs) are (unreactive) organic compounds, which constitute a class of 
209 congener groups. The commercial production of pulp bleaching, herbicides, metal smelting, by-
products in combustion processes of incineration, chlor-alkali and coal-fired power stations or 
processes are main sources of PCBs stable compounds. Rudel et al [68] had listed their uses as 
electronic components, pesticides extenders, cutting oils, sealants, adhesives, stabilizing additives in 
flexible PVC coatings of electrical wiring, wood floor production, finishers, flame retardants, 
hydraulic fluids, paints, de-dusting agents coolants, insulating fluids for transformers, capacitors, and 
in carbonless copy paper.  PCBs are stable, very resistant to oxidative degradation, only degrade 
anaerobically and readily persist longer [69]. On human health effects, anemia, thyroid gland injuries, 
impaired reproduction, stomach and liver injuries have all been reported [70, 71].  Exposures of PCBs 
can interfere with oestrogen levels of animals [72].  Impairments of immune system, lowering of 
testosterone levels in males, elevating the levels of progesterone in females and disruption of thyroid 
hormone function [73].  Bioaccumulation of PCBs induces oestrogenic effects in animal tissues [74]. 
Additional studies from Whyatt et al [75], Lilienthal [76] and Korach [77] have all further confirmed 
that the chlorinated congeners are more stable and persistent longer than less chlorinated compounds. 
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Table 1:  Organic contaminants in sewage sludge [15 – 61]. 
Pollutants Sources/usages Analytes                        Matrix Ref 
Organochlorine Pesticides 
and  PCBs          
Agricultural control   of 
pests, transformer   
fluids, plasticisers 
PVCs and  artificial    
Rubbers            
g-HCH, Aldrin,  
Endrin, PCBs,   
Dieldrin        
sewage            15, 16 
     
Chlorophenols & 
chlorophenoxy  acids                                                       
Herbicides 4-chlorophenol 
2-chlorophenol, 
2-chloro-6-MP 
 MCPA; 2,4-D                                                                    
Sewage 16-19 
     
Organophosphorus 
Compounds 
Pesticides   residues                            Sewage 20, 21 
     
Nitrosamines &  
Nitroaromatics 
Control nematodes              Dimethylnitrosamine; 
NDMA; NDEA; 
NPYR; NMOR. 
Sewage 21, 22 
     
Mineral oils                Engine oils, paints               Paraffine, 
alkybenzene  
cycloparaffine      
Sewage 23, 24                                                                                                 
     
Alkylphenols Detergents, surfactants       4-alkylphenol; 
polyetho- xylates; 
4-nonylphenol (NP); 
Monoethoxylates 
(NP1EO); (NP2EO) 
Sewage 25, 26 
     
Lipids                          Petroleum hydrocarbon      Phosphatidyl serine,  
Phosphatidyl 
ethanolamine,     
Phosphatidyl choline       
Sewage            24, 27 
     
Acrylamide Monomer Coagulants   Polyacrylamide    Sewage 28 
     
Phthalates esters          Plasticisers bis-(2-
ethylhexyl)phthalate     
Sewage             29 
     
Organotin compounds Stabilisers in PVCs  
biocides,  foams               
Tributyltin oxide             Sewage   30-32 
     
Surfactants & 
Related residues    
 
Chlorobenzenes 
 
         
Detergents 
 
Paint removers                   
 
Linear alkylbenzene   
Sulphonates (LASs),   
 
chlorobenzenes 
Sewage 
 
Sewage 
 
33-38 
 
39-46 
 
Polychlorinated 
dibenzodioxins (PCDD)  
         
 Pulp bleaching Congener group Sewage 47-54 
Polycyclic-aromatic hydro 
carbons (PAHs)                 
Pyrolysis of organic 
materials.          
Naphthalenes Sewage 55-61 
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1.2 Pharmaceuticals in aqueous environment 
 
Pharmaceutical substances are pollutants that are steadily increasing in wide variety in the aquatic 
environment apart from the traditional pollutants like polychlorinated biphenyls (PCBs), pesticides 
and polycyclic aromatic hydrocarbons (PAHs) in recent years [78-83].  Despite the rapid rise and 
continuous discharge of these chemicals of which some are carcinogenic, reproductive toxic and 
mutagenic in environmental matrices [84-87], studies have indicated that their removals have been 
found to be incomplete and inadequate attention on the fate and behaviour during the transport of 
many drugs after their intended use have increased the risks of possible environmental effects [88-92]. 
The active ingredients of medicinal products with a wide range of chemical structures are excreted as 
parent drugs with associated metabolites after metabolism by dosed user and these are further 
subjected to biotransformation in the sewage treatment processes producing more polar degradation 
products of which many complex modes of biochemical pathways are poorly understood. This has led 
environmental research’s increasing attention to pharmaceuticals and their corresponding metabolites 
considering the production of large number of registered pharmaceuticals and those procured illegally 
for illicit use or without prescription [89]. Yet, large quantities of different chemical classes of new 
pharmaceuticals enter the already saturated marketplace and these are disposed through agrochemicals 
runoff and the sewage systems to the aquatic environment. As shown in Fig. 2, the literature shows 
that many parent drugs escape biodegradation and possible metabolic conjugates of excreted 
metabolites are often revert back to their original parent form after microorganisms’ cleavage and 
these may lead to increase in concentration of parent pharmaceutical in the sewage [89-93]. 
 
Figure 2:  Microbial cleavage of excreted metabolic conjugates into unchanged parent drug [89] 
One of the major sources is excreta and urine containing the unmetabolized drug residues and its 
active metabolites being flushed down in the toilets, many unwanted and expired prescription drugs 
are deliberately disposed of via drains [95-97]). Also, Richardson & Bowron [93] reported that most 
of the drugs like antiseptics and lotions are assumed acceptable to be diluted to low levels in crude 
sewage when sluiced away. Numerous papers have reported the distribution of different chemicals 
belonging to  different   therapeutic classes such as antibiotics, anti-inflammatory drugs, lipid 
regulators, beta-blockers, β2 –sympathomimetics, antiepileptics, antidepressants, antineoplastics, 
contraceptives, tranquilizers, diagnostic contrast media, preservatives and sunscreen agents  in 
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different media of the environment at the specific levels ranging from ngL
-1
 to µg L
-1
 [98-101].  Also 
reported at microgram  levels in rivers were theophylline, erythromycin and tetracycline and some 
amounts of oestrogen from oral contraceptive in sewage systems excreted by human population [102]   
In Switzerland, about 4 tonnes/year of fluoroquinolones (antibacterial drug) are sold and 14 
tonnes/year in Italy [90, 103, 104], while 100 tons of annual drug prescription in Germany alone does 
not include several other pharmaceuticals that have been reported in aquatic samples in numerous 
papers ranging from ngL
-1 
to µg L
-1
 levels [87, 90,  104-106]. The recent analytical studies in UK   
further show that some pharmaceuticals are incompletely removed from sewage treatment works and 
surface waters such as lakes, rivers and seas have some detectable pharmaceuticals present [84, 105, 
107-110].  
In the following, a survey of different therapeutical classes of pharmaceuticals with chemical 
structures are discussed and their manifestation in the surface, drinking and underground waters.  
1.2.1 Acidic pharmaceuticals and phenolic antiseptics 
The antiseptic biphenylol, antiphlogistic ibuprofen, salicylic acid and bezafibrate (lipid regulator) are 
examples of acidic compounds because of their carboxylic and one or two phenolic hydroxyl group 
moieties. Different methods exist for the enrichment and derivatization of acidic drugs, but 
simultaneous determination by diazomethane methylation or trifluoroacetylation has been performed 
using different batches of solid phase extraction (SPE) with over 80% recoveries. Figure 3 show the 
chemical structures of four selected acidic drugs and antiseptics: 
 
Figure 3: Chemical structures of four selected acidic drugs and antiseptics [89] 
1.2.2 Betablocker and β2-sympathomimetics 
Selected betablockers (sotalol, antenolol, metoprolol) and β2-sympathomimetics (salbutamol) 
illustrate a secondary aminoethanol and several hydroxyl groups in the structures of the both 
medicinal classes. The functional groups make the compounds very polar; hence a gas 
chromatography quantitative analysis requires derivatization by silylation and trifluoroacetylation of 
hydroxyl and secondary amino groups respectively. Mean recoveries of over 70% has been recorded 
after extraction and derivatization. Figure 4 show the chemical structures of four selected betablocker 
and β2-sympathomimetics. 
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Figure 4: Structures of four selected betablocker and β2-sympathomimetics [89] 
1.2.3 Neutral pharmaceuticals 
Compounds with no acidic functional groups belong to ‘neutral pharmaceuticals’. Antiphlogistics, 
vasodilators, lipid regulators, antiepileptic agents and psychiatric are different medicinal classes of 
drugs that are neutral or weakly basic and therefore require no derivatization when analysed by gas 
chromatography. With recoveries of over 70% in GCMS, they are also enriched in the reversed 
phased sorbent at neutral pH in HPLC conditions similar to betablockers and β2-sympathomimetics. 
Figure 5 show the chemical structures of four selected neutral pharmaceuticals. 
 
Figure 5:  Structures of four selected neutral pharmaceuticals [89] 
 
1.2.4 Antibiotics  
In the literature, about 18 antibiotics belonging to different groups of penicillin, tetracyclines, 
sulphonamides and macrolide have been determined in waters with recoveries exceeding 80% with 
standard deviation between 5 – 26% using SPE ( 500 mg RP-C18) [89, 113]. Similar SPE methods 
18 
 
using LC-MS with electrospray ionization and surrogate standards in water matrices has been 
described [114]. Figure 6 show the chemical structures of four selected antibiotics. 
 
Figure 6: Structures of four selected antibiotics. [89] 
1.2.5 Iodinated X-ray contrast media. 
These medicinal compounds display high polarity and usually persistent to environmental degradation 
and against metabolism by organisms making the concentration of contrast media in ground water and 
surface water found at the lower range of 7- 10 ng L
-1
 in the literature [115]. Figure 7 show the 
chemical structures of three selected Iodinated X-ray contrast media 
 
Figure 7: Structures of three selected Iodinated X-ray contrast media [89] 
1.2.6 Estrogens 
Natural (17β –estradiol) and synthetic estrogens (17α-ethinylestadiol) contains phenolic and aliphatic 
hydroxyl groups and due to their properties they can be analysed simultaneously. The excreted 
quantities compared to other pharmaceuticals are often low because of their high lipophilicity (log Pow 
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3.5-4.6). But a literature source has given a method that determined estrogens in sewage samples and 
river waters to 0.5 ng L
-1
 [80].  Figure 8 show the chemical structures of three selected estrogens 
 
Figure 8: Structures of three selected estrogens [89] 
Table 2 lists data of the main pharmaceuticals monitored in German STWs as well as German rivers 
and streams with 10,11-dihydro-10,11-dihydro-carbamazepine (DHH), a metabolite of  antiepileptic 
carbamazepine having highest influent and effluent concentration of 4100 and 2600 ng L
-1
. 
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Table 2: Occurrence of psycho-active drugs and beta blockers in STWs [116]. 
 
Substances 
Influent Effluent 
LOQ 
[ng L
-1
] 
No of 
samples 
Max 
[ng L
-1
] 
LOQ 
[ng L
-1
] 
No of 
samples 
Max 
[ng L
-1
] 
       
Antiepileptics       
Carbamazepine 200 9 1000 100 9 1200 
DH-CBZ 100 7 30 50 8 30 
DHH 200 9 4100 10 9 2600 
Primidone 
 
200 9 420 10 9 250 
Antidepressants       
Doxepin 200 9 100 10 9 190 
       
Opioids       
Oxycodon 200 0 - 10 0 - 
Dihydrocodeine 200 9 140 10 9 70 
Codeine 200 9 160 10 9 30 
Morphine 200 9 440 10 9 29 
Methadone 100 9 130 5 9 120 
Tramadol 200 6 470 10 6 370 
       
Tranquilizers       
Diazepam 200 0 - 10 0 - 
Nordiazepam 200 0 - 10 0 - 
Oxazepam 200 6 190 10 6 180 
       
Beta blockers       
Atenolol 100 9 910 5 9 370 
Sotalol 100 9 1300 5 9 1200 
Metoprolol 100 9 1200 5 9 1100 
Propranolol 5 9 70 3 9 60 
Bisoprolol 100 9 380 5 9 270 
Celiprolol 100 9 160 5 9 160 
Betaxolol 5 4 10 3 1 - 
Note: DH-CBZ (10, 11-dihydrocarbamazepine 
Table 3, shows antiepileptic carbamazepine has highest concentration of 6300 ng L
-1
,  X-ray contrast 
media were between 11, 000-15, 000 ng L
-1
 [117]. About 31 pharmaceuticals and five metabolites 
were found in at least one sample of 40 German rivers. Out of 69 target compounds, only 10 were 
found in drinking water [119]. The survey of exposure effects and other environmental relevance is in 
the literature reviews [83, 120]. 
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Table 3: Pharmaceuticals in German STW effluents, rivers and streams [81, 105, 116, 117] 
                                                   
Analyte                                   
 
STWs    Rivers/streams  
LOQ 
(ng L
-1
)        
Number  
STWs           
Maximum   
(ng L
-1
) 
 
 
LOQ     
(ng L
-1
)                
Maximum   
 (ng L
-1
)              
Lipid regulator       
Bezafibrate                           250          49 4600  25 3100 
Gemfibrozil                          50        49 1500  10 510 
Clofibric acid 50 49 1600  10 550 
Fenofibric acid 50 49 1200  10 280 
Antiphlogistics       
Diclofenac 50 49 2100  10 1200 
Ibuprofen 50 49 3400  10 530 
Indomethacin 50 49 600  10 200 
Naproxen 50 10 520  10 390 
Ketoprofen 50 49 380  10 120 
Phenazon 100 30 410  20 950 
Acetylsalicylic acid 100 49 1500  20 340 
Salicylic acid 50 36 140  10 4100 
Betablocker       
Metoprolol 25 29 2200  10 2200 
Propranolol 25 29 290  10 590 
Betaxolol 25 29 190  10 30 
Bisoprolol 25 29 370  10 2900 
β2-Sympathomimetics       
Terbutalin 50 29 120  10 <LOQ 
Salbutamol 50 29 170  10 35 
Psychiatric drug       
Diazepam 30 20 40  30 <LOQ 
Antiepileptic       
Carbamazepine 50 30 6300  30 1100 
Antibiotics       
Clarithromycin 20 8 260  20 260 
Roxithromycin 20 10 1000  20 560 
Chloramphenicol 20 10 560  20 60 
Sulfamethoxazol 20 10 2000  20 480 
Trimethoprim 20 10 660  20 200 
Dehydrato-erythromycin 20 10 6000  20 1700 
X-ray contrast media       
Iopamidol 10 25 15000  10 2800 
Iopromide 10 24 11000  10 910 
Diatrizoate 10 25 8700  10 ca.100 
Iomeprol 10 12 3800  10 890 
Estrogens       
Estrone 1 38 70  0.5 1.6 
17β-Estradiol 1 38 3  0.5 <LOQ 
17β-Estradiol-17-valerate 4 38 <LOQ  2 <LOQ 
17α-Ethinylestradiol 1 38 15  0.5 <LOQ 
16α-Hydroxyestrone 1 15 5  0.5                  <LOQ 
1.3 Illicit drugs in aqueous environment 
The term “illicit drug or drug of abuse” is normally used to describe those drugs that are controlled 
under the Misuse of Drugs Act, 1971. The legislation regulates controlled drugs into classes 
depending on the harm they cause, and there are various offences including the unlawful possession 
of a controlled substance [121]. The emerging risks with the prevalence and trends in the illegal 
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production and abuse of illicit drugs have prompted the establishment of many International Agencies 
[122, 123] to monitor and conduct the risk assessments of the social, economic and environmental 
impacts the menace are eliciting, particularly in the consumer countries. The common classes of illicit 
drugs are cocaine, amphetamine, opioid, lysergic acid diethylamide (LSD), hallucillogen and 
cannabinoid, and by the hidden activity of their users, it has helped its purported widespread and 
continual escalating use [83]. The idea of Daughton [101] to use a non – intrusive approach to 
approximate the level of illicit drugs consumption at community level which was later demonstrated 
by Zuccato et al [124] determined the levels of cocaine in waters and related the quantity to the 
amount of drug consumed by a local population. The approach apparently provided information 
needed by environmental scientists and appropriate authorities involved in the fight against the drug 
menace. It has been argued that the sewage systems constitute one of the potential routes those drugs 
enter the environment; other highly dispersed sources include disposals by drug and manufacturing 
laboratories [125]. 
Until few years ago, nearly nothing was known about the environmental impact of the illicit drugs, 
whether the illicit drugs similarly exist and survive in the environment like other medicinal drugs 
[126-127].  Generally, the illicit drug detection has been limited to the continuous screening of 
individual’s biological fluids (urine, blood, oral-fluids and sweat), population survey with crime, drug 
production data, drug seizures and medical records [128-129]. The official estimates of the 
community consumption of illicit drugs from these exercises can be very unreliable because of the 
hidden nature and network of manufacture, importation, supply and usage without authorisation.  
Globally, United Nation Office of Drugs and Crime, (UNODC) estimates that between 149 and 272 
million people, or, 3.3% to 6.1% of the population aged 15-64 used illicit substances at least once in 
the previous year [130]. Drugs are used in many ways and in many combinations by prescription for 
medical purposes, some illicit drug users often utilise therapeutic pharmaceuticals to supplement their 
illicit drug use by diverting common pharmaceuticals for illicit   personal use and this illegal practice 
have affected societies in a myriad of ways. However, with the continuing pattern of escalation in use 
of illicit drugs and the discharge of their bioactive metabolites to sewage systems, and the present 
mode of sewage disposal (e.g. to grassland, landfills, incineration, horticulture, land reclamation) as 
complex mixtures so the processes involved in drugs removal at various STWs are not fully 
understood.  Table 4 therefore summarises and compares the levels and distribution of the drugs from 
different STWs as reported in the literature in the last ten years. In Table 4, it was observed that the 
relative concentrations of drugs influents were higher compare to the effluents indicating the degree 
of removals. For example in 5 STWs in Spain, cocaine and benzoylecgonine in the influents were   
225 and 2307 ng L
-1 compare to only effluent cocaine concentrations of 47 ng L
-1
.  The relative 
concentration of benzoylecgonine for example is about 10 times higher than the parent drug.
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Table 4                    Survey of illicit drugs and pharmaceuticals concentration in wastewaters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analytes Matrix Influent 
 (ng L-1 ) 
Effluent  
(ng L-1 ) 
Surface Water  
(ng L-1 ) 
Ref 
 
Cocaine 
 
5 STPs, Spain 
 
225.0  
 
47 
 
10 
 
[131] 
 5 STPs,  Belgium 22 -678 - 1.2 - 26 [132] 
 37 STPs, Belgium 32 – 753 - - [131] 
 3 Rivers, Italy - - 0.3 – 44 [133] 
 5 STPs, Ireland, UK 489 ± 117 25 - 248 ± 20 0 – 33 ± 11 [134] 
 Eastern Spain 370 – 1000.24 30 – 560 - [135] 
 30 STPs, Belgium 09 – 683 - - [136] 
 2 STPs, Italy 218.4 – 421.4  0.9 – 10.7 ± 3.2 - [137] 
 4 STPs; River Po. 42 – 120 - - [124] 
 42 STPs, NE Spain 04 – 4700 01 – 100 - [138] 
 Barcelona, Spain 2.40  - - [139] 
      
Benzoylecgonine 5 STPs,  Spain 2307.0 - 111 [131] 
 5 STPs,  Belgium 82 – 1 898 928 44 - 191 [132] 
 37 STPs, Belgium 46 –2258 - - [133] 
 3 Rivers, Italy 2.2 – 183 - - [133] 
 5 STPs, Ireland UK 290 ± 11 22 - [134] 
 Eastern  Spain 150 – 1000.5 22 ± 4 – 31 ± 18 - [135] 
 30 STPs, Belgium 37 – 1550 6.0 – 7.9 - [136] 
 2 STPs, Italy 547.4 -197.2  - - [137] 
 4 STPs; River Po. 420 - 750 0.92 – 100.3 ± 28.6 - [124] 
 42 STPs, NE Spain 09 – 7500 - - [138] 
  Barcelona, Spain 5.24 01 – 1500 - [139] 
 12 STPs, Germany 65± 5 77± 9 71 [140] 
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Table 4 (contd)                 Survey of illicit drugs and pharmaceuticals concentration in wastewaters 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analytes Matrix Influent 
 (ng L-1 ) 
Effluent  
 (ng L-1 ) 
SW  
(ng L-1 ) 
Ref 
Nor- BE 3 Rivers, Italy - - 0.2 – 8.4 [133] 
 Eastern  Spain 150 - 430 30 – 170 - [135] 
 2 STPs, Italy 18.8± 5.6 – 36.6 ± 7.8 <LOQ – 7.5 ± 2.9 - [137] 
 
Cocaethylene 2 STPs, Italy 5.9 ± 2.6 – 11.5 ± 5.1 0.2 ± 0.5 - [137] 
 Barcelona, Spain 77.5– 78.5±33.2 1.71– 4.2± 1.2 4.63 [139] 
 3 Rivers, Italy - - 0.07 – 0.2 [133] 
 
Nor-cocaine 
 
3 Rivers, Italy 
Eastern Spain 
2 STPs, Italy 
 
- 
0.15 – 0.43 
4.3 ± 0.9 – 13.7 ± 5.3 
 
- 
0.03 - 0.17 
0.7 ± 0.5 
0.15 – 3.6 
- 
- 
[133] 
[135] 
[137] 
Amphetamines 
 
 
 
 
 
 
Metamphetamines 
 
 
 
 
 
 
 
 
MDA 
 
 
 
3 Rivers, Italy 
Eastern Spain 
2 STPs, Italy 
42 STPs, NE Spain 
Barcelona, Spain 
5 STPs,  Spain 
 
5 STPs, Nebraska USA 
3 Rivers, Italy 
Eastern  Spain 
2 STPs, Italy 
42 STPs, NE Spain 
3 STPs, USA 
Barcelona, Spain 
Murray, USA 
 
42 STPs, NE Spain 
3 Rivers, Italy 
Eastern  Spain 
2 STPs, Italy 
5 STPs,  Spain 
 
- 
1400 
5.4 – 14.7± 10.6 
03 - 6880 
20.8 – 41.1± 9.1   
15 
 
1.3 ± 0.1 – 1.4  
 0.1 – 62.6 ± 13 
- 
<500 
3 - 277 
15 ± 2 – 66 ± 14 
4.8 – 18.2 ± 5.8 
6.0 - 34 
 
03 - 266 
- 
500 - 1400 
4.6 ± 7.3 – 8.7 
03 - 266 
 
- 
110 – 210 
2.8 
04 - 2100 
0.45– 2.2 ±  0.1 
<1.0 
 
35.0± 7.3 
- 
<100 - 540 
<1.11 – 3.5 ± 2 
3 - 90 
0.8 – 1.3 
2.1 – 6.3  ± 0.6 
03 - 7 
 
01 - 200 
- 
41.0 – 68.0 
0.9 ± 1.9 – 1.1± 1.5  
1 - 200 
 
<0.65 
- 
- 
- 
2.84 
<0.8 
 
- 
<0.41 – 1.7 
- 
- 
- 
- 
2.87 
- 
 
- 
3 ± 0.3 – 4 
- 
- 
- 
 
[133] 
[135] 
[137] 
[138] 
[139] 
[131] 
 
[141] 
[133] 
[135] 
[137] 
[138] 
[141] 
[139] 
[142] 
 
[138] 
[133] 
[135] 
[137] 
[131] 
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Table 4 (contd)            Survey of illicit drugs and pharmaceuticals concentration in wastewaters 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Analytes Matrix Influent  
(ng L-1 ) 
Effluent  
 (ng L-1 ) 
SW  
(ng L-1 ) 
Ref 
MDMA 
 
 
 
 
 
 
 
 
MDEA 
 
3 Rivers, Italy 
Eastern  Spain 
2 STPs, Italy 
5 STPs,  Spain 
STP, Italy 
Barcelona, Spain 
Murray, USA 
42 STPs, NE Spain 
 
5 STPs,  Spain 
2 STPs, Italy 
STP, Italy 
STP, Spain 
42 STPs, NE Spain 
- 
326 – 2700.5 
13.6 – 14.2  
91 
2 - 598 
133– 135.13 ± 29.8 
<1.0 – 10.0 
2 - 598 
 
27 
4.19 – 1.5 ± 3.8 
6 - 114 
<500 
06 - 114 
 
- 
100 – 210.2 
4.4 ± 3.7 – 5.1± 3 
67 
2 - 267 
8.2– 14.8 ± 2.2 
- 
2 - 267 
 
<2.1 
<1.64 
12 
<100 
12 
1.1 – 4.0 
- 
- 
3.5 
- 
129 
- 
- 
 
- 
- 
- 
- 
- 
[133] 
[135] 
[137] 
[131] 
[138] 
[139] 
[142] 
[138] 
 
[131] 
[137] 
[135] 
[138] 
[138] 
Opiates 
Heroin 
 
 
Morphine 
 
 
 
 
 
  
 
Nor-morphine 
 
 
6 ACM 
 
 
Barcelona Spain 
STP, Italy 
 
5 STPs, NE Spain 
3 Rivers, Italy 
5 STPs, Ireland 
2 STPs, Italy 
Barcelona, Spain 
12 STPs, Germany 
STP, Italy 
 
5 STPs, NE Spain 
1 STP, Italy 
 
3 Rivers, Italy 
2 STPs, Italy 
Barcelona, Spain 
 
 
2.4 
20.0 
 
25.9 – 96.7 
- 
874 ± 86 
83.3– 204.4  
68.1 – 162.9 ± 20.0 
123 ± 6 
7.1 – 96.7 
 
30.7 
<25 
 
- 
10.4± 4.8 – 11.8 ± 8.5 
8.4 – 12.8 ±3.1 
 
 
1.2 
<20.0 
 
20.9 – 81.1 
- 
452  
5.5 ± 11.1 
21.8 ± 3.0 
9.0 ± 1.2 
0.1 – 8.1. 
 
- 
<2.5 – 3.7 
 
- 
- 
2.5 – 3.6 ± 0.5 
 
 
- 
<1.5 
 
- 
3.5 - 38 
- 
1-2L 
3.25 
83 
4.8 – 6.3 
 
- 
<12..5 
 
0.93 
- 
- 
 
 
[139]  
[142] 
 
[142] 
[133] 
[134] 
[137] 
[139] 
[140] 
[142] 
 
[142] 
[142] 
 
[133] 
[134] 
[139] 
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Table 4. 
 
 
 
  
 
  
 
  
 
 
 
 
 
 
 
  
Analytes Matrix Influent 
 (ng L-1 ) 
Effluent  
 (ng L-1 ) 
SW 
 (ng L-1 ) 
Ref 
 
 
 
M3G 
 
Methadone 
 
 
 
 
 
Codeine 
 
 
 
Nor-codeine 
 
6 Acetyl codeine 
 
EDDP 
 
12 STPs, Germany 
STP, Italy 
 
2 STPs, Italy 
 
5 STPs,  Spain 
3 Rivers, Italy 
2 STPs, Italy 
12 STPs, Germany 
 STP, Italy 
 
5 STPs, NE Spain 
3 Rivers, Italy 
12 STPs, Germany 
 
5 STPs, NE Spain 
 
3 Rivers, Italy 
 
3 Rivers, Italy 
5 STPs, Ireland UK 
2 ST1 STP, Italy 
STP, Italy 
8.4 – 12.8 ±3.1 
102 ± 14 
 
2.5 ± 7.1 – 18.1 ± 30 
 
4.0 – 239 
- 
11.6± 1.7 – 49.7 ± 9.6 
123 ± 6 
4 – 23.9 
 
18.1 – 119.7 
- 
80 ± 5 
 
5 – 68.0 
 
- 
 
- 
9.0 – 206 ± 10 
19.8 ± 3.1 – 91.3 ± 19.2 
4.5 – 41.3 
0.9 ±1.2 
<3.1 
 
<0.48 
 
4.0 – 24.7 
- 
9.1 ± 0.5 – 36.2 ± 2.8 
9.0 ± 12 
2 – 2.7 
 
3.1 - 397 
- 
7.7 ± 8 
 
15.5 – 22.9 
 
- 
 
- 
- 
22.6± 0.6 – 72.1± 8.7  
4.9 – 56.7 
 
83 
<0.9 – 3.4 
 
- 
 
- 
4.9 – 10.1 
- 
83 
4.9 – 10.1 
 
- 
1.0 - 51 
90 
 
- 
 
<0.31 
 
9.9 – 18.0 
- 
- 
9.61 – 17.5 
[140] 
[143] 
[142] 
[137] 
 
[142] 
[133] 
[137] 
[140] 
[142] 
 
[142] 
[133] 
[143] 
 
[142] 
 
[133] 
 
[133] 
[134] 
[137] 
[142] 
THC 
 
 
 
 
THC-COOH 
 
 
OH- THC 
 
5 STPs, NE Spain 
2 ST1 STP, Italy 
Barcelona, Spain 
 STP, Italy 
 
3 Rivers, Italy 
STP, Italy 
5 STPs, NE Spain 
Barcelona, Spain 
 
11.3 – 31.5 
62.7 ± 5 – 91.2 ± 24.7 
4.3– 21.03 ± 7.8 
8.3 – 31.5 
 
- 
12.5 – 96.2 
37.8 – 96.2 
8.4 – 46.3 
 
- 
<0.94 – 7.2 ± 3.7  
8.4 ± 3.8 – 11. 23 
<8.3 
 
- 
12.5 
14.8 – 48.1 
4.8 – 15.3 
 
- 
- 
2.65 
<7.0 – 13.6 
 
0.48 -3.7  
16.4 – 34.1 
- 
10.7 
 
[142] 
[137] 
[139] 
[142] 
 
[133] 
[142] 
[142] 
[139] 
 
The illicit drugs and their metabolites are mainly from faeces and urination, the pattern of lavatory use 
fluctuates between individuals, certain periods of work and the population of residents in a particular 
environment, the load pattern of illicit substances would likely fluctuate in similar way [144]. Since 
many active researches have been on detection of illicit drugs and related products, studies on their 
fate and behaviour are therefore most warranted. The need to critically review the present current 
development on the degradation processes (fate and behaviour) before and after sewage disposal from 
STWs to the environment and the current analytical methodologies that meet particular application 
should not be overlooked [145].  
1.4 Human metabolism of environmentally relevant drugs. 
In the human body, drugs are bio-transformed into one or more metabolites and after the loss of 
pharmacological activity the metabolites and unchanged parent drugs are eliminated from the body 
systemic circulation via urine or faeces. A number of parameters which include age, gender, ethnicity, 
patient and the time of administration have been associated to degree of metabolism. In Figure 9, the 
metabolism of drugs in the human body shows Phase I and Phase II reactions. The phase I comprises 
of oxidation reaction such as in aliphatic hydroxylation of ibuprofen and diclofenac, epoxidation of 
carbamazepine and ring oxidation of propranolol, while reductions, alkylations and dealkylations are 
other reactions.   
 
Figure 9:  Simplified scheme of dug metabolism in the human body [92] 
The conjugation reaction type occurs when polar molecules in Phase I transfer to the metabolites in 
Phase II such as the transfer of glucuronic acid to phenols, hydroxyls, caroxyls, thiols, amines and 
hydroxylamino groups. [92]. There is therefore interest in identifying the metabolites that may  pass 
on to the sewage, and those that might stay longer in the STWs and enter the environment through 
untreated water effluents or sewage biosolids.  
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In the following sections, the metabolisms of the five major classes of illicit drugs found in various 
wastewaters are discussed. 
1.4.1. Human metabolism of cocaine 
Cocaine is extracted from the leaves of two species of coca: Erythroxylum coca and Erythroxylum 
novogranatense. The cocaine hydrochloride is normally formed after the alkaloids are precipitated 
with sodium carbonate and then dissolved in dilute HCl containing about 40% of cocaine, but when 
cocaine hydrochloride is extracted with ether in aqueous alkaline solution, it produces “free base” 
which contains 85-90% of pure cocaine [94,146]. The street cocaine used by addicts is often mixed or 
cut with a number of diluants [147], and these adulterants are sometimes the cause of poisoning. 
Cocaine is a powerful addictive stimulant drug with three common routes of administration: smoking, 
intravenously and intranasally (through the nose). Figure 10 shows only the compounds we 
determined in the results, however, cocaine is spontaneously metabolized by the action of pseudo 
cholinesterase and hepatic esterase to give ecgonine methylester (EME) with the loss of benzoyl 
group [148-151].  A non-enzymatic hydrolysis at pH above 6 converts cocaine to benzoylecgonine 
(BZE) by demethylation as its main metabolite. BZE can be detected in the urine 48 hours after 
cocaine administration with a urinary excretion half-life of 6-8 hours [152, 153].  The N-
demethylation of cocaine leads to norcocaine (NC) (the most toxic metabolite) by P450 enzymes and 
then metabolized to N-hydroxynorcocaine by brain FAD –containing mono- oxygenases [154, 155]. 
Norcocaine can further be hydrolysed to benzoylecgonine. Cocaine undergoes trans-esterification by 
enzymatic reaction in the liver in the presence of alcohol to form cocaethylene (CE); which has been 
reported to be more toxic than cocaine [156]. When cocaine is smoked, anhydroecgonine methylester 
(AEME) is produced and through enzymatic hydrolysis get converted to anhydroecgonine (AE) or 
ecgonidine [157]. The other metabolites of cocaine (ecgonidine, norecgonidine methylester, p- 
hydroxyl-benzoylecgonine, and m- hydroxyl-benzoylecgonine) found in human urine  have minor 
metabolic- pathways that involve  the aromatic meta- and para- hydroxylation of cocaine followed by 
partial hydrolysis to the corresponding HO-Be isomers [158]. About 1-9% of cocaine has been 
excreted unchanged in the urine with much higher proportion in acid urine; its metabolites are 
recovered in variable proportions which depend on the route of administration [159]. 
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Figure 10: Degradation pathways of cocaine in the human body [145]. 
1.4.2. Human metabolism of amphetamine 
Among the drugs classified as amphetamines are amphetamines (AM), methamphetamines (MA, 
“speed”) and methylenedioxymethamphetamine (MDMA, “ecstasy or Adam”). They are usually 
taken orally but can be snorted, smoked or injected. They are addictive stimulant drugs that affect the 
central nervous systems among other risks of dependence and abuse. Other designer drugs are 
methylenedioxyethylamphetamine (MDE, “eve”) and 3, 4-methylenedioxyamphetamine (MDA, “love 
pills”) [160]. 
The major metabolic pathway involves deamination of cytochrome P450 to para- hydroxyl 
amphetamine and phenylacetone, this later compound is oxidised to benzoic acid and excreted as 
glucuronide or glycine (hippuric acid) conjugates. Smaller amounts of amphetamine are also 
converted to norepheridine by oxidation. Although most enzymes involved in amphetamine 
metabolism have not been clearly defined, CYP2D6 is known to be involved with the formation of   
4- hydroxylamphetamine [161, 162] 
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Figure 11: Main metabolites of 3, 4-methylenedioxymethamphetamine (MDMA) in urine [127].  
1.4.3. Human metabolism of opiates. 
Opium comes from the opium poppy (papaver somniferum), a conjugated juice from the unriped 
capsule. It is an ingredient in morphine, codeine and theobaine. Several illegal drugs are produced 
from the opium poppy and the common ones are morphine and heroin, while 6-monoacetylmorphine/ 
and morphine are their related metabolites. The phenolic hydroxyl at position 3, the alcoholic 
hydroxyl at position 6 and the nitrogen atom plays important roles in morphine metabolism.  
Figure 12 oly show how heroin (diacetylmorphine) degradation pathways to produce main 
metabolites that we determined in the current work. But different morphine conjugates may arise from 
the actions of different enzymes, this emphasises the complexity of morphine metabolism [163]. 
Approximately 90% of an administered dose of morphine is excreted in the urine only about 10% is 
excreted as unchanged morphine. Morphine -3- glucuronide (M3G) is the major metabolite, while 
Morphine -6- glucuronide (M6G) is a minor one [164], and nor- morphine and nor-morphine-6-
glucuronide have also been found in human urine and detected in wastewaters [Table 4]. Other minor 
metabolites  like codeine (3-O-methylmorphine) and morphine- N- oxide have been identified in the 
urine of chronic users [165].  
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Figure 12:  Degradation pathways of heroin and its main metabolites in living organisms. [168]. 
1.4.4. Human metabolism of Lysergic Acid Diethylamide (LSD) 
Lysergic acid diethylamide is a compound derived from ergot alkaloids, a powerful hallucinogenic 
drug commonly sold as “acid” on the street as a drug of abuse. It is a non-addictive drug that comes in 
tablets or blotting paper, though liquid LSD is also available [166]. The drug is quickly metabolized 
in the body, where it is dispersed in the biological fluids in very low concentration and very small 
amount of the original dose is eliminated in the human urine [167]. In Figure 13, the following LSD 
metabolites have been identified in human biological fluids: 13-hydroxy-LSD, 14-hydroxy-LSD, N-
demethyl LSD, 2-oxo-LSD, and 2-oxo-3-hydroxy-LSD [121-123]. The main metabolite of LSD is 2-
oxo-3-hydroxy-LSD and 13- and 14- hydroxyl-LSD are excreted as glucuronide conjugates in urine 
[169]. In a review paper of Reuschel et al [217], evidences supporting a much higher concentration of 
2-oxo-3-hydroxy-LSD in human urine of LSD users than the parent drug and 2-Oxo-LSD 
concentrations were reported. The iso-LSD and LSD exist as stereoisomers in illicit preparations and 
therefore iso-LSD is not a metabolite, it’s frequently found in urine as a main contaminant of LSD 
[170]. Additional metabolites have also been identified in the laboratory animals but are yet to be 
found in human fluids [171]. The LSD compounds were however not studied in the current work. 
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Figure 13:  Lysergic Acid Diethylamide and metabolites in human fluids [168] 
1.4.5. Human metabolism of Cannabinoids 
The cannabinoids, of which the most important one is tetrahydrocannabinol (THC) is the active 
chemical in cannabis sativa L, other active constituents are cannabidiol and cannabinol. Cannabis is 
commonly known as the source of the ‘marijuana’ drug and for centuries, this plant has been widely 
cultivated around the world for its fibres. The cannabinoids are non-polar compounds with low 
solubility in water but are soluble in fat, alcohol and many organic solvents, they are self-administered 
by smoking. The volatilized fractions are inhaled to give physiological effects. It is non-addictive and 
there are no withdrawal symptoms but one of the common side-effects of its use is making the user 
drowsy with reduced concentration and short term memory [172]. About 66 types of cannabinoids 
have been isolated from the cannabis plant but three of them have received most attention from 
researchers as a result of their natural prevalence. These are: phytocannabinoids (obtained from 
cannabis plant), synthetic cannabidiols (prepared from laboratory) and endogenous cannabinols 
(obtained from the body of humans and animals).  
On ingestion, the cannabinoids are metabolized in the liver, especially by cytochrome P450 mixed-
function oxidase, mainly CYP2C9. It is stored in the fat where Δ9-THC is metabolized to 11-hydro-
Δ9-THC, which is metabolized to 9-carboxy-THC [173], but the metabolism of THC is still not 
properly understood. 
Figure 14 shows the structure of Δ9-tetrahydrocannabinol (THC) and its metabolites in human urine 
[127]. The main metabolite is Δ9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) and it is 
excreted as glucuronide-acid conjugate THC-COOH- glucuronide) [174], the metabolites can be 
detected in the body after weeks. It appears that the illegal status of the plant in most countries 
affected its systematic studying. 
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Figure 14: Major metabolites of Δ9-tetrahydrocannabinol (THC) in urine [168]. 
1.5. Sewage Water Treatment Operations 
The operation of sewage water treatment includes the removal of contaminants from wastewater 
runoffs, domestic and industrial sewage before it can be safely returned to the environment. The 
removal of physical, chemical and biological contaminants involves the physical, chemical and 
biological process treatments with the main objective being to protect the public from diseases and 
produce environmentally safe water quality suitable for disposals. The three main sources of 
wastewater are domestic wastewater (human and household wastes, sinks, baths and showers), 
industrial wastewater (wastes from factories, industrial chemicals, airports, shopping centers and 
schools) and storm runoff and ground water (street drains and storm runoff via cracks into sewer and 
interceptor lines. Therefore to achieve the goal of cleaning used water, human intervention becomes 
necessary and the process goes through primary, secondary and tertiary treatment as shown in Figure 
15. 
 Primary treatment: The waste stream from homes and businesses (influent) are carried in 
sewers to the treatment works and enters through bar screens and this includes temporary 
holding of waste stream in a quiescent basin to remove the heavy solids and pollutants while 
the floating lighter matter, oils and grease may also be removed and the trash collected at the 
bar screen is disposed off. The waste stream is passed onto the grit chambers, where the 
wastewater slows down to allow solids such as sands, grits, plastics, broken glass and other 
particles to settle and be removed. The wastes stream flows from the grit chamber into a 
primary clarifier (sedimentation tank) which collects the smaller particules and dissolved 
solid matters (primary sludge), which includes scum, and floating grease, through special 
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devices or scrapers. About 40 – 50% of the solids are removed in the primary treatment 
process.  
 Secondary treatment refines and removes 85 – 90% of the contaminants from the waste 
stream passed to it from the primary clarifier and flows into the aeration tank which supplies 
air to the wastewater to speed up the microorganisms and oxidizes the harmful organic 
matters. The aeration process reduces the organic matter and the waste stream flows into the 
secondary clarifier (secondary sedimentation) where the dispesed solids and flocs of bacteria 
(from activated sludge plant) or humus sludge (from trickling filter works) settles. The 
activated sludge is usually re-circulated back into the aeration basin to provide more bacterial 
population to aid degradation/decomposition of incoming matters. 
 Tertiary treatment consists of chemical disinfection of waste stream carried out by 
disinfectants, ozone, UV, or chlorine to kill the disease-causing organisms before the treated 
waste stream (effluents) finally leaves the sewage treatment works to a local stream or river 
(receiving waters). Typically, the final effluent is sufficiently clean to be discharged to the 
receiving river while the sludge (biosolids) is continuously being removed, stabilized, 
dewatered and utilized for agricultural applications [349]. 
 
 
Figure 15: Process flow diagram for a typical large-scale treatment plant [350] 
1.6. Sewage Treatment Works as transport routes of pollutants. 
Conventional sewage treatment works are the most significant routes through which the drugs enter 
the environment via untreated sewage and domestic sewage treatment systems. The ingested 
chemicals and associated metabolites are excreted via faeces and urine and passed onto sewage 
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treatment systems. Discharges from manufacturers, commercial, domestic and run-off areas of 
unwanted and unused chemicals to the domestic sewage system are other major sources. Sewage 
sludge is the remaining residues after sewage treatment and the treated sewage sludge has several 
valuable properties which are agriculturally relevant; these include soil building potential giving it a 
strong hold, availability of nutrients and valuable trace elements essential to animals and plants, an 
efficient and sustainable alternative source to inorganic fertilisers and mineral fertilisers such as 
phosphate, and soil nutrient recovery through slow release of nitrogen. 
Residues of pharmaceutical and illicit compounds have been found in surface waters in concentrations 
from ngL
-1
 to ugL
-1
 in many countries with the levels and distribution of these illegal compounds as 
found in wastewaters reported in Spain, Belgium, Italy, Germany, UK and USA [124, 131, 137, 141, 
243-249]. Apart from the active sludge processes, percolating filters, nitrification and de-nitrification 
facilities, investigations into the treatment technologies for the potential removal of drug residues and 
other organic compounds from the effluents of STWs have additionally identified ozonation [250-
252] and membrane bioreactors (MBR) [253, 254] as biological means to provide improved potential 
in removing trace pollutants from the urban wastewaters. Microbial degradation has been suggested as 
the most important removal process in the sewage treatment works and with the continuing extensive 
studies on the metabolism and transformation of pharmaceuticals and other organics in humans and 
mammals, the microbial biodegradation pathways of some these chemicals, the persistence of their 
products and likely toxicity would largely be known [255]. Figure 16 below illustrates a typical 
interplay of complex physical, biochemical and transformational routes of pollutants in STWs and 
each transport route depends on the nature of influents [255-261].  
 
Figure 16: Organic contaminant fate and distribution in the environment [291] 
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The microbial degradability of the illicit drugs in the sewage as well as their degradation pathways 
has not been reported. However, small studies on selected pharmaceuticals with the identification of 
some microbial degradates suggest that similar processes are likely to affect the illicit drugs [258-
260].  In 2009, the understanding of the STWs systems and the degradation processes involved were 
observed by Kasprzyk-Horden et al [261] on selected pharmaceuticals and illicit drugs (cocaine, 
benzoylecgonine and amphetamine) where the differences in the performance of activated sludge and 
trickling filter on a 5-month monitoring program was undertaken from two different STWs in South 
Wales, UK.  However, the choice of sampling points was just to verify the removal efficiency of the 
two contrasting STWs and the work recorded over 85% removal efficiency of most drugs with STW 
utilising activated sludge compare to less than 70% reported for trickling filter.  
However, for the first time, direct measurement of the illicit drug removal rates in laboratory (batch) 
studies would carried out to  improve upon the understanding of the degradation rates of cocaine 
(COC); benzoylecgonine (BZE); heroin (HER); 6- monoacetylmorphine (6-MAM); morphine (MOR) 
and diazepam (Diaz) under different conditions to obtain removal rates.  The capabilities of the 
current experimental batch data in generating removal rates of drugs would be applied in mass 
balance calculation to improve influent measurement. 
 Also, no publication to our knowledge has been found on the ecotoxicological impacts of chronic 
exposure of illicit drugs and their metabolites as the STWs procedures cannot effectively remove all 
the drugs or polar compounds due to their hydrophobic/lipophilic character [111]. Apart from 
volatilisation, hydrolysis (abiotic) and biodegradation (biological processes), physical-chemical 
adsorption of polar compounds onto the biosolids surfaces also occurs. The interaction of compounds 
with high adsorption coefficients in particular determines the extent of the removal. Natural solids like 
clay, sediment and micro-organisms and added solids (e.g. active carbon, coagulants) facilitate STWs 
removal processes [126]. Those adsorbed on solids and passed as sludge enter the environment when 
spread on agricultural lands as manure and the compounds continue in the ecosystems or are possibly 
leached into underground waters; while those with low adsorption coefficients are released as 
effluents into the receiving waters.  The removal of organic compounds is often incomplete in most 
municipal STWs, the sewage-sludge and effluent waters are therefore the primarily routes at which 
these chemicals enter the environment. Apart from the biodegradation, chemical degradation and 
sorption processes in typical STW details of which are not well understood because of the complex 
mixtures present are the other main removal processes during the wastewater treatment. The 
physicochemical properties of the contaminants ultimately determines their extent of persistence, 
toxicity and potential environmental effects after the sewage-sludge disposal to agricultural lands or 
effluents waters disposed of to seas.  
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The existing priority substance classifications by the European Communities Priority Substances 
Directive notwithstanding [262], the emerging priority contaminants groups like ‘illicit drugs and 
their metabolites’ have no safe-levels because of insufficient information on their biodegradability 
and persistence after their disposal to lands or receiving waters. Insufficient information, decisions 
and policy thrusts regarding the future practices of safe sewage-sludge disposal mean that complete 
removal of contaminants from STWs effluent-waters becomes difficult. 
Existence of uncontrolled discharges of different types of compounds from humans and from 
veterinary treatment into the environment via STWs is shown in the anticipated exposure in Figures 
17 and 18. Drugs for human treatment are primarily exposed to the environment from routes Fig 17 
(F1 & F2) and enter different treatment fate processes at points F3 & F4 and terminate at F8 and F9. 
 
Figure 17. Anticipated exposure routes of drugs for human treatment in the environment [120] 
The effects on terrestrial and aquatic organisms continue with drugs from veterinary treatment in Fig. 
18 (F10-F13) in another complete process of bio-chemical reactions and mechanisms with anticipated 
toxicity impacts on the ecosystems not yet understood. 
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Figure 18. Anticipated exposure routes of drugs for veterinary treatment in the environment [120]. 
 
 
1.7 Microbial degradation in the aquatic environment. 
Studies in the literature have confirmed the enrichment of the sewage sludge partitioning of chemicals 
onto sludge solids or suspended in solution is due to their hydrophilicity/lipophilicity properties 
compared to influent sewage [175-177]. Understanding of the fate and behaviour of pollutants during 
sewage treatment will show the degradation possibility of compounds that are completely or partially 
degraded in aqueous and solid phases, sorbed to sludge solids or mineralised. In a study reported by 
Strachan et al [178], organic contaminants are located within the fraction of large organic wastes 
(biomass) which are repository of living and dead micro-organisms required for degradation 
processes.  
Investigations on the levels of removal of organic residues from a wastewater plant studies have 
shown toxicity correlation of wastewater effluents on aquatic organisms to determine the response 
levels with degree of contamination [179-181]. Biodegradability studies of organic priority pollutants 
and reduction in toxicity of these pollutants in wastewaters treatment processes have also been carried 
out [182, 183]. Also evaluated were 22 priority pollutants belonging to the class of phthalates, 
pesticides, polycyclic aromatic hydrocarbons and phenols in an activated sludge pilot plant [111, 
182]. About 80-99% removal efficiency was recorded from the parallel and spiked treatments of 
between 50-150 µg L
-1
 concentrations. The results indicated a degradation of phenols, enrichment of 
PAHs to about 64% from the mass balance calculations while pentachlorophenol was associated with 
the solid phases. Table 5 presents percent sewage sludge disposal in the last 3 years, and the 
39 
 
subsequent transport of these residual organic pollutants in the sewage which enters the environment 
and becomes the issue of current concern. 
Table 5: Sewage sludge disposal in England, 2008-2011 [184] 
*EfW = Energy from waste 
Sewage is a complex association of wastes of human excreta containing mixtures of fats, sugars, 
lignin, protein, cellulose, humid materials, amino acids and fatty acids. Wang et al [185] studied the 
partitioning mechanism of the organic residues within the biomass and sorption onto the sludge 
surface as a two-stage process. Determination and prioritisation of typical sewage sludge can be a 
complex task because of many synthetic organic materials with various residues of diverse origins due 
to 1) interferences of co-contaminants in complex matrices, sample extraction and clean ups, sensitive 
techniques needed to determine low concentrations  2) the fate and behaviour of sludge-derived 
residues after disposals requires investigation to monitor persistence and environmental impacts and 
3) bio-transformation arising from degradation of residues generates toxic by-products, but 
unavailability of some compounds, sorped onto sewage solids to bacteria for degradation can be 
significant as little is known about the final fate of these organics [186-190]. Difficult isolation of 
sludge samples arises also from non-uniformity of extraction procedures and variability in obtaining 
grab samples as a representative of all various genotoxins in the sludge matrix [191-193]. Different 
processes or techniques are often adopted for specific effluents depending on the origins of the 
contaminants. Generally factors often considered, though contaminants can be lost during treatments 
in a complex variety of ways are: 1) sorption/association with sewage solid surfaces 2) abiotic 
processes/hydrolysis involving chemical degradation 3) volatilisation and 4) biodegradation [111].  
Humans are typically exposed to numerous organic and inorganic pollutants, as by-products from 
treatment of waste water from domestic, agricultural and industrial sources which constitutes sewage 
[194]. The presence of intestinal pathogenic bacteria and animal parasites in sewage sludge has been 
confirmed from several investigations [195,196]. However, sewage sludge may contain relatively 
large amounts of heavy metals as well as organic pollutants such as phthalates, polychlorinated 
biphenyls (PCBs), alkyphenols, and organoclorine pesticides compared to normal environmental 
levels in soil, water, and air [2]. Increasing amounts of sewage sludge are used for land filling and 
Mode of disposal %  Total disposed 
 2008/2009 2009/2010 2010/2011 Jan-Dec 2011 
Tonnes  % Tons % Tons % Tons % 
Land fill 
Incineration with EfW* 
Inicineration without EfW 
Recycled/Composted/Reused 
Other 
13784 
3325 
6 
10082 
198 
 50 
12 
0 
37 
1 
12490 
3610 
6 
10275 
255 
47 
14 
0 
39 
1 
11391 
3975 
5 
10588 
356 
43 
15 
0 
4 
1 
10135 
4577 
4 
10844 
404 
39 
18 
0 
42 
2 
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agricultural land including pastures grazed by ruminants following the ban on ocean dumping of 
sludge [197]. The potential health risk imposed due to the presence of organic and inorganic 
compounds found in sewage sludge is of concern in humans [198,199] if they are delivered at high 
enough doses to cause effects through the consumption of products derived from animals grazing on 
contaminated pastures [200]. Adverse effects which have been reported in humans include 
perturbation of male reproductive tract, certain male and female cancers, declined fertility, thyroid 
dysfunction and ill impacts on the central nervous system, gastroenteritis, damage to liver, kidneys 
and blood, hepatitis, occupational asthma, infection of skin or eyes and inflammation of the lung 
following sewage sludge exposure.  Different groups of environmental chemicals with a variety of 
mechanisms and disrupting activities have been identified and discussed [201-206]. 
In the literature, degradation studies of pharmaceuticals have identified degradates of anti-
inflammatory, analgesics and blood-lipid regulators. In batch studies of acetylsalicylic acid with 
suspended activated sludge, the decrease of about 70-99% in concentration after 6, 24 and 72 h was 
observed but no metabolites were detected using GCMS [89]. The degradation studies of anti-
inflammatory and blood-lipid regulators such as bezafibrate, diclofenac, naproxen and ketoprofen in 
activated sludge were carried out, but only ketopofen biotransformed into [3-(hydroxyl-carboxy-
methyl) hydratropic acid and [3-(keto-carboxyl- methyl) hydratropic acid [89]. Biodegradation of 
trimethoprim showed resistance to degradation in a reactor filled with activated sludge, but its 
degradation in a nitrification process was completed in 3 days. In a similar study, Ternes et al [89] 
investigated degradability of estrogens in aerobic batch reactors at two different concentrations using 
GCMS. The 17β-estradiol was oxidised to estrone without any detectable degradates. Also, 16α-
hydoxy-estrone was similarly degraded without degradation products. In a subsequent work, the 
biodegradation studies of trimethoprim, anti-tumorals cisplatin, cyclophosphamide, cytarabine, X-ray 
contrast agents, iopromide and diatrizoate has been carried out but not all the details of metabolites 
identification were reported [89]. 
Concerning the degradability of illicit drugs, apart from sample degradation, biodegradation is a 
natural process that has been reported by the stability experiment conducted by Georghe et al [132] 
and which observed that the concentration of cocaine and ecgonine methylester changed in surface 
water by 40 and 95% after 5 and 24 h test period respectively. However, benzoylecgonine   level was 
constant or increased in the study. Photodegradation is another abiotic process involving complex 
reactions and pathways that could affect the aquatic fate of compounds, particularly when degradates 
are resistance to hydrolytic processes [207].  Four relatively new metabolites of cocaine: ecgonidine, 
norecgonidine methylester, p- hydroxyl-benzoylecgonine, and m- hydroxyl-benzoylecgonine [208], 
and two conjugates of metamphetamines: p-hydroxy-metamphetamine (p-OHMA-sulfate), (p-
OHMA-Sul) and (p-OHMA) (p-OHMA-glucuronide) [207] have been identified in human urine. 
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The identification of this phase-II degradates and other metabolites in urine indicate likelihood of 
their presence in wastewater samples, unless they are further degraded in the sewage treatment works.   
In a study, Pizzolato et al [168] observed the 40-80% degradation of cocaine and its metabolites in 
river waters under sunlight and pseudo-sunlight after 11 days of exposures as compared to HPLC 
grade water. Degradation was about 80% faster in river water as cocaine degraded to benzoylecgonine 
confirming the effects of both biodegradation and photodegradation.  
Identification of microbial metabolites of ibuprofen has been found to be identical with the compound 
human metabolites [234,235]. During wastewater treatment, apart from the sorption behaviour of 
potential organic contaminants to the sludge solids, the removal of organic residues and associated 
metabolites are through microbial degradation as earlier reported  as part of the removal mechanism 
of some pharmaceuticals and endocrine disrupting compounds (EDCs) in the sludge [80-83]. 
Hydrolysis (abiotic process) is the most important mechanism in the chemical degradation 
pathways through which compounds are removed [236]. The enrichment of the sewage sludge 
partitioning of chemicals onto sludge solids or suspended in solution is due to their 
hydrophilicity/lipophilicity properties compared to influent sewage [175-177]. 
Table 6 summarises the drugs and their metabolites identified from both human biological fluids and 
aquatic environments.  
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Table 6: Illicit drug metabolites of human origin detected in the environment* 
Compound    Human metabolites identified   in biological fluids    
[214-233]                                                                                                                           
Human metabolites 
identified in the
aquatic environment   
[116, 131, 134, 136, 
139, 142, 208-212]                    
Amphetamine 
 
Amphetamine (AM)                                             
3, 4-methylenedioxyamphetamine (MDA) 
Methylenedioxymethamphetamine (MDMA) 
Methylenedioxyethylamphetamin (MDEA) 
Methylbenzodioxolylbutanamine (MBDB) 
Metamphetamine (MA) 
p-hydroxy-metamphetamine  (p-OHMA) 
p-OHMA-glucuronide (p-OHMA-Glu) 
p-OHMA-sulfate (p-OHMA-Sul) 
Detected 
Detected 
Detected 
Detected 
Detected 
Detected 
- 
- 
- 
   
Cocaine 
 
Cocaine (Cocaine) 
Benzoylecgonine (BE) 
Ecgonine methyl ester (EME) 
Cocaethylene (CE) 
Norcocaie (Nor- COC)                           
Ecgonidine 
nor-ecgonidine 
nor- ergonine methylester 
m-OH-benzoylegonine 
ecgonine 
ecgonidine methylester 
Detected 
Detected 
Detected 
Detected 
Detected 
- 
- 
- 
- 
- 
- 
   
Opiates 
 
Heroin 
Morphine 
Nor-morphine 
6-monoacetylmorphine (6-ACM) 
Morphine -3- glucuronide (M3G) 
Methadone 
2-ethylene-1,5-dimethyl 1-3,3-diphenylpyrolidene (EDDP) 
Ethyl morphine 
Detected 
Detected 
Detected 
Detected 
Detected 
Detected 
Detected 
- 
   
LSD 
 
Lysergicdiethylamide (LSD) 
Hydroxyl Lysergicdiethylamide (OH-LSD) 
Nor - Lysergicdiethylamide (Nor-LSD)                                                                             
Iso - Lysergicdiethylamide (Iso-LSD) 
2-oxo-3-hydroxy-LSD (2-Oxo-3-OH-LSD) 
Detected 
Detected 
Detected
Detected 
- 
   
Cannabinoids 
 
Δ9-tetrahydrocannabinol (THC) 
Δ9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) 
THC-COOH- glucuronide (THC-COO gluc.) 
Hydroxyl -THC- conjugate (OH-THC) 
Detected 
Detected 
Detected 
Detected 
* No identified microbial degradates in the literature 
Appreciation of the degradation possibility of compounds whether they be completely or partially 
degraded in aqueous and solid phases, sorbed to sludge solids or mineralised is an important step in 
understanding the fate and behaviour of pollutants during sewage treatment. Within the large organic 
wastes in sewage is biomass of living and dead micro-organisms required for degradation processes 
within which some fractions of organic contaminants could be found. Sequential biological processes 
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in alternating oxidative and reductive conditions for recalcitrant organic compounds plays a major 
role in removal mechanism [111, 178, 237]. 
In the degradation studies of alkylphenol polyethoxylate (APEO) surfactants, the recalcitrant and 
estrogenically active alkylphenols (APs) were produced from commercial NPEO using synthetic 
activated sludge in batch tests. The levels and distribution of the short chain compounds after NPEOs 
degradation confirmed in many ways these routes by which pollutants are discharged to the aquatic 
environment due to incomplete removal from treatment processes [238]. In activated sludge, viable 
and diverse bacterial population is maintained when the biological sludge is re-cycled from settling 
tank back to the aeration tank to produce high quality effluent, reduced biomass, maximised 
conversion of substrate and less production of waste sludge The oxidation of organic matter in an 
biological aerobic process generates carbon dioxide and water with the new but reduced biomass and 
dissolved residual organic matter in the effluent [236]. In related studies, Richardson and Bowron [93] 
assessed the biodegradability of some specific chemicals as presented in Table 7, but yet to be 
investigated are the degradation processes as well as the extent of transformations in producing 
different chemical metabolites [111]. Pathways of microbial degradation of selected acidic 
pharmaceuticals and their occurrence in municipal wastewater treated by a membrane bioreactor have 
been reported [239]. To further understand the behaviour of compounds in sewage plants, studies of 
metabolites from the biodegradation of pharmaceutical residual of ibuprofen in biofilm reactor also 
confirmed the effects of biodegradations [234] 
Table 7: Assessment of the biodegradability of pharmaceutical chemicals [93, 111] 
Compound Test result 
Amitriptyline 
Ampicillin 
Aspirin 
Caffeine 
Chlorhexidine 
Clofibrate 
Codeine phosphate 
Dextropropoxyphene 
Ephedrine 
Erythromycin 
Ibuprofen 
Menthol 
Meprobamate 
Methyldopa 
Metronidazole 
Naproxen 
Paracetamol 
Phenylpropanolamine 
Sulphamethoxazole 
Sulphasalazine 
Tetracycline 
Theobromine 
Theophylline 
Tolbutamide 
Non-biodegradable 
Biodegradable 
Readily biodegradable 
Readily biodegradable 
Non-biodegradable 
Non-biodegradable 
Non-biodegradable 
Non-biodegradable 
Readily biodegradable 
Non-biodegradable 
Biodegradable 
Readily biodegradable 
Non-biodegradable 
Non-biodegradable 
Non-biodegradable 
Non-biodegradable 
Readily biodegradable 
Readily biodegradable 
Non-biodegradable 
Non-biodegradable 
Non-biodegradable 
Readily biodegradable 
Readily biodegradable 
Non-biodegradable 
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Elimination of selected acidic pharmaceuticals from municipal wastewater using activated sludge 
systems and membrane bioreactors [240], modelling versus measurement experiment of effluent from 
hospitals and private households to the total loads of diclofenac and carbamazepine in municipal 
sewage effluent [241] and identification of microbial degradation of trimethoprim in nitrifying 
activated sludge batch studies have been reported in the literature.  
1.8. Stability of drugs and metabolites. 
The stability of drugs and their metabolites in the aqueous environment depends on some conditions 
of temperature and pH to minimise degradation of analytes. Studies recommended the acidification of 
samples to pH 2 and - 20
o 
C for storage in a stability study of cocaine and its metabolites (e.g. 
benzoylecgonine and ecgoninemethylester) where a pond free of drugs was spiked with different 
concentration of cocaine and benzoylecgonine at modified pH values of 2 and 6 and temperatures (-
20
o
C, +4
o
C and +20
o
C) for 5day stability tests. The 22% degradation of cocaine after 3 days and 35% 
after 5 days at pH 6 and +4
o
C were observed. Also, ca.75% degradation was observed at +20
o
C at pH 
> 6 for 1 day [131]. Using different preservation conditions, some decreases in the concentration of 
cocaine (36%), cocaethylene (13%), nor-cocaethylene (15%) and M3G (96%) and changes led to  
corresponding changes in the levels of  metabolites (BZE, nor-BZE and MOR) respectively with 
the optimal conditions for storage similar to that observed for Cocaine, BZE and EME [132]. Similar 
works have also shown preserved samples at -20
o
C with addition of HCl (pH 2) stopping bacterial 
action. Cocaine stability in wastewater at 4
o
 C for 48 hours was investigated but no changes were 
observed. Storage experiments with methanolic extracts for 7 days at different temperatures observed 
degradation of up to 15% with extracts stored at +4
o
C but no changes with those stored at -20
o
C [134, 
137, 242]. Stability of other drugs of abuse like heroin, amphetamines-like substances and lysergic 
acid and their metabolites were not found in the literature. 
1.9. Analytical Methodologies 
In recent years, important advances in the development of chromatographic and mass spectrometric 
methods have been made, particularly in the detection and quantitative measurement of illicit drugs 
and their metabolites in various biological and aquatic matrices. The techniques based on liquid 
chromatography- mass spectrometry (LC-MS) or liquid chromatography tandem mass spectrometry 
(LC-MS
2
) and gas chromatography-mass spectrometry (GC-MS) or gas chromatography tandem mass 
spectrometry (GC-MS
2
) are very popular primarily because of their ability to detect and measure 
chemical substances at very low concentration. In addition to analytical methods for tracing 
pharmaceuticals residues in water and wastewaters that have been extensively used [93, 97-101], 
other analytical   procedures for quick screening of drugs residue in aqueous environments including 
several inexpensive immunochemical approaches, as an alternative method to the chromatographic 
techniques for the efficient analysis of pharmaceuticals have also been published [96]. 
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1.9.1 Chromatographic techniques  
Table 8 shows the survey of chromatographic techniques from peer-reviewed literature in the 
determination of illicit drugs and human metabolites in waters. The review covers the extraction 
volumes, mobile phases, detectors (interfaces) and acquisition modes used by different scientists to 
provide sensitivity and selectivity. Also included are limits of quantifications depending on matrices 
for quantification and confirmation of drugs. The HPLC separation procedures rely on the principles 
of reversed-phase columns with different solvent gradients depending on applications [142,210]. 
Recently, variations over conventional LC-MS method have appeared in the literature eg. Ultra-
performance liquid chromatography (UPLC-ESI-MS/MS), the ultra-fast UPLC-MS
2
 is unique for its 
short columns packed with small particles sizes and stability at different pH range [135, 266 -268]. 
With the development of this relatively new technology, a shorter analysis time as well as gain in 
separation efficiency, resolution and sensitivity has been reported. To minimised the effects of ion 
suppression on the analytical signal, a relatively new HILIC; Hydrophilic interaction chromatography 
technique was also carried out in some experiments. Analytes were better retained on HILIC column, 
unaffected by ion suppression and a reduction in analytical signal was minimised [132,131].  
The use of MS/MS with triple quadrupole (QqQ) analyzers with electrospray ionization (ESI
+
) were 
mostly used in selected reaction monitoring mode (SRM) to minimize the matrix interferences. The 
choices of ionization in ESI positive-ion mode were to have achieved ionizations and simultaneous 
determinations of analytes.  
The HPLC-MS methods are also used in the analysis of illicit substances in the literature [208,214]. 
Both HPLC and GC-MS have been applied in the determination of pharmaceuticals in different 
matrices of biological fluids [271-274] especially urine [275-277], oral fluid [214, 215], and blood 
[216] samples. The advantage of HPLC-MS in the determination of the main illicit drug classes 
including cocaine, amphetamines, opiates and synthetic opiods, cannabinoids and their metabolites is 
due to its no hydrolysis, no derivatization, one- step extraction and with the introduction of 
atmospheric pressure ionisation (API) interfaces, the technique has been popular [277]. HPLC is a 
good and popular technique for highly polar, high molecular weight and thermolabile compounds.  Its 
reproducibility, sensitivity and overall lower costs have therefore made it a convenient method. The 
use of GCMS is very rapid, faster and highly specific with in-built NIST library softwares for 
compound identification and elimination of matrix effects. 
Principle of the choice of method (SPE-GC-MS):  The trace analysis in wastewater can be captured as 
simple liquid chromatographic process where the SPE sorbent acts as the stationary phase and water 
constitutes the mobile phase during the extraction. During the percolation step, analytes that are 
trapped and cannot elute constitute the sample matrix. The enrichment of analytes from a large 
volume of aqueous sample on sorbent depends on how strongly the analytes are retained while 
allowing low retention during elution with organic solvents. 
Table 8    Chromatographic (LC-MS/MS) methods for the determination of illicit drugs and human metabolites in water (2000-2011) 
 
 
Analytes             Matrix         Sample Preparation                                             LC                                                                    MS                     Method                Ref.     
                                                ______________________________________  ____________________________________    _____________(LOD/LOQ)  
                                                   Volume            Extraction          Method           C’graphic          Mobile            Detector            Acq. 
                                                   (mL)                                            Recovery (%)  Column             Phase        (Interface)        Mode                (ng L
-1
)  
3 Cocaine: 
(CO, BE,  
EME)                                                                                                                         
WW 
 SW 
100 SPE (Oasis, 
HLB, 500 
mg)
73-96               Zorbax 
Extended 
C18(2.1mm x 
50mm x 
3.5µm) 
HILIC: Rx-
SIL (2.1 x 
150mm,5µm)       
250 µL/min. 
A:H2O/AcN 
(92:2),10mM 
NH4HCO2. 
(pH 3). B: 
ACN. 
ITMS 
(ESI
+
) 
MRM     2-4WW      
    20
SW
         
[132]
 
 
 
           
1Cocaine 
1 Opoiod.    
1Cannabiniod 
3 ALC.                           
WW - SPE (Oasis, 
MCX, 
200mg) 
- HPLC: 
XTerraMS C18 
(100mm x 
2.1mm,3.5µm) 
250 µL/min.  
A: 0.1%  in 
H2O. B: AcN                                                                                                                              
QqQ  
(ESI
+
) 
SRM - [269] 
           
5 Cocaine 
4 ALCs  
3 Opiods   
1Cannabiniod                                      
SW 250 mL      SPE (Oasis, 
MCX,60mg)        
96-105 
97 10 
85-90 
69-84 
HPLC: 
XTerraMS 
C18(100mm x 
2.1mm,3.5µm) 
250 µL/min.   
A: 0.1%  in 
H2O. B: AcN                                                                                                                            
QqQ 
(ESI
+
) 
SRM 0.02-0.05     
0.01-0.35 
0.02-0.28 
0.14-0.36 
[131] 
           
2 Cocaine SW 
WW 
100 mL 
500 mL 
SPE (Oasis, 
HLB, 500 
mg)                          
- HILIC: 
Zorbax Rx-
SIL (2.1 x 
150mm, 5µm)          
- ITMS 
(ESI
+
) 
MRM ≤ 20             [131] 
           
2 Cocaine SW 500 mL SPE (Oasis, 
MCX, 
60mg) 
90 HPLC: A 
Luna  C18   
(50mm x 2mm 
i.d, 3 µm)                                                                                     
250 µL/min 
A: 0.1%  in 
H2O. B: AcN                                                                                                                
- MRM - [124] 
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Analytes             Matrix       Sample Preparation                                             LC                                                                    MS                          Method                 Ref.     
                                                ______________________________________  ____________________________________    ______________  (LOD/LOQ) 
                                                     Volume          Extraction        Method            Chromatographic Mobile       Detector          Acq. 
                                    (mL)                                          Recovery (%)   Column  Phase       (Interface)       Mode                   (ng L
-1
)     
3 Cocaine 
1ALC 
3 Opiods 
1LSD 
                                                                         
WW 500 mL    SPE (Strata- 
XC, 200mg) 
50-65 HPLC: 
Phenomenex 
Onyx C18  
(200 x 3.0mm                                       
   36-120            [134] 
5 ALCs   
5 Cocaine 
5 Opiods   
1Cannabiniod                                                                                                                                                                                                                                    
WW 50 mL       SPE (Oasis, 
MCX, 
60mg)     
50-105 HPLC: 
XTerraMS 
C18(100mm x 
2.1mm, 
3.5µm)     
250 µL/min 
A:CH3COOH/ 
H2O. B: AcN 
A2: 0.05% 
TEA/ H2O  
QqQ (ESI
+
) MRM 300 
pg/L
wwinf    
1 ng/L 
wweff 
[209] 
           
2 Cocaine SW 
WW 
100 mL   
500 mL        
SPE (Oasis, 
HLB, 500 
mg)                                 
- Zorbax Rx-
SIL (2.1 x 
150mm, 5µm)                                                                                  
- ITMS MRM 
(ESI
+
) 
20 [270] 
           
1 ALC WW 250 mL      SPE (Oasis,  
HLB, 200 
mg)                            
36-49                  HPLC:Varian 
Pursuit XRs 
C18 (100mm x 
2.0mm, 3µm)              
A:water/0.5%  
HCOOH                                                
B: 82% 
CH3OH/ 18% 
AcN/0.5% 
HCOOH                                        
- Scan    
(CID) 
0.25-5.0           [142] 
           
5 ALCs    
2 Cocaine.   
1LSD 
1Opiod                                                     
WW 100 mL SPE (Oasis 
HLB, 200 
mg)                            
70-110           UPLC:Acquity 
BEH C18    
(100mm x 
2.1mm, 1.7 
µm)            
A: AcN/0.1% 
HCOOH. B: 
30mM 
HCOOH/ 
NH4HCO2                                                
QqQ (ESI
+
) - 5 - 850        [138] 
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Table 8   LC-MS/MS methods for the determination of illicit drugs and human metabolites in water (2000-2011) 
Analytes               Matrix       Sample Preparation                                             LC                                                                    MS                         Method              Ref.     
                                                ______________________________________  ____________________________________    _______________(LOD/LOQ) 
                                                     Volume          Extraction        Method            Chromatographic Mobile       Detector          Acq. 
                                    (mL)                                         Recovery (%) Column                 Phase       (Interface)       Mode                 (ng L
-1
) 
1 ALC 
2 Cocaine.                                            
SW 100 mL    SPE (Oasis,  
MCX,60mg)                                          
65-106                 UPLC: 
Acquity 
BEH C18 
(1.7µm, 1 
mm x  
100mm)                                                 
A:94.5% 
H2O. 5% 
MeOH, 5% 
CH3COOH 
(pH 2.8)  
B:99.5%
MeOH +  
0.5% Acetic                         
QqQ (ESI
+
) MRM 0.3-50              [266] 
           
8 Opiods   
2Cannabiniod    
SW  
WW 
200 mL    SPE (Oasis, 
HLB, 200 mg)                                   
40-70 UPLC: 
Acquity 
BEH C18 
(1.7µm, 1 x   
100mm)                                                                                                                                                                  
A: MeOH 
B: 5 mM 
NH4HCO2 
QqQ (ESI
+
) SRM 0.1-25 [135] 
           
8 Opiods   
2 Cannabiniod    
SW 
WW 
50 mL       SPE (Oasis,  
MCX,(150mg)           
69-94% UPLC: 
Acquity 
BEH C18 
(1.7µm, 2. 1 
mm x50mm)                                                       
A: MeOH  
B: 5 mM 
NH4HCO2  + 
1% formic 
acid         
QqQ (ESI
+
)                                                                                                                        SRM - [142]
           
Acq. Mode - Acquisition mode- SRM, Selected reaction monitoring; CID, Collision-induced dissociation. 
Detector and Interface used – QqQ, Triple quadrupole; ITMS, Ion Trap mass spectrometry, ESI, Electrospray ionization. 
MeOH – Methanol; TEA, Triethylamine; NH4HCO2, Ammonium acetate; AcN, Acetonitrile, H2O, Water.                 
WW, Wastewater;  SW, Surface water; WW
inff
, Waste water influent;  WW
eff
, Waste water effluent.  
RPLC, Reversed-phase liquid chromatography; UPLC, Ultra- performance liquid chromatography; HILIC, Hydrophilic interaction chromatography. 
 
The method of coupling of SPE to GC-MS can be directly integrated as an online analytical system or 
off-line where subsequent chromatographic analysis is completely separated from the sample 
treatment. As long as the compounds are sufficiently thermally stable and volatile enough, gas 
chromatography (GC) allows a broad variety of samples to be analysed. As for all other 
chromatographic techniques, a mobile (carrier gas e.g. helium, argon, nitrogen, etc. ) and a stationary 
phase (packed column or solid support coated with the liquid stationary phase of high boiling polymer 
e.g capillary columns of a small-diameter tube like 0.25 mm film in a 0.32 mm tube) are required . 
Different compounds are separated due to the interaction of the compound with the stationary phase 
(“like-dissolves-like”-rule). The stronger the interaction is,  the longer the compound remains attached 
to the stationary phase, and the more time it takes to go through the column (longer retention time). 
GC-MS is a good combination of coupled analytical systems as GC separates the compounds then MS 
identifies them based on their fragmentation pattern. 
1.9.2. Solid Phase Extraction (pre-concentration). 
 
Table 9 shows the multi-step extraction procedures of different protocols which have been reported in 
the peer-reviewed literature, to eliminate the influence of matrices [124,137]. Apart from matrix 
effect, improved recovery, stability under pH and ability of delivering clean extracts have resulted 
into various tests of several SPE adsorbent to determine suitable parameters relevant to a particular 
application need. Several SPE methods and adsorbents have been developed and used in conjunction 
with LC-MS
2
 or GC-MS
2
 in the determination of illicit drugs and their metabolites in aquatic media at 
very low concentrations (ng L
-1
 levels). Recently, Oasis MCX
®
 (500mg/6mL) adsorbent, a polymeric 
sorbent with mixed–reversed/strong cation-exchange sulfonic acid group located on the surface of a 
(divinylbenzene-co-N-vinyl pyrrolidone) has been used [266, 269] to extract drug analytes from 
aqueous samples. After the samples were adjusted to pH 2 with 37% HCl or 0.01NHCl, the cartridge 
was pre-conditioned with 6ml of MeOH, 3mL of milli-Q water and 3mL water at pH 2. Samples were 
loaded into the cartridges at flow rate between 5-20mL min
-1
, vacuum-dried for 5min and eluted with 
6mL of MeOH and 6ml of 5% NH3 in MeOH. The cartridges were found to be stable perhaps because 
of its two phases that were assumed could retain all compounds investigated. In related development 
Wylie et al [214] and Miltona et al [275] have used Bond Elut Certify
®
,
 
a lipophilic and strongly 
cationic- adsorbent with similar conditioning and washing steps as used with Oasis MCX
®
 adsorbent, 
the only difference was 2 x 4 mL of 80:20 DCM/isopropanol mixtures with 2% NH3 in elution step.  
Traditional SPE materials such as the modified silica’s e.g. C8, (octyl), C18 (octadecyl) or CN 
(cyanopropyl) materials have low pH range, poor selectivity and residual silanol group which often 
leads to low recoveries in aqueous sample [82,90].                                                                                                                                       
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Table 9.   Solid Phase Extraction (SPE) protocols in wastewater pre-treatment
Protocols 
Types    Sorbent 
materials              
Conditioning Washing Elution    Ref 
 
Isolute, pH
®   
(1000 mg/6 mL)                
                                  
 
Silical treated 
with phenyl 
groups in which 
silanol group are 
end-capped.                                                    
 
2 mL of MeOH 
and 6 mL  of 
milli-Q water, 
sample  loading 
at (pH 6)        
 
6mL of 5% 
MeOH  in 
water, drying 
in  in vacuum 
for 15 min                    
 
2 x 4 mL of 5% NH3 
in acetone              
 
[132] 
      
Oasis, MCX® 
(500 mg/6 mL )                  
Polymeric 
sorbent with 
strong  cation –
exchange 
sulfonic group 
located on 
surface of 
poly(Divinyl 
benzene-Co-N-
vinyl py 
rrolidone) 
copolymer .                                                                                                                                                          
6 mL of MeOH , 
3mL of   milli-Q 
water and 3 mL 
of water at pH 2, 
sample load- ing 
at pH 2.                                                                                                              
3 mLof milli-
Q water  at pH 
2, dryingfor 15  
min. under 
vacuum       
6 mL of MeOH   
and 6 mL of 5% 
NH3  in MeOH                                                  
[137,266, 
124,269, 
133] 
      
Bond Elut 
Certify
®   
(300mg/6 mL)                             
Lipophilic and 
strongly cationic  
properties                                          
3 mL of MeOH 
and 3 ml  of 
milli-Q water, 
sample  Loading 
at pH 6.                                   
2 mL of of 
milli-Q H2O at 
at pH 2, and 3 
mL of  MeOH, 
drying for 15 
min under 
vacuum                              
2 x 4 mL of  80:   20 
DCM/isopropanol 
mixture with 2% 
NH3         
[214,215] 
      
SCX
®  
(500 mg/6 
mL)           
- 2 mL of MeOH, 
I mL of   milli-Q 
water and 1 mL 
of 0.25 M 
phosphate   
buffer (pH 3), 
loading at pH 3                                                          
I mL of 0.25 
M phosphate 
(pH 3), 0.5 mL 
of  0.1M acetic 
acid and  1 mL 
of MeOH, 
drying for 30 
min             
1.5 mL of 3%  
NH4OH in 1.5 mL 
of  MeOH                 
[135] 
      
Phenomenex 
Strata-X™   (200 
mg/6 mL)                                                                                
- 2 x 6 mL of 
MeOH and   2 x 
6 mL of H2O,
sample loading 
at pH 6.                                    
50 mL of 10% 
MeOH in 100 
mM formic 
acid + 500 µL 
of acetic acid, 
drying for 30                                      
10 mL of 5% v/v 
NH4OH in 1:1 
acetone: ethyl 
acetate                                
[134]           
      
Strata-XC™ 
(200mg/6mL)          
-        -same-                                                                              -same- -same-              [134] 
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Table 9  Solid Phase Extraction (SPE) protocols in wastewater pre-treatment (contd) 
 
 
Protocols 
Types    Sorbent materials                            Conditioning Washing Elution    Ref 
Chrolut, ENV
®
 
(500 mg/6 mL)                               
Hyper-crosslinked 
polystyrene-divinyl 
benzene polymer 
based.                                                                        
3 mL of MeOH 
and 3 mL    of 
milli-Q water, 
sample loading. 
                
air through the 
column for 1 
hr.      
5 mL of 
MeOH                         
[82] 
Isolute, ENV
®
 
(500 
 mg/6 mL)                                 
Hydrophobic sorbent 
with  hydroxylated 
polystyrene  divinyl 
benzene copolymer                                               
2 mL of MeOH 
and 6 mL  of 
milli-Q water, 
sample  loading 
at pH 6                                         
6 mL of 5% 
MeOH   in 
water, drying 
under vacuum 
for 15 min.           
2 x 4 mL of  
MeOH.                           
[132] 
      
Chromabond, 
Easy (500 mg/6 
mL)                
 
         
Bifunctional 
polystyrene   divinyl 
benzene copolymer                                  
5 mL of hexane, 
5 mL of ethyl 
acetate, 10 mL of 
MeOH and 1 mL 
of  Milli- Q 
water.                
5 mL of milli-
Q water   
drying under 
vacuum for 15 
min.         
2 x 4 mL of  
MeOH                           
[132,270] 
      
Oasis, HLB
® 
 
(500  
mg/6 mL)                            
Divinylbenzene/N-
vinyl    pyrrolidone) 
copolymer   with 
hydrophilic/lipo 
philic properties                                                  
3 mL of  MeOH 
and 3 mL   of 
milli-Q water, 
sample  loading 
at pH 6               
3 mL of 5% 
MeOH  in 
milli-Q water  
drying under 
vacuum for 15 
min                          
2 x 4 mL of  
MeOH                          
[132, 278]   
      
Oasis, HLB
® 
 
(500 
 mg/6 mL)                                
-same-                                                5 mL of hexane, 
5 mL of   ethyl 
acetate, 10 mL of   
MeOH and 1 mL 
of  Milli-Q water                     
5 mL of milli-
Q water drying 
under vacuum      
for 15 min.       
2 x 4 mL of  
MeOH                        
[83,278] 
 
      
Isolute ,C18 (EC)
® 
(500 mg/6 mL)                              
Strongly apolar and 
lipo- philic based on 
octadecyl   silica with 
end capping of   free 
silanol group.                                                                                                         
2 mL of MeOH 
and 6 mL of  
milli-Q water, 
sample   loading 
at pH 6
6 mL of 5% 
MeOH  in 
milli-Q water 
drying under 
vacuum for 15
min.                             
2 x 4 mL of  
5% NH3 in  
acetone                          
[132,279] 
      
Oasis, Max (60 
mg)                                                   
Strong anion-
exchange mixed 
mode polymeric           
2 mL of MeOH 
and 2 mL  of 2% 
HCOOH (pH 2.1)               
2 mL of 2% 
HCOOH/   
H2O, wrapped 
in aluminium          
1 mL of 
MeOH and 2 
mL of  5%  
NH4OH in 
MeOH.                    
[266] 
52 
 
Table 9:  Solid Phase Extraction (SPE) protocols in wastewater pre-treatment (contd) 
 
Bones et al [94] investigated the use of three sorbents: Phenomenex Strata- X™, Strata- XC™ and 
Strata- XCW™, all in 200mg sorbent mass pre-packed in to 6mL cartridges, but Strata- XC™ 
provided the highest analyte recovery. In other experiments, the Oasis HLB
®
 (500mg/6 mL) adsorbent 
[278], MCX
®
 (500mg/6mL) [137], Isolute ENV+
® 
(500mg/6 mL) and Isolute PH
®
 (1000mg/6 mL) 
adsorbents  [136], and Bond Elut Certify
®
 adsorbent [214] were compared with other adsorbents by 
Gheorge et al [132] in the extraction of cocaine and its metabolites in waste and surface water and the 
authors recommended the use of Oasis HLB
®
 (500mg/6 mL, protocol 1) as most suitable adsorbent 
for organic compounds because of its lower solvent  usage, time, stability to pH range and over 75% 
recovery for most analytes in aquatic medium.  
 
 
 
 
 
Protocols 
Types    Sorbent materials                            Conditioning Washing Elution    Ref 
 sorbent built  upon 
HLB copolymer  
(application: 
acids)                                                                                   
 foil and stored 
in a freezer until 
eluted.       
  
      
Oasis, WCX (60 
mg)                                                 
Weak cation-
exchange mixed 
mode polymeric 
sorbent built upon 
HLB copolymer 
(application: 
strong bases). 
         
2 mL of MeOH 
and 2 mL  of 2%  
HCOOH (pH 2.1)                                    
-same-                                    1 mL of MeOH 
and 2 mL of  
5%  NH4OH in 
MeOH 
[266] 
Oasis, WAX  (60 
mg)                                              
Weak anion- 
exchange mixed 
mode polymeric 
sorbent built upon 
HLB copolymer 
(application: 
strong acids). 
       
-same-                                    -same-                                    -same-                                    [266]
Chromabond, C18  
(200 mg).                                       
Silical-based, 
endcapped sor-
bent (non-polar 
compounds).                
-same-                                    -same-                                    -same-                                 [266]
      
Isolute, HCX (200 
mg)     
Weak anion- 
exchange mixed 
mode (non-polar 
and basic analyte). 
-same-                                 -same-                                 -same-                                 [266]
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1.10. PhD Research Objectives: 
To date, there is paucity of information,  to our knowledge in the literature on the fate and behaviour 
of illcit drugs in the aquatic environment. Also not very clear was the use of simple mass balance 
calculations to assess degradation pattern and the removal rate of the compounds from municipal 
STW as outlined in the following research objectives. 
 To determine trace drugs analysis in environmental media and quantification using GCMS 
technique. 
• To analyse actual influents wastewater, effluents and sludge from sewage treatment works 
(STWs) to assess licits and illicit drugs content. 
            
• Use of sewage sludge in batch studies to investigate degradation of selected drug materials in 
such media. 
 
• Use of mass balance calculations to assess drugs mass-flow, their removal rates and estimate 
influents from effluent concentrations using the batch studies data. 
 
1.11. Criteria for selection of compounds used in sewage batch tests 
 
The literature search showed that many classes of illicit drugs exist and survive in the environment 
like other pharmaceutical/medicinal drugs, but while many of these drugs break down rapidly, others 
show some degree of resistance to degradation in the environment [275, 281].  
In this current study, simple and systemic random samplings of wastewaters on different days showed 
the presence of 13 different compounds: cocaine, benzoylecgonine, codeine, diazepam, morphine, 
ephedrine, lidocaine, diacetylmorphine, ibuprofen, procaine, amphetamine, ecgonine methylester and 
bromacil (herbicide) as detected at the river outflow of Stoke Bardolph STW, Nottingham. The 
concentrations of these drugs were analysed in wastewaters at ng L
-1
 to µg L
-1
 levels. Of these 
compounds; 6 compounds selected for experimental batch studies were: cocaine and its metabolite 
benzoylecgonine; heroin and its metabolites 6-monoacetylmorphine and morphine and diazepam 
representing two classes of illicit drugs and abused pharmaceutical based on their presence in Stoke 
Bardolph STW’s effluent which allowed some presence of residues in detectable concentration (Table 
10). Moreover, examination of the literature indicates either there is no work, or no UK research was 
found on the degradation studies of these drugs having been carried out.  But continuous exposure of 
these chemicals to the aquatic environment may have only imperceptible consequences to aquatic 
environment [101].   
The selection of these 6 compounds for experimental batch studies therefore aims to make available 
exposure data for the aquatic realm on the behaviour of selected compounds within the UK sewage 
works. 
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Table 10: Data of illicit compounds and a pharmaceutical used in batch studies [134]. 
Class of drugs Compounds Log Kow Structures 
Cocaine Cocaine 2.3 
 
 Benzoylecgonine 1.3 
 
Opiates Heroin 1.7 
 
 6-monoacetylmorphine 1.6 
 
 Morphine 0.9 
 
Benzodiazepine Diazepam 2.9 
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CHAPTER 2:  Materials and Methods 
2.1. Experimental preparation 
 A simple experiment to simulate conditions in actual STWs was designed to use raw sewage in batch 
studies to provide natural bacterial species and population that can allow continuous degradation of 
metabolites slowly and naturally in contrast to utilising synthetic activated sludges. Three hours 
duration for the degradation studies was chosen as this permitted an intensive subsampling and 
processing allowing data-intensive assessments for an anticipated fast (min hr
-1
) degradation rate. 13 
different compounds, including cocaine, benzoylecgonine, codeine, diazepam, morphine, ephedrine, 
lidocaine, diacetylmorphine, ibuprofen, procaine, amphetamine, ecgonine methylester and bromacil 
(herbicide) as detected in random wastewater samplings from Nottingham STW effluents. But only 6 
compounds were used in spiking (batch) studies and these are cocaine and its metabolite 
benzoylecgonine; heroin and its metabolites 6-monoacetylmorphine and morphine and diazepam as 
shown below in Table 10. 
2.2. Chemicals and materials 
 
Standard compounds of cocaine, benzoylecgonine, heroin, 6-acetylmorphine, morphine, diazepam, 
ephedrine, lidocaine, codeine, ibuprofen, procaine, amphetamine, ecgonine methylester, cocaethylene, 
nordazepam, caffeine, nicotine and bromacil (herbicide) were purchased under license from both 
Sigma Aldrich (Gillingham Dorset, UK) and LGC standards (Teddington Middlesex, UK). Analar 
grade hydrochloric acid (HCl), ammonium hydroxide (NH4OH) and methanol (MeOH) used for pH 
adjustment and sample preparations were obtained from Aldrich. A derivatizing agent, N, O, bis 
(trimethylsilyl) trifluoroacetamide (BSTFA with 1% trimethylchlorosilane, TMCS) was purchased 
from Cerrilliant (Round Rock, TX, USA). The choice of BSTFA as a silylating agent for derivatizaion 
is due to its faster reaction and volatility of its by-products. Pyridine was also purchased from Aldich 
and was used to provide appropriate derivatization reaction medium. Reagent water was from a 
Millipore milliQ water purification system (ELGA labwater, UK).  Stock solutions of each chemical 
at 100 µg L
-1 
were prepared in methanol and were stored at  -20 
o
C in the dark at pH = 2 with 37% 
HCl until analysis [132], while working solutions were prepared from appropriate dilutions. Oasis 
HLB® sorbent in a 47mm SPE disc format and disc holder were purchased from Waters (Elstree 
Herts, UK). A Phenomenex SPE Vacuum Manifold (Macclesfield Cheshire, UK) with 12 ports and a 
self-cleaning and drying vacuum was  used for loading and elution of samples with appropriate 
solvent mixtures 
2.3 Description of the STWs studied with sampling location 
2.3.1. RAF Molesworth Sewage Treatment Work 
Royal Air Force (RAF) base Molesworth is located in Molesworth, Suffolk, approximately 20 miles 
from Cambridge. There are no residents on the base. However, the base operates 24 hours per day 
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with approximately 1,200 personnel (over 2 shifts), with an overnight staffing around 400 personnel. 
The STW is located within the RAF base and utilises activated sludge for secondary biological 
treatment. The plant is consented to discharge a maximum of 360 m
3
day
-1
 (0.1Mgal day
-1
). The 
average volume treated by the works is approximately 78.4 m
3
 day
-1
 (0.02 Mgal day
-1
).  RAF 
Molesworth has separate wastewater and surface water drainage networks and wastewater is pumped 
from across the base to a biological treatment works where it is treated prior to discharge to a tributary 
of ‘Cock Brook’. The existing works which is shown schematically in the diagram below in Fig. 19 
has four different stages: pre-treatment, primary treatment, secondary treatment and reed beds. The 
sewage plant process starts from terminal pumping station where sewage is pumped to a raised inlet 
works and screened. A storm overflow diverts excess flow to the storm tanks and settled material 
accumulates in the storm tanks which are always manually cleared. Wastewater gravitates to a 
primary tank which removes coarse materials and a recently installed the submerged aerated filter 
(SAF process) removes biochemical oxygen (BOD), ammonia and finely dispersed solids. This new 
process replaced the previous plastic media filter system. Humus tanks are used to remove any 
secondary settleable material. The recirculation pumping system has not been used as it was installed 
to ensure the required wetting rate of the old plastic media filter was maintained. The reed beds polish 
the final effluent to required quality standards before being finally discharged to the neighbouring 
rivers. 
The supernatant constitutes the effluents that are passed forward. The excess secondary sludge, the 
solids from primary sedimentation and sedimentation of solid wastes and liquid stream in humus 
tanks are recycled back into the inlet of the plant. Co-settled sludge is pumped from the primary 
sludge well to a sludge storage tank. Decant liquors can be removed from the tank by an adjustable 
decant arm. The sampling points for the analysis are: (i) inlet to the grit removal unit (influent 
wastewater), (ii) inlet to primary sedimentation tank (primary sludge), (iii) inlet to submerged aerated 
filter reactor (SAF-1), (iv) mixed SAF, (v) secondary sedimentation unit (humus sludge) and (vi) 
outlet of sedimentation unit (effluent) [292].  
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Figure 19: Diagram of the Molesworth sewage treatment work at RAF showing location of the sampling points (SP1=primary sludge tank; SP2 = submerged aerated filter 
tank; SP3 = mixed submerged aerated filter tank and SP4 = humus tank [292] 
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2.3.2. Stoke Bardolph STW, Nottingham Sewage Treatment Work (STW) 
The Stoke Bardolph STW is located just outside Nottingham and it is a total distance of about 10 
miles from Nottingham Trent University, Clifton Campus. The STW has serviced large increases in 
population in the last decades, the largest sewage treatment works in Nottinghamshire. Nottingham 
STW at Stoke Bardolph is also the largest works in the East Midlands serving half a million people 
and an additional 200 000 ‘population equivalent’ from trade effluents. The treatment plant employs 
both primary and secondary treatment using activated sludge and on average it handles 170 million 
litres of sewage per day. The inlet removes 2000 tonnes of ‘road’ grit a year and a further 330 tonnes 
of paper and plastics. It takes a total of 16 hours (including recycling stages) to completely treat the 
liquid phase before returning it as a high quality final effluent to the River Trent [289]. The influent 
wastewater goes through several treatment stages, shown schematically below (Figure 20). 
 
Figure 20: Illustration diagram of Stoke Bardolph STW showing location of the sampling points (SP1 = 
influent waste water tank; SP2 = primary sedimentation tank and SP3 = secondary sedimentation tank) [289]  
At Stoke Bardolph, the treatment process proceeds as follows: 
 Primary Treatment:  Coarse solids are removed in the bar rack and the grit is removed in a 
grit chamber.  The heavier organic matters are settled in primary settlement to form a primary 
sludge. The sludge is removed by pumps and transferred to another part of the site for 
treatment. The heavy organic solids are collected at the primary clarifier where 50 to 70% of 
the suspended solids and 25 to 40% of the biochemical oxygen demand (BOD) are removed. 
 Secondary Treatment: In the aeration tanks, the aerated biological process utilises useful 
micro-organisms. The influent of the aeration tank is mixed with activated sludge and the 
mixed liquor is aerated and the aerobic processes stimulated with the growth rate of bacteria 
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becoming faster. Flocculation takes place as a result of bacteria depletion of biomass to form 
insoluble substrate which becomes a solid biomass and these flocs sediment in the secondary 
clarifier.  
 Tertiary Treatment: Chemical disinfection of waste stream is carried out here by disinfectants 
such as ozone, UV, or chlorine to kill the disease-causing organisms. Finally, the final 
effluent water is discharged to the receiving waters. 
 Sludge Treatment: Sludge from primary treatment, surplus activated sludge and activated 
sludge from outlying smaller treatment works is treated at Stoke Bardolph. Digestion is 
carried out in 4 primary digesters before being transferred to 4 secondary digesters. Sludge 
can then be pumped to land but is usually dewatered to produce a cake which can also be 
applied to agricultural land. 
  Recycling: A series of underground pipes allow sludge to be distributed to fields on the Stoke 
Bardolph and Bulcote estate. A tractor pulling specially designed equipment injects the sludge 
into the soil. This provides nutrients for a range of crops which are grown on the farm [288, 
289]. 
 2.4. Sampling section. 
 The sampling plan we adopted was identification of the appropriate sites at both Stoke Bardolph 
STW Nottingham STW and RAF Molesworth STW at Cambridge to collect samples. Sampling 
operations started with the collection of wastewaters and sewage samples between 22nd February 
2010 to 18
th
 June 2011.  Final effluents were sampled and analysed to assess the levels of pollutant 
arising from the STWs discharges. No samples were collected during heavy rain or storm weather to 
prevent dilution and possible analyte losses due to overflow. Plastic containers were used to collect 
the grab waste water samples and Winchester bottles used to collect and store sewage samples from 
the locations.  
Wastewaters (effluent only) were filtered over Whatman GF-C glass microfiber filter (~ 30 µm) to 
remove solid particles and transfered into pre-cleaned Winchester glass bottles, adjusted to pH = 2 
with 37% HCl and stored at 4
o
C until analysis to minimise bacterial activity and prevent degradation 
of drugs and its metabolites arising during storage; which was carried out within 24hrs in the 
laboratory [178, 296]. Sewage sludge samples were directly collected in pre-cleaned Winchester glass  
bottles and stored at -20 
o
C to preserve samples. Sampling expeditions are shown in Table 11 below. 
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Table 11: Sampling expeditions, dates and locations 
 
 
Initially, a simple random sampling approach was used in the 1
st
 sampling session at the two STWs to  
minimise the possibility of bias [343]. Systemic sampling approach was adopted in the 2
nd 
 sampling 
session of wastewater at Stoke Bardolph STW, Nottingham from Tuesday, 04 May – Monday, 10 
May 2010 (Table 10), where the first sample taken was random and the subsequent sample collections 
every 24 hrs to monitor daily variation. As with analytical processes, analytical measurement can 
introduce errors due to: 
1. Variations inherent in the bulk sample i.e. collection at various points can introduce variation 
Sampling dates Samples collected Locations 
Mon.   22-2-2010 
Thur.  25-2-2010 
Thur.    4-3-2010 
Thur.  11-3-2010 
Mon.   15-3-2010 
Thur.  18-3-2010 
Fri.      23-4-2010 
Sat.     24-4-2010 
Effluent wastewaters 
Effluent wastewaters 
Effluent wastewaters 
Effluent wastewaters 
Effluent wastewaters 
Effluent wastewaters 
Effluent wastewaters 
Effluent wastewaters 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Tue.      4-5-2010 
Wed.     5-5-2010 
Thur.    6-5-2010 
Fri.        7-5-2010 
Sat.        8-5-2010 
Sun.       9-5-2010 
Mon.   10-5-2010 
Effluent wastewaters 
Effluent wastewaters 
Effluent wastewaters 
Effluent wastewaters 
Effluent wastewaters 
Effluent wastewaters 
Effluent wastewaters 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
Fri.    29-10-2010 
Thur.    5-5-2011 
Tue.      7-6-2011 
Sat.      18-6-2011 
Sewage sludge, influent  
& effluent wastewaters 
Sewage sludge, influent  
& effluent wastewaters 
Sewage sludge, influent & 
effluent wastewaters. 
Effluent wastewaters 
Molesworth STW at RAF base 
Molesworth STW at RAF base 
Nottingham STW at Stoke Bardolph 
Nottingham STW at Stoke Bardolph 
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2. Variation due to the sampling process. 
In this current work, representative samples were taken with the following measures taken to ensure 
the impacts of variation were minimal: 
1. Ensured adequate sample storage at appropriate temperature and pH, handling and proper 
samples labelling. 
2. Avoided cross-contamination in the laboratory environment 
3. Ensured potential cross-contamination by instruments were considered and avoided. 
2.5. Experimental programme 
 
During primary and secondary wastewater processes, the fate of cocaine, benzoyecgonine, heroin, 6-
monoacetylmorphine, morphine and diazepam were determined under different conditions in a series 
of jar tests. In a series of experiments with 250 mL of the aliquots of raw sewage in the conical flasks 
spiked with 1 mL of 12.5 mg of separate standard of drugs (not a mixture). Background 
concentrations of the six analytes were measured and none of the compounds under investigation 
were detected in the original sludge samples. The initial concentration was thus 50 mg L
-1
 equivalents 
for each of the six drugs of interest and each batch test was initially 0.5 mg of drug in 10 mL of raw 
wastewater or sewage samples. 
The choice of 12.5 mg/250 mL of sample for each of the selected compounds was used to achieve 
optimal experimental strategy that would provide evidence of the presence of residual compounds at 
concentration in the lower ng L
-1
 range for the batch test after 3h duration. Therefore adequate spiking 
concentration for batch eperiments was selected after initial trial experiment to determine adequate 
concentration that would allow measurable concentration of parent drug and associated degradation 
products. No possible evaporation occurred during the batch studies as aluminium foil caps were 
securely placed on the flasks with the jar tests carried out in the incubator to maintain a typical 
activated sludge plant constant temperature. Batch experiments were conducted at two temperatures 
of 19 ± 0.5
o
C and lower abiotic temperature of 4±0.5
o
C. Sample were agitated using magnetic stirrer 
throughout to obtain homogenous sample of which 10 mL of batch sample was removed at every 15 
min intervals. These subsamples were centrifuged (1500 rpm for 5 min) and filtered using 0.45 µm 
cellulose acetate Whatman and the aqueous phase was extracted by solid phase extraction using Oasis 
HLB (500mg/6 mL) adsorbent (made up of a divinylbenzene/N-vinylpyrrolidone copolymer with both 
hydrophilic and hydrophilic properties) with very good recovery data [278] compared to other 
adsorbents such as MCX
®
 (500mg/6mL) [137], Isolute ENV+
® 
(500mg/6 mL) and Isolute PH
®
 
(1000mg/6 mL) adsorbents  [136], and Bond Elut Certify
®
 adsorbent [214]. The choice was based on 
the use of Oasis HLB
®
 (500mg/6 mL) in the extraction of cocaine and its metabolites in waste and 
surface water in the literature, and it was recommended as most suitable adsorbent for organic 
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compounds because of its lower solvents usage, time, stability to pH range and over 75% recovery for 
most analytes in aquatic medium was achieved [132]. The solid phase was extracted by shaker 
extraction for 15 min after initial drying with about 2 g of anhydrous sodium sulphate followed by 
addition of 2 x 5 mL each of ethyl acetate and dichloromethane. 
2.5.1. Spike recovery studies of compounds from sewage sludge samples. 
Recovery rates of the drugs depended on the nature of the samples collected from each RAF sampling 
point: primary sludge (PS), submerged aerated filter -1 (SAF-1), mixed secondary aerated filter 
(MSAF) and humus sludge (HS) and Stoke Bardolph STW sampling points: influent wastewater -1, 
influent wastewater – 2, primary effluent,  secondary effluent –North, secondary effluent –South, and 
secondary effluent –New. Recovery experiment for 1L of wastewater were spiked at mixed 
concentrations of 100 ug mL
-1 
, while the liquid phase of the raw sewage samples were spiked with 
known concentration of drugs (50 mg L
-1
) and analysed in exactly similar ways as in the full batch 
studies. There were only one recovery values for liquid phase (re-computed into the data) as presented 
in Table 13 and 14 (Result section- Chapter 3.1.1 ad 3.1.2). The recovery experiment for solid phase 
could not be completed in particular because the drugs were not enough for batch studies - our most 
suitable options in the situation. However, this may introduce uncertainties in the data. 
2.5.2. GCMS operation and quantitation of compounds in Nottingham STW effluents. 
GCMS Instrumentation:  
The two major building blocks in gas chromatography-mass spectrometry are gas chromatography 
(GC) and mass spectrometer (MS). The GC separates mixtures into different components depending 
on the chemical properties of molecules, column’s phase properties and dimensions (length, diameter, 
film thickness) as the sample travels in the capillary column of the gas chromatograph. The 
interactions between the column and the molecules allow the molecules to be retained and come off 
(elute) at different retention times from the column. These molecules are now captured, ionized into 
fragments and are detected separately by MS downstream. The electrical signals are produced from 
the ionized fragments detected usually by an electron multiplier diode. Single ion mode (SIM) scan 
was used in the instrument method to target a range of mass fragments. SIM analysis allows for a 
smaller quantity of a compound to be detected and measured using Excel software for quantification. 
A quadrupole mass spectrometer (Mass Selective Detector) is a popular detector and others that can 
be encountered include: ion trap mass spectrometer (IoT), tandem quadrupoles (MS-MS) and time of 
flight (TOF). The standard ionization technique is electron impact (EI), where a high energy electron 
typically 70 eV (electron Volts) produced by a /filament (quadrupole source) bombards the molecules 
into characteristic and reproducible fragments [339]. The electron ionization process in gas phase is 
described as: M + e
- → M+∙ + 2e-  
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[Where M = analyte molecule being ionized, e
- 
= electron and M = M
+•
 is the resulting ion]. The 
generated spectra can be compared with the in-built library spectra software supplied by National 
Institute of Standards (NIST-USA) employing matching algorithms such as Probability Based 
Matching [340] and dot-product [341] for compound identification. 
GCMS Operation and quantitation of compounds:  
In the current work, gas chromatography mass spectrometry analyses were performed with an Agilent 
6890 GC coupled to Agilent 5975 inert XL mass selector detector (MSD: 2564.7 eV), using a 
capillary column (HP5-MS) (30.0 x 0.25mm x 0.25 um film thickness) with helium as carrier gas (1 
mL min
-1
). With sample injection in splitless mode, the analyte separation was achieved with the 
temperature programming: 50
o
C (hold 2min), rise to 300
o
C at 10
o
C min
-1
 and then held at 300
o
C for 3 
min. The standard software supplied by the Agilent Chemstation (manufacturer) was used for data 
acquisition and analysis. The mass spectrometer was in electron impact (EI) ionization mode at 70eV. 
Quantitation was determined using total ion corresponding area (TIC) with the EI mass spectra 
recorded in scan mode (scan range 45- 550m/z) with GCMS method total run time of 30 min.  
The linear calibration curves using five point curves from a spiked  water concentration range of 2-10 
ugL
-1
 were obtained after appropriate dilutions from 100 ugmL
-1
 and all the compounds (ibuprofen, 
benzocaine, caffeine, lidocaine, cocaine, codeine, amphetamine, metamphtamine,  ecgonine 
methylester, methadone, heroin, benzoylecgonine, cocaethylene, ecgoninemethylester, morphine, 
nicotine, 6-acetylmorphine, 6-acetylcodeine, diacetylmorphine, diazepam and procaine) prepared in 
methanol (blank). The m/z major characteristic mass fragments and retention times of compounds 
identification were presented in Table 12. The characteristic mass fragments and retention times of 
analytes were used for both qualitative and quantitative determinations with the mass spectrometer in 
electron impact (EI) ionization mode at 70eV and quantitation was determined in single ion mode. 
Table 12: m/z ions selected for substances identification 
 
 
 
 
 
 
 
 
 
 
 
 
Compound   Major ions   
(molecular &  
two product  ions)                                    
Retention 
time  
(min) 
Amphetamine                         m/z 206, 116, 73                                10.0
Ecgonine methyl ester   
Nicotine           
m/z 199, 96, 82 
m/z  162, 133, 84                                
11.7 
12.9
Ibuprofen-O-TMS m/z 278, 160, 73                                  15.6
Benzoylecgonine-N-TMS                              m/z 237, 222, 192                                17.3
Caffeine m/z 194, 109, 67                                  18.2
Lidocaine 
Bromacil 
m/z 234, 86, 58 
m/z 205, 190, 162                                
18.7 
19.4
Procaine                                   m/z 235, 99, 88                                   20.2
Cocaine     m/z 303, 182, 82                                   21.9
Codeine-O-TMS m/z 371, 178, 73                                  24.0
Diazepam   m/z 283, 256, 221                                 24.1
6-MAC m/z 341, 282, 229                                 24.6
6-MAM m/z 327, 268, 215                                 24.9
Heroine m/z 369, 310, 268 
                                
26.3 
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2.5.2.1 Instrumental detection limits. 
Detection limits which were obtained from injection of low spiked mixed concentrations of each 
analyte were used to calculate the limits of detection; LOD and quantification; LOQ using the 
formula:  
LOD = 3 x hmax x R                                                                                                       [eqn. 1]                                                                                           
(where hmax =  maximum amplitude of the noise; R =  concentration of compound (in ng L
-1
)/peak 
heights).  
Example: hmax (maximum amplitude of the noise for cocaine) = 50 (TIC value) 
R (concentration of cocaine) = 2000 ngL
-1
 
Peak height for cocaine = 382576 (as presented in Appendix 4): 
                                                LOD = 3 x 50 x 2000 ÷ 382576 = 0.78 ng L
-1
                 
The LODs for the remaining compounds are presented in Table 13 
 All the calculated LODs, expressed in ng L
-1
 were significantly lower than the concentrations of 
analyte deteted in Stoke Bardolph STW, Nottingham effluents. The empirical values of both LOD 
presented greater probability to real values and not just some random fluctuations of the blank reading 
[97,132]. (Result section – Chapter 3). 
2.5.3. The physico-chemical characterization of the wastewaters 
Total suspended solids (TSS), chemical oxygen demand (COD), organic carbon (OC), ash and pH 
were determined by standard methods [282-284] as outlined below. Results are presented in Table 15 
(Result section – Chapter 3) 
2.5.3.1. Total suspended solids (TSS) determination. 
The TSS in the sludge samples, influent (raw) and effluent (treated) wastewater were determined after 
filtration through GF/C (1.2 µm) using equation 2: 
 TSS conc. (mgL
-1
) = [Wsand+silt+clay (g) / Vsample (mL) x 10
6
]                                                   [eqn. 2] 
Example: Total suspended solids (TSS) determination of influent sample (InfWW-1) collected on 
Saturday, 18 June 2012 from Stoke Bardolph Nottingham STW: 
Influent-1 wastewater (InfWW-1) = 1000 mL 
Weight of solid (Wsand+silt+clay) = 0.7979 mg 
TSS conc. = [0.7979 mg/1000 mL x10
6
] = 797.9 (mgL
-1
) of influent sample    
2.5.3.2. The pH measurement. 
The unfiltered wastewaters and sludge samples were measured directly with pre-calibrated pH meter 
(HANNA HI 4212 model). 
2.5.3.3. The ash content. 
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Organic carbon was determined by combustion method. 1.0 g of sewage was placed in a crucible and 
put into a furnace at 350
o
C for an hour, after which the temperature was raised to 550
o
C and left for 
24 hours. The ash content is the measure of inorganic component of the sewage samples and the 
equation below worked the calculation of ash content using 1.0 g of sewage. 
Total ash content (g) = [Wc1+ Wash] (g) – [Wc1] (g) [eqn. 3] 
(Where Wc1 = initial weight of crucible; Wash = weight of ash) 
Example: The ash content determination of HS sludge sample collected on Friday, 29 October 2010   
from Molesworth STW: 
Wc = weight of crucible (33.7535 g) 
Wsample1 = initial weight of sample (1.0 g) 
Wsample2 = final weight of sample 
Total ash content = [34.7535 – 34.8172] = 0.0637 (g/g). 
2.5.3.4. Organic carbon content. 
Organic carbon was determined by combustion method. 1.0 g of sewage was placed in a crucible and 
put into a furnace at 350
o
C for an hour, after which the temperature was raised to 550
o
C and left for 
24 hours. The remaining ash was weighed and organic C was calculated from the loss in weight 
during ashing. 
Organic C (g) = Wsample (g) - Wash (g)                                                                                  [eqn. 4] 
Example: Organic carbon content determination of MSAF sludge sample collected on Friday, 29 
October 2010  from Molesworth STW: 
Wsample (g) = 1.0 g 
Wash (g) = 0.0637 
Organic C = [1.0 – 0.0637] = 0.9363 (g/g) 
2.5.3.5 The Chemical Oxygen Demand (COD) determination. 
The COD was measured after appropriate dilution of 1mL of each sample with distilled water:                                
1. RAF Molesworth STW wastewaters: 
Raw influent (dilution factor of 200) 
Treated effluent (dilution factor of 10) 
Humus & SAF sludges (dilution factor of 100) 
PS & MSAF sludges (dilution factor of 150) 
2. Nottingham STW wastewaters: 
Raw influent (dilution factor of 100) 
Treated effluent (dilution factor of 10) 
After 2 ml of each of the pre-diluted sample was dispensed into a COD tube in triplicate, 1 mL of 
potassium dichromate (0.0083 M) was added while a fourth tube with 2 mL of distilled water acted as 
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a control (blank). In a fume-cupboard, 2 mL COD sulphuric acid (a mixture of sulphuric acid and 
silver sulphate) and 2 mL of acidified 5% mercurous sulphate solution (masking of chloride) were 
added. After the tubes were placed in the heating block and reflux for 1 hr. The sample and blank 
were finally titrated with the standardized ferrous ammonium sulphate, FAS (0.005 M) using a drop 
of ferroin indicator with a colour change from blue-green to grey orange. The COD was calculated 
using the following equation 5: 
                               COD (mgdm
-3
O2) = 800 x M x [Vblank-Vsample] ÷ 50                           [eqn. 5] 
 
Example: The chemical oxygen demand (COD) determination of HS sludge sample collected on 
Friday, 29 October 2010  from Molesworth STW: 
Sample of humus wastewater taken = 1 mL each (diluted to 100 mL with distilled water in triplicate)   
Vblank = blank titration reading volume of FAS used (average of triplicate readings) = 13.75 
Vsample = sample titration reading volume of FAS used (average of triplicate readings) = 7.20 mL 
Standardization of FAS (mL) against 20 mL of potassium dichromate (0.0083 M): 
Volume of FAS used after titration = 32.50 mL. 
Therefore, concentration of FAS = 0.0083 x 20 ÷ 32.50 = 0.0051M. 
Substitution in equation 5 gives: 
                               COD = 800 x 0.005 [(13.75 – 7.20) ÷ 50] 
                                        = 0.524 (mgdm
-3
O2) 
Multiplying by dilution factor (100) then; 
                               COD = 52.4 (mgdm
-3
O2) 
The explanation of calculations with worked examples of LOD, ash, organic carbon, TSS and COD 
contents are discussed in Table 15 (Results - Section 3.1.4). 
2.6 Wastewater analysis 
 
Buchner bottles were used to collect the grab samples and were all stored in glass bottles, adjusted to 
pH of 2 with 37% HCl and stored at 4
o
C for preservation. The pH adjustment was to prevent 
degradation of drugs and metabolites arising during storage. Water samples (1L) in triplicates, before 
extraction, were filtered over a glass Whatman GF-C glass microfiber filter (1.2 µm) to remove solid 
particles. Afterwards, the filtrates were adjusted to pH of 6 using HCl and NH4OH as appropriate and 
were extracted by solid phase extraction using Oasis HLB (500mg/6 mL) made up of a 
divinylbenzene/N-vinylpyrrolidone copolymer with both hydrophilic and hydrophobic properties 
[132]. The cartridge was soaked and conditioned with 5 mL of methanol without vacuum for 5 min 
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and 10 mL methanol followed by 10 mL water with vacuum, respectively.  Wastewater samples (1L) 
at 100 ml per minute (c.a.10 psi pressure) were introduced and the cartridge was then washed with 10 
mL reagent water, air-dried under vacuum for 15 min. Elution was performed in three steps: (i) 5 mL 
of methanol using no vacuum was added and after 2 minutes vacuum was turned on to collect first 
eluates. (ii) 12 mL of 12% ammonia in methanol was added to collect second eluates and (iii) 6 mL 
of 50:50 acetone/methanol was finally added and the combined eluents were evaporated to dryness 
using a nitrogen stream and a sand bath set to 70
o 
C [283]. The mixed-eluates were added with 50 µL 
BSTFA + 1% TMCS in 50 uL of pyridine as solvent added, incubated at 70
o 
C for 20 min (~ total 
volume 100µL ) as chemical derivatization step to improve the analysis of primary and secondary 
amines/alcohols containing compounds as their trimethylsilyl derivatives [215].  The derivatized 
extracts were filtered (nylon membrane 0.45µm) and centrifuged for 5 min at 1000 rpm. The clean 
filtrates were then transferred to glass 250 mL vials and placed in an auto sampler for gas 
chromatography mass spectrometry analysis.  
Chemistry of derivatization (silylation) of analytes using BSTFA with 1% TMCS:  
A derivatizing agent, N, O, bis (trimethylsilyl) trifluoroacetamide (BSTFA with 1% 
trimethylchlorosilane, TMCS) is an effective trimethylsilyl donor and it is most versatile when used to 
enhance GC performance by blocking protic sites, thereby reducing dipole-dipole interactions and 
hydrogen bonding, and increasing volatility. Silyl groups, for example, trimethylsilyl (-SiMe3) are 
introduced as protecting groups to replace acidic hydrogen on the compound: 
RH → R− + H+ 
R
−
 + R'3SiCl → R-SiR'3 + Cl
− 
It has advantage of the volatility of its by-products, mono-(trimethylsilyl) trifluoroacetamide and 
trifluoroacetamide over many others because they elute with the solvent front which rarely interfere 
with analyte peaks in chromatograms. The use of large excess of derivatising agent and solvent 
(where necessary) can help to minimise problems of interference by moisture or other sample 
impurities [342]. 
2.7 Sewage sludge batch tests 
For batch studies, 250 ml of each unfiltered sludge sample were measured in a conical flask and 
spiked with 12.5 mg of standard drugs (Sigma Aldrich analar grade: cocaine, benzoylecgonine, 
heroin, 6 – monoacetylmorphine, morphine and diazepam). Blanks of deionised water after extraction 
and concentration were treated with similar solvents (pyridine and BSTFA + 1% TMCS) used in 
batch studies and run in GC. Samples for the determination of drugs were taken at 15 min intervals 
over a period of up to 3h. The analytical method used was a modified published analytical method 
[238] and is described below. Samples (10 mL) were centrifuged (Jouan C31, VWR, UK) at 1500 rpm 
for 5 min to separate the solid and aqueous phase. After the addition of 2g oven dried sodium sulphate 
(VWR, Lutterworth, UK), extraction of the solid phase was by shaker extraction for 15 min each with 
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5 ml ethyl acetate twice and finally 5 mL dichloromethane (DCM). Fractions were combined and 
dried under nitrogen and reconstituted with 50 µL each of pyridine and BSTFA + 1% TMCS. 
Supernatant aqueous sample after separation from solid sample was put for SPE enrichment and 
analysed on GCMS as described in wastewater analysis above. 
2.8. Operational issues encountered with batch studies. 
Municipal STWs contain lot of different trace polluting substances received from many sources as 
earlier mentioned, therefore carrying out degradation studies of drugs and the analysis of their 
metabolites using solid phase extraction (SPE), derivatization, detection and confirmation by gas 
chromatography mass spectrometry (GCMS) in highly contaminated sewage samples would normally 
be met with some operational issues. To guarantee accurate and reproducible data in highly polluted 
sewage, some operational issues and treatment options were anticipated (see below). Considerable 
efforts were made to enable a simple, robust and complete picture of the degradation studies to model 
a chemical fate in the STW and our most suitable options in the situation are presented: 
1. On the basis of precautionary measures after ensuring none of the compounds under 
investigation were detected in the original sludge, the samples from different processing units 
of RAF Molesworth STW in Cambridge were obtained to minimise unnecessary drug-drug 
interferences that may influence some chemical properties of drugs or inhibit their 
biodegradability potential 
2. Studies on samples from Stoke Bardolph STW, Nottingham were also conducted to see 
expected variability since the configuration of municipal treatment works vary in design 
capacity and location but both are considered for effects of degradation in different treatment 
facilities or sludge types. 
3. The spiking concentration of 12.5 mg of each drug in 250 mL flasks was considered adequate 
after initial random degradation studies to allow measurable concentration in the lower ugL
-1
 
range after 3h period of exposure. 
4. Pre-selection of environmentally relevant compounds for batch studies were based on the 
initial results of the analysis of survey of water effluents from Stoke Bardolph, Nottingham 
STW which showed the presence of these drugs in the samples collected as well as their 
concentrations in other UK wastewater as reported in the literature. 
5. Heroin was purchased under license from Sigma Aldrich (Gillingham Dorset, UK). As a 
supplement to the commercial heroin (Sigma Aldrich), additional heroin was required for 
batch experiments. Pure heroin was not enough for batch studies, but street heroin was used 
as a substitute. 
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6. The street heroin GC chromatogram (Figure 21) was analysed for its percentage purity to 
estimate the right quantity to conclude batch experiment.  From this, 0.5mg of street heroin 
was dissolved in 10 mL of chloroform with triplicate samples run on GC to estimate the 
concentration of heroin below: 
 
Calculation to derive  12.5 mg  of  pure heroin from street heroin samples for batch studies: 
 
Figure 21: Chromatogram of street heroin showing other adulterants 
TIC data A = 29136226 
TIC data B = 28766483 
TIC data C = 28050152 
TIC data (mean) = 28650954 
Heroin standard calibration equation (y) = 106632x                                                [eqn. 3] 
Substitution gives = 28650954/106632 = 268.690 µg mL
-1
 
Therefore, the amount of heroin in 0.5 mg of street sample = 268.690 (0.269 mg) 
% purity = 268.690/500 = 53.738 
If 0.269 mg of actual heroin was found in 0.5 mg of street heroin. 
To calculate the amount of street heroin that would give 12.5 mg of actual heroin: 
0.269 mg of actual heroin was in 0.5 mg of street heroine. 
Amount of street heroin required to give12.5 mg of actual heroin = 0.5 x 12.500 ÷ 0.269 = 23.261 mg 
of street heroin 
The 23.261 mg of street heroin would contain exactly 12.5 mg of actual heroin needed 
7. In Stoke Bardolph STW Nottingham, sampling consist of only (i) inlet to the grit removal 
unit, (ii) primary sedimentation tank and (iii) outlet of the secondary sedimentation tank 
leading to outflow which discharges to River Trent.  Site constraints did not allow collection 
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of raw sewage samples at different processing units and this made it difficult to assess the 
total performance of the system using only 3 sample points. However, the sampling regime 
has been produced to make the best use of the available resources as complete comparison of 
samplings of various units with that of Molesworth STW units were impossible in the 
circumstances of this study. 
8. In RAF Molesworth STW, samples were from four sampling units for batch studies and the 
results were used to assess plant efficiency at each of the selected process stages. 
9. In the scope of this current work, 6 representative drug: cocaine and benzoylecgonine 
(cocaine group), heroin, 6-monoacetylmorphine, morphine (opiates) and diazepam 
(pharmaceutical) were used for degradation tests using activated sludge as inoculum; a 3h 
degradation time as a model system for municipal sewage treatment was chosen in excess of 
normal 2h typical hydraulic retention time (HRT) for unit treatment in many STWs. The high 
HRT and sludge age of some works may contribute to increased biodegradation rates. 
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CHAPTER 3: Results & Discussion 
3.1 Effluent evaluation of Stoke Bardolph, Nottingham STW 
In this chapter, the analysis of the recovery data is summarised for the spiked wastewaters and the 
sewage samples collected from Stoke Bardolph, Nottingham and Molesworth STWs. The data 
obtained includes only the recovery data for the compounds in aqueous phase, quantitation of 
compounds and characterization of wastewaters with the measurements of pH, total suspended solids 
(TSS), ash content, organic carbon content and the chemical oxygen demand (COD). 
Data from real-water effluent is presented with their respective limits of detection.  The results found 
in the Nottingham STW effluent generally compares well with results obtained from other 
wastewaters treatment sites around the world (Table 4). 
3.1.1. Recovery data and quantitation of compounds in spiked waters. 
Standard compounds and sources used for recovery experiment were already mentioned in the 
Method Section 2.2. All the selected 16 compounds in their underivatized form and as their 
trimethylsilyl derivatives are shown in the representative chromatograms Fig 22 showing the 
separation of drugs were used for standard calibrations and recovery calculations. Preliminary tests 
indicated no background contaminations were present as interferences with our recovery experiments  
 
Figure 22: Total ions chromatogram of compounds their underivatized forms/trimethylsilyl derivatives 
obtained from extraction of de-ionised water sample spiked with standard analytes concentration of  4ug L
-1
 (1 = 
Amphetamine-N-TMS; 2 = Ecgonine methyl ester-O-TMS; 3 = Metamphetamine; 4 = Aspirin-N-TMS; 5 = 
Ibuprofen-O-TMS; 6 = Benzocaine-N-TMS; 7 = Caffeine-N-TMS; 8 =Lidocaine; 9 = Procaine-N-TMS; 10 = 
Methadone; 11 = Cocaine; 12 = Codeine-O-TMS; 13 = Diazepam; 14 = 6-acetylcodeine-O-TMS; 15 = 6-
acetylmorphine-O-TMS; 16  = Diacetylmorphine) 
The few examples of reference mass spectra of above selected compounds from the NIST library and 
sample spectra are shown in Appendix 1, which also includes the fragmentation ions, retention data 
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and the GC TIC traces of all analytes for identification as shown in Table 13. Mean recoveries were 
evaluation of triplicates measurements of mixed drugs at 2 and 4 ug L
-1
 with standard deviations. 
Table 13: Performance characteristic of SPE –GCMS with spiked de-ionised water (n=3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reproducibility/repeatability is a measure of consistency of the results obtained and this was 
determined by measuring the two levels of drug concentration at three separate GCMS runs. 
The percentage recoveries ranged from 74.5 – 109.6% for all 18 compounds extracted were achieved 
and the values compare  well with the recoveries values in Table 4 for many illicit compounds, such 
as cocaine (69 – 105%), opiates (85 – 90%) and cannabinoids (69 – 84) [131]. 
The coefficient of variation (R
2
) indicates the linearity of the calibration graphs used to derive 
concentration values and these are higher than 0.99 in most cases (0.9534<r
2
 <0.9998). 
3.1.2. Recovery data from different sewage matrices (aqueous) 
 
The recoveries for the compounds were only done for the liquid phase of the sewage and since these 
recovery data were used for both liquid and solid phases it would introduce uncertainty. However, the 
aqueous phase data ranged between 75.8  – 96.2 % from different sewage matrices and are presented 
in Table 14 and the final results were adjusted for each drug accordingly to reflect the recovery rates.  
The results compares well with other discovery experiments carried out in other places, like the 
    Analyte                   LOD          % Recovery (mean ± STD) 
 
 (ng/L) 2000 (ng/L) 
 
4000 (ng/L) 
 
Substances 
studied in batch 
experiments and 
their matabolites 
 
 
 
 
0.8 
83.0 ± 2.4 
 
 
 
 
85.9 ± 2.1 Cocaine 
Benzoylecgonine 4.6 109.6 ± 9.7 90.2 ± 2.3 
Ecgonine ME 6.9 92.5 ± 1.2 92.2 ± 1.7 
Cocaethylene 0.9 85.2 ± 1.8 90.8 ± 1.3 
Heroine 4.3 74.5 ± 4.7 82.7 ± 1.9 
6- acetylmorphine 4.6 107.5 ± 8.6 87.6 ± 2.1 
Morphine 0.9 88.5 ± 1.0 79.2 ± 2.1 
Diazepam 1.9 76.6 ± 2.6 86.0 ± 4.7 
    
Other compounds 
analysed in 
wastewaters 
 
 
 
Nicotine 12.7 101.6 ± 2.6 98.4 ± 1.9 
Codeine 0.2 78.4 ± 2.8 81.9 ± 2.3 
Lidocaine 1.5 83.6 ± 2.3 91.7 ± 1.4 
Caffeine 8.6 86.0 ± 2.4 91.0 ± 1.4 
Procaine 
Ephedrine 
9.2 
0.1 
88.8 ± 1.6 
81.0±1.4 
86.7 ± 0.6 
83.7± 4.3 
Ibuprofen 5.9 89.6 ± 4.3 75.3 ± 3.4 
Amphetamine 3.3 83.9 ± 1.6 70.6 ± 1.7 
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average levels of cocaine and its metabolites (benzoylecgonine, BZE) in the River Po which have 
shown recoveries of > 90% for the two compounds [132]. 
Table 14: Recovery data for the compounds in aqueous phase (%) (n=3, mean ± STD). 
 
Drug 
 
                                   Aqueous matrix 
PS SAF-1 MSAF HS SB 
      
 
Cocaine 
 
91.5±1.8  
 
90.1±1.3 
 
86.6±6.5 
 
95.4±1.2 
 
94.2±0.7 
Benzoylecgonine 96.2±0.8 88.1±2.7 85.3±2.4 92.5±3.1 93.4±7.5 
Heroin 86.3±2.9 83.4±1.8 87.2±6.4 87.4±6.8 82.6±2.5 
6-monoacetylmorphine 94.5±1.0 89.3±1.2 86.4±6.2 94.2±2.0 93.3±0.8 
Morphine 78.4±4.4 76.1±3.1 75.8±3.6 79.2±2.3 80.2±4.1 
Diazepam 92.1±3.4 84.2±1.0 82.5±3.2 92.7±2.6 93.7±1.3 
Note: PS (primary sludge); SAF-1 (submerged aerated filter-1); MSAF (mixed SAF); HS (humus sludge) and 
SB (Stoke bardolph primary influent) 
 
In a related investigation, 500mL of wastewater samples were filtered through micro-fibre filters and 
extracted by Strata- XC™ SPE cartridge, the filtrate was adjusted to pH 6 with HCl with recovery for 
most analytes found in the region of 50-65% [134]. Cocaine (COC), benzoylecgonine (BE) and 
ecgonine methylester (EME) have been determined on 100mL and 500mL in wastewater and surface 
water by a method that involved the use of SPE and LC-MS analysis [134] and the overall method 
variability was ≤10% for the influents, ≤ 5% for effluents and recoveries in wastewater were ≥ 80%. 
At the Toxicological Centre, University of Antwerp, Belgium, researchers have carried out the 
measurement of spatial and temporal variations in the occurrence of cocaine and benzoylecgonine in 
waste and surface water with overall removal efficiency of the compounds from the STWs of ≥93%. 
In addition to the same analytical procedure, the determination of illicit drugs in wastewater effluents 
using Polar Organic Chemical Integrative Samplers (POCIS) methodology for sampling was 
introduced [141]. The estimated detection limits for most compounds were less than 1pg µL
-1
 while 
the averaged recovery was 123±30%; however, the determination of the uptake rates for the 
compounds of interest for quantitative analysis is the limitation of POCIS.  
 In other developments, the occurrence of psychoactive drugs in wastewaters and recoveries have 
been reported between 70 - 101% from simultaneous determination of amphetamines, cocaines, 
cannabis and their metabolites in wastewaters  after SPE enrichment of the analytes, while recoveries 
of 70 -120% were reported with precision of ≤ 20% for other substances, such as nicotine, cotinine, 
caffeine, paraxanthine, methadone and ketamine [138]  
3.1.3. Match probability data of analytes from Stoke Bardolph, Nottingham wastewaters 
The extract match probability data for selected analytes obtained from the GC NIST Search library are 
in Table 15 with our defined terms of likelihood in percentages into unlikely, possible match, 
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probable match and highly probable match for qualitative aspects of our findings. The probability 
match groups:  ibuprofen, caffeine, procaine, ephedrine, dihydrocodeine (as highly probable match); 
cocaine, benzoylecgonine, diazepam, lidocaine, bromazil and nicotine (as probable match); codeine 
(as possible match) and morphine (as unlikely match). 
 Table 15: Match probability data table for selected compounds obtained from the GC NIST Search Library 
 
Terms of likelihood in percentages: 
Highly probable match = 70% above  
Probable match = 50 – 69% 
Possible match = 30 – 49% 
Unlikely match = ≤ 30% 
Further comparison of reference compound retention time with the analytes provided valuable 
confirmatory processes in the matching probabilities of compounds with lower percentages. 
3.1.4. Characterization of wastewaters from Stoke Bardolph, Nottingham and Molesworth STWs 
Due to variability in the overall composition of wastewaters as a result of continuous discharges and 
potential matrix effects on degradation studies, the sewage sludge characterizations for wastewaters 
and sewage samples were analysed for total suspended soilds (TSS), organic carbon (organic C), ash 
and chemical oxygen demand (COD) and results are shown below in Table 16. 
 
Compound 
Library 
Search 
Analyte 
Match 
Reference 
Match 
Probability 
     (%) 
Analyte 
Retention 
Time 
Reference 
Retention 
Time 
Remarks 
(Terms of 
Likelihood) 
Procaine R 846 904 71.5 20.25 20.27 H. probable 
Ephedrine M 599 692 88.4 15.21 15.09 H. probable 
Dihydrocodeine M 585 740 85.4 23.50 23.50 H. probable 
Benzoylecgonine ni 747 864 45.1 16.38 16.42 Probable 
Diazepam ni 751 841 56.4 24.10 24.04 Probable 
Morphine M 731 763 22.7 24.50 24.49 Unlikely 
Lidocaine R 758 834 58.0 18.76 18.72 Probable 
Bromazil ni 777 852 56.4 19.41 19.49 Probable 
Codeine R 688 772 38.2 24.05 24.04 Possible 
Nicotine M 841 940 53.0 12.99 12.96 Probable 
Ibuprofen M 859 878 90.7 16.13 15.68 H. probable 
Paracetamol M 836 877 92.6 17.56 17.55 H. probable 
Caffeine M 876 889 92.3 18.65 18.26 H. probable 
Cocaine M 758 686 52.4 21.89 21.99 Probable 
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Table 16.   Characterization of wastewaters from RAF Molesworth and Nottingham STWs (June 2011) 
  
Note: InfWW = influent wastewater; EffWW = effluent wastewater; PS = primary sludge; MSAF = mixed SAF;    
SAF-1 = secondary aeration filter; HS = Humus sludge; InfWW-1= primary influent -1; InfWW = primary 
influent -2; 1
o
EffWW = primary effluent; 2
o
EffWW = primary influent (north); 2
o
EffWW = primary influent 
(south); 2
o
EffWW = primary influent (new). 
 
Table 16 above shows the mean results as presented and explained in the worked calculation above to 
illustrate the total COD, organic C and TSS contents achieved from different  samples collected from 
the two different STWs. The highest effluent COD concentration from both STWs was 6.2 mgdm
-3
O2, 
and this was below the consent limit of 15 mg L
-1
 BOD shown in Table 16 [292], while the highest 
concentration of COD observed for influents were 216.8 mgdm
-3
O2 (RAF Molesworth STW) and 48 
mgdm
-3
O2 (Nottingham STW), indicating the nature of sewage and different treatment processes can 
influence the kinetics of degradation [281]. The COD values obtained from the influent and effluent 
samples collected from Stoke Bardolph Nottingham and Molesworth STWs therefore compares well 
with the values reported for primary effluent (309 mgdm
-3
O2 COD), food processing sewage (7249 
mgdm
-3
O2 COD), swine waste (67,444 mgdm
-3
O2 COD), secondary effluent (35 mgdm
-3
O2 COD ), 
lagoon (27089 mgdm
-3
O2 COD) and effluent (71 mgdm
-3
O2 COD) in a study [294]. This would 
indicate that the values produced in this work are in line with typical STW [294], ensuring sewage 
characerisics in the current work batch studies can be assumed to be representative of most municipal 
sewage types. 
Similar studies carried out in two other places have also reported a range of 65 – 686  mgdm-3O2  
[295] and 86 – 2852 mgdm-3O2 of COD [287] in sewage. In this current work, the difference in 
influent and effluent results as reported may form a basis of empirical relationship between COD 
 
Matrix 
pH (Temp;
 o
C)  
     
TSS  
(mg/L) 
Organic C    
   (g) 
Ash 
content 
(g) 
COD  
(mgdm
-3
O2) 
Molesworth STW      
InfWW   8.5 (17.1)           36243.0              216.8 
EffWW 7.8 (18.7)                     5.5                    1.8 
PS 5.7 (14.4)           77386.5            0.95             0.07                162.6 
MSAF 5.7 (14.4)               8465.0           0.93              0.05                138.0 
SAF-1                       7.1 (14.6)           70793.5            0.95             0.07                82.0 
HS    7.1 (14.2)               3563.5           0.94 0.06                52.4 
      
Nottingham STW      
InfWW- 1                 8.4 (12.7)               797.9              36.0 
InfWW- 2                8.1 (12.1)                599.1            28.6 
1
o
EffWW 7.7 (12.2)                897.0            48.0 
2
o
EffWW (north) 7.7 (12.3)                 9.7                6.2 
2
o
EffWW (south)     7.9 (12.2)                 9.9                5.1 
2
o
EffWW (new)       8.0 (12.4)                 8.6                3.6 
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removal and the quality of treatment processes of sewage or wastewaters and these functions may be 
used to develop a gauge for sewage treatment to confirm adequate efficiency so that effluent quality is 
sufficiently good. 
Treatment of organic matter in an activated sludge plant has also produced 22.7 – 253 mg L-1 TSS 
[275] in a study, but in Nottingham and Molesworth STWs, the remaining suspended particulates 
after treatments represent the final effluent (TSS) concentrations found to be 5.5 mg L
-1
 (Molesworth 
STW) and 10.0 mg L
-1
 (Stoke Bardolph STW, Nottingham) compared to influent (TSS) 
concentrations of 797.9 mg L
-1
 (Stoke Bardolph, Nottingham) and 36243.0 mg L
-1
 (Molesworth STW) 
while 897.0 - 77386.5 mg L
-1
 of TSS were observed for  sewage sludges from both STWs. However, 
it is important to note the large difference in the levels of TSS from influent and effluent from the two 
STWs as quoted as this was evidence of extent of removals. Since domestic sewage differs in strength 
due to strong temporal variation, function controlling sludge characteristic can only be measured 
when effluent performance is compared to influent data and this was satisfactory with respect to our 
experimental results of TSS from both STWs. In addition, the TSS found in the effluents of the two 
STWs was significantly less than the 30 mg L
-1
 consent limit set by UK Environment Agency 
Compliance - Discharge Consent as presented in Table 17 [292]. 
 
 
              Table 17: UK Department for Environment, Food and Rural Affairs [292] 
 
 
 
 
 
In our current work, the average concentration of organic carbon found in all the four sewage types 
collected from Molesworth STW was 0.94 g per 1.0 gram of sewage samples
. 
The levels of organic 
carbon were expectedly higher in the sludge due to myriads of materials as they facilitate compound 
degradation and removal, since the extent of drug removal to particulates/solids depends on the 
amenability of drugs to degradation on association to biological solids and possible volatilisation 
[297]. Unfortunately, direct comparison and evaluation of the organic carbon from sewage sample 
from the Stoke Bardolph STW Nottingham was impossible due to inability to obtain raw sewage due 
to site restrictions. 
3.1.5. Occurrence of compounds in Stoke Bardolph STW Nottingham effluent. 
The 12 compounds, including cocaine, benzoylecgonine, codein, diazepam, morphine, ephedrine, 
lidocaine, diacetylmorphine, ibuprofen, procaine, amphetamine, ecgonine methylester and an 
herbicide (bromacil) were detected in random wastewater sampleings from Nottingham STW 
effluents. 
 
Parameter  Consent Limit (mgL
-1
) 
Biochemical Oxygen Demand (BOD)  15 
Ammoniacal Nitrogen expressed as N (NH4-N)  5 
Total Suspended Solids (TSS)  30 
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Example of calculations of wastewaters concentration values for codeine from Stoke Bardolph 
STW Nottingham effluents collected on Monday, 22 February 2010: 
 
For example, using codeine GC TIC and calibration data (presented in Appendix 2A). 
 
Linear calibration equation for codeine: y = 26382267.9x  
Codeine TIC area: 2843877 (presented in Appendix 3) 
Substitution gives, 2843877 / 26382267.9 = 0.1077 ng/ uL = x  
 
(Note: Detector concentration in ng/µL (equivalent to µg/mL of real solution concentration) 
           
Therefore,   0.1077 (ng/µL) is equivalent to 0.1077 (µg/mL) = x   
Volume presented to detector: 100 uL 
100uL (0.1 mL) represents 1000 mL of wastewater from which codeine was actually concentrated.  
Since 0.1077 µg of codeine is contained in 1mL from calibration 
 
Therefore, 0.1 mL will contain:   0. 01077 µg/mL = x  
 
Conversion to ng (multiply by 1000): 
 
                    
 
                     0.01077 (µg/mL) x 1000 = 10.8 ng/mL 
 
The concentration values presented in Table 18 and 19 were raw values of the analytes, as their 
various percentage recoveries were not re-computed back into the calculations. However, it can be 
seen that our results can still be in line with the results obtained previously using different techniques. 
In the current work, the occurrence of drugs in wastewaters with the mass spectrometer in electron 
impact (EI) recorded in scan mode (scan range 45-550 m/z)  gave abundant molecular ion of each 
compound and two precursor ions: cocaine (303>182; 303>82), benzoylecgonine (290>168; 
290>150)codeine (371>178; 371>73), diazepam  (285>256; 283>221), morphine (181>124; 
>181>96), ephedrine (230>179; 230>58),  lidocaine (234>86; 234>58), diacetylmorphine (369>310; 
>369>268),  ibuprofen (278>160; >278>73), procaine (235>99; >235>88),  amphetamine (206>116; 
206>73), ecgonine methyl ester (199>96; 199>82),  bromacil (270>205; 270>187), caffeine 
(194>109; 194>67), and nicotine (161>84; 161>131). The fragmented ions produced the 
characteristic and reproducible m/z signals used for individual compound identification/quantification. 
Effluent at Stoke Bardolph Nottingham compared to other sites: 
Literature has shown many determinations of various illicit drugs and pharmacuticals and their 
metabolites in different matrices of the aquatic environment [131-142, 298 -307].  In this current 
work, the effluents from RAF Molesworth didn’t contain any drug concentrations and so is not 
discussed here.  
 
78 
 
Table 18: Analyte concentration of wastewater from Nottingham STW effluents (February- April 2010). (mean ± STD, n = 3) 
Compound 
(ng/L)                
 Sampling days 
Mon 
22/02/10        
Thur 
25/02/10        
Thur 
04/03/10        
Thur 
11/03/10       
Mon 
15/03/10          
Thur 
18/03/10       
Fri 
23/04/10         
Sat 
24/04/10 
 
Cocaine 
  
1.9 ± 0.02             
 
< 0.8 
 
< 0.8 
 
< 0.8 
 
< 0.8 
 
< 0.8 
 
< 0.8 
 
< 0.8 
Benzoylecgonine  < 4.6 < 4.6 < 4.6 32.9 ± 1.4       23.7 ± 4.7 12.2 ± 4.2          < 4.6 < 4.6 
Ecgonine methyl E  < 6.9 < 6.9 < 6.9 < 6.9 < 6.9 < 6.9 8.1 ±2.04 17.3 ± 0.2 
Diacetylmorphine  < 4.3 < 4.3 < 4.3 49.1 ± 0.03 < 4.3 < 4.3 < 4.3 < 4.3 
Morphine  < 4.6 < 4.6 < 4.6 42.5 ± 2.0 < 4.6 < 4.6 < 4.6 < 4.6 
Diazepam  3.9 ± 0.03 < 1.9 < 1.9 41.7 ± 1.3 58.9 ± 0.5 105.2 ± 0.5 < 1.9 < 1.9 
Amphetamine  < 3.3 < 3.3 < 3.3 < 3.3 < 3.3 < 3.3 3.9 ±1.32 < 3.3 
Ephedrine  < 0.1 < 0.1 15.8 ± 1.8 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 
Lidocaine  37.4 ± 1.0           76.4 ± 3.5 < 1.5 22.7 ± 0.6 21.2 ± 0.2  15.8 ± 0.1           70.5 ± 0.9 43.5 ± 1.4 
Ibuprofen  < 5.9 < 5.9 < 5.9 84.6 ± 3.8 < 5.9 < 5.9 < 5.9 < 5.9 
Procaine  161.9 ± 13.4     < 9.2 < 9.2 < 9.2 99.2±0.5 < 9.2 < 9.2 < 9.2 
Amphetamine  < 3.3 < 3.3 < 3.3 < 3.3 < 3.3 < 3.3 3.9 ±1.3 < 3.3 
Bromacil 
(herbicide) 
 1140.1 ± 32.8                                                                                                                    < 0.9 140.9 < 0.9 338.0 196.7 1090.5 ± 14.4 1806.8 ± 5.7 
Note: < detection limits (LOD) 
Table 19:  Analyte concentration of wastewater from Nottingham STW effluent (May-June 2011) (mean  ± STD, n = 3) 
Compound (ng/L)                Sampling days 
Tue 
4/05/10        
Wed 
5/05/10        
Thur 
6/05/10        
Fri 
7/05/10       
Sat 
8/05/10          
Sun 
9/05/10       
Mon 
10/05/10         
Sat 
18/06/11 
 
Bromacil (herbicide) 
  
124.4 ± 15.6             
 
995.6±71.7 
 
1187.9±122.4 
 
1052.4±110.6 
 
1218.1±75.9 
 
1191.8±110.1 
 
1230.2±120.3 
 
< 0.9 
Lidocaine  < 1.5 781.8±132.9 358.2±63.2 211.9 ± 8.7       182.2± 10.9 75.7± 6.9          59.4±6.9 < 1.5 
Codeine  < 0.2 < 0.2 < 0.2 5.8± 2.4 29.6 ± 2.9 14.4 ± 1.2            12.1 ± 0.5 < 0.2 
Caffeine  < 8.6 < 8.6 < 8.6     < 8.6 < 8.6 < 8.6 < 8.6 213.4±13.0 
Nicotine  <12.7 <12.7 <12.7     <12.7 <12.7 <12.7 <12.7 252.5±2.2 
Ibuprofen  < 5.9 < 5.9 < 5.9     < 5.9 < 5.9 < 5.9 < 5.9 3147±3.5 
Note:  < detection limits (LOD) 
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It was expected because it’s an RAF base so it is very unlikely any illicit drug metabolites will be 
detected in that effluent. The results of simple and random sampling operations of only effluents 
collected from the Stoke Bardolph STW Nottingham are discussed below: 
Cocaine compounds: 
As presented in Table 18 and 19, cocaine concentration was found to be 1.9 ng L
-1
 with LOD of 0.8 
ng L
-1
 and this was within the range of 0.9-10.7 ng L
-1
 reported from a site in Italy [137] and 01-100 
ng L
-1
 from 42 STWs in North East Spain [138]. However, the value of 1.9 ng L
-1
 reported here was 
lower than 47 ng L
-1
 detected from the other STWs effluents in Spain [131] and 10 ng L
-1
 of cocaine 
in surface water had been from in Belgium [94], but cocaine levels between 1.2-26.0 ng L
-1
 were also 
detected from three rivers in Italy by the Department of Environmental Health Sciences, Mario, Negri 
Institute for Pharmacological Research, Milan [132].  Illicit drugs and their metabolites analyses in 
urban waters have also reported 0.2-1 µg L
-1
 for cocaine [137]. Cocaine was also found in the range of 
25 – 248 ng L-1 in 70% of the river water samples collected in Dublin, Ireland [134]. 
Benzoylecgonine, a major metabolite of cocaine was found in our result in the range of 12.2-32.9 ng 
L
-1
 and this compares well with the values of  25 ± 5 ng L
-1
 from River Po, Italy with total recoveries 
of  ≥ 90% [124] but our value was much lower than 77 ng L-1 previously reported from Germany STP 
effluents [140].  Similarly, samples of river water in Dublin detected benzoylecgonine in the range of 
22 – 290 ng L-1 [134].  Perhaps the strict legislation for unlawful possession of controlled substances 
in United Kingdom under the Misuse of Drugs Act, 1971 [121] could generally be the reason for the 
low detection of illicit drugs in the effluents. 
Ecgonine methyester was 8.1 ng L
-1
 with LOD of 6.9 ng L
-1
 as detected in the current analysis. 
Interestingly, cocaine, benzoylecgonine, ecgonine methylester and amphetamine were all recorded on 
Monday and Friday sampling periods and the occurrence can be explained as being recreational drugs 
that are mostly used on weekends but this may also depend on HRT or delay [221]. 
Opiates: 
Identification and measurement of illicit drugs and their metabolites in urban waters which included 
80-200 ng L
-1
 for morphine and 10 ng L
-1
 for 6-acetylmorphine have also been carried out [137], 
whereas morphine, codein, diacetylmorphine and ephedrine from current study were 42.5 ng L
-1
, 3.3 - 
33.5 ng L
-1
, 49.1 ng L
-1
 and 15.8 ng L
-1
 with their corresponding LODs as presented in Table 13, 
respectively. Also, the determination of illicit drugs using a triple quadrupole mass spectrometry 
equipped for water samples has reported 0.93 ng L
-1
 for 6-acetylmorphine [133].  
Amphetamines: 
Amphetamine was found in Stoke Bardolph STW Nottingham effluent to be 8.1 ng L
-1
 with LOD of 
0.7 ng L
-1
 but this was observed to be very much lower than the range of 110-210 ng L
-1
 previously 
found in surface and urban wastewaters in the literature [135]. Also, 20 ng L
-1
 for amphetamines has 
been reported in another measurement of illicit drugs and their metabolites in urban wastewaters 
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[137], but the value obtained from the current study falls within 0.4-2100 ng L
-1
 recorded from 
experimental determination of psychoactive stimulatory drugs in wastewaters in north-eastern Spain 
[138].  
Other substances detected in effluents: 
High levels of procaine (161.9 ng L
-1
) with LOD of 9.1 ng L
-1
 in wastewater may be explained as due 
to its local use as anesthetic and its presence in wastewater could be explained since comparable 
concentration data in the chemical literature could not be found, we may as well assume that this is 
the first time procaine presence would be reported which make Nottingham STW effluent analysis 
significantly different. 
Diazepam concentrations in Stoke Bardolph STW Nottingham were between 3.9-105.2 ng L
-1
 and the 
results compares well with an investigation of levels of community consumption of illicit drugs and 
abused pharmaceuticals  with 38 ng L
-1
 - 127 ng L
-1
 of diazepam estimated in the analysis of 500mL 
of wastewater samples in Dublin, Ireland. Morphine, methadone and tempazepam were the other 
substances detected, while analytical sensitivity of the LC-MS-MS to test the sample matrix was in 
the range of 1 – 10 g L-1 in the water [134].   
Ibuprofen was initially detected in effluent as 84.6 ng L
-1
 with LOD of  5.9 ng L
-1
 in March 2010 and 
this was lower than 5.8 ug L
-1
 found in Spain STWs in 2004 [263]. But further sampling of 
wastewaters in June 2011 showed the presence of  ibuprofen (3147.0 ng L
-1
), caffeine (213.4 ng L
-
1) 
and nicotine (252.5 ng L
-1
) with LODs of 5.9, 8.6 and 6.4 ng L
-1
, respectively.These values are higher 
than the ones previously reported in a Spain STW influent with concentration between 2.6 and 5.7ng 
L
-1
, respectively [116] and the 175 – 198 ng L-1 of nicotine also found in three rivers in Spain [351]. 
However, a range of  428 – 3786 ng L-1  of nicotine detected in the simultaneous analysis of hospital 
effluents in Spain using GCMS which was higher than the levels found in our study[352]. Stumpf et 
al [286] has also reported ibuprofen concentration of 0.3 ug L
-1
 in Brazilian STW influent. Since these 
drugs are common analgesic and antipyretic drugs commonly used for the relief of fever, headaches 
and other minor aches and pains, their presence in wastewaters may be as a result of medicinal and 
therapeutic use rather than abused or illicit consumption [134].   
Nicotine, likely from tobacco sources and its high concentration in effluent may suggest possibility of 
its higher concentration in influents, but a variety of processes during wastewater treatment, 
culminating in transformation of organic contaminants leading to a reduction in concentration of 
significant amounts of synthetic contaminants, during sewage treatment and in effluent would have 
drastically reduced its concentration [111]. 
The systematic sampling approach was adopted in the second sampling section to monitor possible 
daily variation in the concentration of analytes between 04 May – 10 May 2010 as presented in Table 
19 showed bromacil, codeine and lidocaine mostly detected in all the seven daily samples collected 
with varying concentration ranges from bromacil (124.4 -1230.2ng L
-1
), codeine (5.8 – 29.6 ng L-1) 
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and lidocaine (59.4 -781.8 ng L
-1
) with corresponding LODs as presented in Table 13. Lidocaine and 
codeine levels in dissimilar distribution pattern in the river outflow were also observed, but since 
samplings were systematic, the dilution within the receiving water was another possibility of 
concentration gradient, since the levels detected would be expected to be significantly decreased with 
increasing distance from the discharge point. Like procaine, there is paucity of information in the 
literature on the level of lidocaine in wastewaters to compare results.  
Bromacil is an herbicide used in agriculture, its large presence in effluent could not be explained as 
there was no rainfall during the sampling periods to show the possibility of run–off of neighbouring 
farmlands. However, the herbicide’s spread could possibly be explained in terms of delayed-run-off at 
the STW which sometimes leads to particular pattern that cannot be explained as the sampling was 
executed for 7 days. Deliberate deployment of herbicides on farmlands could possibly be another 
reason for such high concentration of bromacil in the effluent. Bromacil could increasingly become a 
major pollutant since it  has been reported previously in 14-36% of wastewater samples collected 
weekly in a typical South Florida watershed where evaluation of its concentration ranged from 0.5 – 
0.6 ng L
-1 
[285]. This may also apply to UK going by the spread and very high concentrations of 
bromacil found in the Nottingham wastewater effluent as reported in the current work. Unfortunately, 
there was no UK reference of bromacil concentrations in wastewaters. 
Similar residues of pharmaceutical and illicit compounds were reported comprehensively in the 
survey of published data from EU countries and USA with different levels and distribution found in 
different STWs as presented in Table 4 [131 - 142]. The results from our current work further 
confirmed conventional sewage treatment works as the most significant routes through which the 
drugs enter the environment but at different rates compared to other sites. Though these substances 
may have possibly escaped detection due to our random sampling strategy, nonetheless the presence 
of some illicit compounds in the results we obtained confirmed them as new challenges of pollutants 
in wastewaters unlike other pharmaceutical compounds that are coming from domestic sewage, 
industrial, hospital and accidental sources and limited data available for most illicit chemicals have 
made treatability in STWs difficult to assess and therefore information from experimental data on 
degradation studies might help STWs upgrade treatment capability. Systemic sampling strategy at 
appropriately determined intervals may allow the evaluation of the pollution in the levels of the new 
analytes that discharge through STWs to the environment to be monitored and appropriately 
evaluated. 
Unfortunately, despite the efforts of Stoke Bardolph STW Nottingham in the reduction of the 
concentrations of many compounds from reaching surface waters, some of these compounds were still 
detected in the effluents. 
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The purpose of Table 20 facilitates comparison of our SPE GCMS method limits of detection with 
percent recoveries that were generally > 70% (Table 13) with the values reported in Dublin, Republic 
of Ireland [133] and Italy [134], using SPE LC-MS-MS techniques. 
Table 20: Method validation for the analysis of illicit drugs and their metabolites in waters from Italy & UK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analyte Zuccato et al [ 133]  Bones et al [ 134] 
% recovery  
(mean ±SD) 
LOD 
(ng L
-1
) 
LOQ 
(ngL
1
 
 
 
% recovery  
(mean ± SD) 
LOD 
(ng L
-1
) 
LOQ 
(ng L
-1
) 
Benzoylecgonine 96 ± 6.7 0.03 0.10  53 ± 3 1 2 
Cocaine 105 ± 1.9  0.04 0.13  56 ± 2 1 2 
Cocaethylene 105 ± 0.2 0.02 0.07  65 ± 3 1 5 
Amphetamine 101 ± 4.5 0.19 0.65  52 ± 1 7 22 
Morphine 85 ± 1.2 0.16 0.55  4 ± 0 257 856 
6-acetylmorphine 87 ± 3.5 0.28 0.93     
Codeine 107 ± 8.6 0.19 0.62     
6-acetylcodeine 114 ± 8.3 0.09 0.31     
Methadone 104 ± 10 0.02 0.07  55 ± 0 4 14 
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CHAPTER 4: Data analysis in batch studies 
 
Batch studies data of each of the six compounds (cocaine, benzoyecgonine, heroin, 6-
monoacetylmorphine, morphine and diazepam) to evaluate their biodegradability under different 
experimental conditions is presented. The experimental parameters for the batch studies for each drug 
include: 
 Evaluation of the degradation and removal of drugs in both primary and secondary sewage 
samples at 19 ± 0.5
o
C. 
 Evaluation of biotic (19 ± 0.5oC) and abiotic (4 ± 0.5oC) degradation processes of compounds 
in sewage. 
 Evaluation of the effect of suspended solids on the removal of compounds. 
Sorption and degradation are two important removal mechanisms of compounds from the Molesworth 
sewage treatment works, explaining the detailed calculation of data in each column of Tables 21-33.  
 
4.2.1 Possible uncertainties/ sources of errors in the experimental data. 
This section acknowledges some steps that may have introduced some possible uncertainties/errors in 
the quantification of the data as highlighted below. 
 Quantification and recovery data: The highest calibration concentrations of compounds used 
in Appendix 2B for the quantification and recovery experiment were lower than the spiked 
concentrations of 500 ug/ mL, and we recognised these could introduce some possible error 
on quantification of those recoveries. However, linearity with very good coefficient of 
variations for all compounds were produced from the lower concentrations used for 
quantification. 
 Recoveries from solid phase: No recovery values from solid phase were used as we used only 
the recovery obtained from the liquid phase for both phases and this may introduce 
uncertainty in the data. A poor recovery could significantly underestimate the amount of illicit 
drug sorbed to the particulate phase and hence ensuing calculations could overestimate 
degradation rates 
 Detection limits: Absence or low detection of some compounds in analysed wastewaters were 
reported as < detection limits values (lower than detection limits) of corresponding drugs. 
 Calculation of water-solid partition coefficient (Kd): If degradation is taking place as well as 
sorption, the estimated (measured) Kd is subject to error and may not accurately reflect the 
actual physical Kd. 
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Worked example of cocaine degradation data in Molesworth primary sludge in Table 21 below: 
To obtain degradation data of cocaine in primary sludge batch tests at 19 ± 0.5
o
C: 
Initial spiked cocaine concentration = 12.500 mg in 250 mL flask (50 mg L
-1
 of sewage). 
Each batch of sample contained 0.5 mg (500 µg in 10 mL). 
Every 15 min, 20 mL of aliquot (2 x10 mL) were removed out and analysed over a total period of 3h. 
The duplicate samples 1 and 2 had cocaine distributed in both aqueous and solid phases as calculated 
in the following steps using calibration graphs in Appendix 2B: 
Cocaine Calibration Equation   (y) =13223636.07x      
(Note: Detector concentration of  ng/µL (equivalent to µg/mL of sample solution concentration) 
 
Step 1: 
 
Cocaine TIC area for sample 1 (aqueous) = 282496537 
Cocaine TIC area for sample 2 (aqueous) = 285194159 
 
Cocaine TIC area for sample 1 (solid) = 69133169 
Cocaine TIC area for sample 2 (solid) = 70759677 
 
Step 2: 
 
Substitution into above calibration equation of cocaine gives: 
sample 1 (aqueous):  282496537 = 13223636.07x 
sample 2 (aqueous):  285194159 = 13223636.07x 
 
sample 1 (solid): 69133169 = 13223636.07x 
sample 2 (solid): 70759677=13223636.07x 
 
Step 3: 
 
Since duplicate of 10 mL of aliquot were concentrated by drying under nitrogen  into 1 mL for 
measurement, therefore: 
Sample 1 (aqueous): x = 21.363 µg in 10 mL                    
Sample 2 (aqueous): x  = 21.567 µg in 10 mL                    
                       Mean = 21.466 µg in 10 mL                    
 
Sample 1 (solid): x  = 5.228 µg in 10 mL 
Sample 2 (solid): x  = 5.351 µg in 10 mL  
                  Mean = 5.29 µg in 10 mL    
Step 4:                 
The concentrations in 250 mL flask with % recovery of cocaine in PS (Table 14) re-computed back: 
Sample 1 (aqueous) = (21.363 µg x 25) = 534.075 µg in 250 mL                    
Sample 2 (aqueous) = (21.567 µg x 25) = 539.175 µg in 250 mL                    
Mean = 536.625 µg in 250 mL ÷   91.5% (cocaine recovery in PS) = 586.5 µg in 250 mL        
 
Sample 1 (solid) = (5.228 µg x 25) = 130.700 µg in 250 mL                    
Sample 2 (solid) = 5.351 µg x 25) = 133.775 µg in 250 mL                    
Mean = 132.238 µg in 250 mL ÷ 91.5% (cocaine recovery in PS) = 144.522 µg in 250 mL                        
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The remaining sewage sample volume in the flask would be 230 mL. 
After 30 min, another 20 mL of aliquot (2 x10 mL) were also removed and analysed as above. 
The concentrations would now be multiplied by 23 to give the cocaine concentration left in 230 mL 
After 45 min, another 20 mL of aliquot (2 x10 mL) was also removed and analysed as above. 
The concentrations would now be multiplied by 21 to give the cocaine concentration left in 210 mL 
 
Duplicate samples were taken at every time scale (15 min) and cocaine concentrations in each of the 
successive 190, 170, 150, 130, 110, 90, 70, 50, 30 mL of sewage samples were calculated for 3hrs. 
Spiked drugs removal rates calculations: 
Cdegrad = C initial – C aqueous - Csolids                                                                                                                             [eqn 6] 
 ‘C’ represents concentrations of each drug in different media. 
Therefore, COC degraded (Cdegrad) = [12500 – 586.5 – 144.5]  
                                                          =11769.0 µg (in 250 mL flask). 
The sorption behaviour using apparent solid-water partition coefficient (Kd, in Kg L
-1
) in treatment 
units was calculated from eqn 7 below [353]:   
                                   Kd = Csorbed/SS. Csoluble                                                                                                            [eqn 7] 
  Where Csorbed = chemical concentration in sorbed phase (µg L
-1
) and Csoluble  is concentration in 
aqueous (µg L
-1
) and SS = suspended solids concentration   (Kg  L
-1
) using data from Table 16. 
So, for cocaine in PS, we have 21.5 µg/10 mL, or 2,150 µg/L in aqueous phase and 5.29 µg in the 
solids from 10 mL . 
From Table 15, the PS has 77, 387 mg/L solids and so in 10 mL sample, 773 mg.  
We have 5.29/773 µg/mg = 6835 µg/kg 
                             Therefore, Kd = 6835/2150 = 3.17 Kg/L 
Any difference in the concentration between original drug concentration in the raw samples and 
concentration in filtered aqueous phase is accounted for by association with solids or degradation. 
Drug concentration as percent removals were therefore expressed using the equation 8 below [281]: 
% removal = 100 [initial drug] – [final drug in aqueous phase] 
                                                             [Initial drug]                                                       [eqn 8] 
                                                = 100 × [12500 - 586.5] ÷ [12500] 
                                            = 95.3% 
Concentration data in the batch experiment are contained in Appendix 4 expressed in duplicate 
measurement and presented below in Tables 21 – 40. 
4.2.2 Evaluation of degradation and removal of drugs in primary and secondary sludge 
treatment samples. 
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For our batch tests, a 3h contact time was selected (though 2h was average period of a process unit in 
RAF Molesworth STW under the hydraulic conditions) to extensively monitor the degradation 
processes. Samples of primary sludge and SAF-1 (250 mL) at 19± 0.5
o
C were spiked with 12.5 mg of 
each drug (cocaine, benzoylecgonine, heroin, morphine, 6-monoacetylmorphine and diazepam). The 
samples were mixed thoroughly and 2 x 10 mL aliquots were removed at timed interval (15 min) over 
a period of 3h. Table 21 shows the degradation of cocaine in both primary and secondary aerated 
sludge increased with exposure time with corresponding increment in their degradation products.  
A very rapid abiotic removal was observed in the first 15 min of cocaine degradation in primary 
sludge in batch sudies. This observation was rather different from generally accepted positions from 
the literature that no significant degradation occurs in primary sedimentation [354]. But over a period 
of 3h, the cocaine showed decline in concentration with its uneven distribution between both solid and 
aqueous phases in a pattern that reflects their hydrophobic/hydrophilic nature.  As compounds become 
lesser in concentration, the degradation products such as ecgoine methyl ester and cocaethylene were 
simultaneously identified and quantified. As degradation progressed the degradation products pattern 
could not be properly followed due to their diffuse nature of being further degraded as they are 
formed. The benzoylecgonine (a principal hydrolysis product) could not be detected possibly due non 
– hydrolysis as cocaine has been reported to be stable in pond water in pH = 2 at 25oC for 5 days 
[132] or low detection. But the presence of ecgonine methyl ester and cocaethylene (other bio-
degradation products of cocaine) were observed as presented in Appendix 4 (Table 1B, 1C, 2B and 
2C) confirming the presence of  bio-degradation processes in primary sludge.It must however be 
generally emphasised that compound removal from aqueous phase in sewage may not indicate their 
complete degradation. 
However, the partition fractions of each batch test with drug and their related metabolites were 
analysed and related to sludge types under the same condition.  Similar degradation was observed in 
both sludges showing that biological aeration sludge in secondary treatment had little influence. The 
sorption behaviour of compounds was assessed by solid-water partition coefficient (Kd, L/Kg), as 
calculated by Csorbed/SS.Csoluble  (where Csorbed = chemical concentration in sorbed phase, Csoluble is 
concentration in aqueous SS = suspended solids). The Kd values were calculated for each time period 
from batch studies data, the 2-3 HRT is the usual processing time in the Molesworth STW. The 
observed low solid-water partition coefficient for cocaine (Kd < 14) in both sludges indicated low 
sorption as the removal mechanism but since recovery experiment for the solid could not completed, 
further experiment is needed fo confirmation. From the results presented here, the Kd values for 
cocaine and other drugs (Table 20- 25) ranged from 1.2 – 68.1 were however generally very much 
lower than the range of 12300 – 37700 L/Kg calculated for detected ten quinolone and 
fluoroquinolone antibiotics in a municipal SWT [290]. 
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Table 21: Degradation of cocaine in Primary and SAF-1 sludge batch tests at 19 ± 0.5oC (Data derived from, 
Table 2A & 5A in Appendix 5) 
*Kd is solid-water partition coefficient (Kg L
-1
). 
 
Over 98% removal of cocaine was achieved in 3h. Comparing removal efficiencies from 
concentration of cocaine in raw pimary sewage and SAF-1 gave about 10% difference in 2h. Also in 
every 15 min, empirical relationship exists between cocaine dissolved, sorbed and degraded as they 
all relate to each other and added up to 12500 ug.  This approach was later applied in mass balance 
calculations to capture the degradation process and transport of compounds in STW units. 
The pattern of degradation observed for cocaine was the same for benzoylecgonine (BZE) but with 
relatively higher degradation in primary sludge (Table 22). As one of the major human metabolites of 
cocaine, its biodegradation studies in aquatic environment become important to understand the final 
fate of cocaine. In the current study, its sorption potential (Kd < 2.5) indicated biodegradation as 
predominant removal process compare to sorption to solids. But the removal efficiencies of BZE in 
both PS and SAF-1 also showed 10% difference in 2h. 
Also, morphine is one of the metabolites of heroin; it was selected primarily to monitor its 
biodegradability and its final fate. Therefore, Table 23 show the result of a relative higher degradation 
of morphine within a biological secondary aerated sludge compare to primary sludge as observed 
from our batch studies, but like cocaine and BZE, a lower sorption potential of 0.1 – 1.3 made  
degradation a significant removal process with 85 – 99% and 94 – 100% removal of morphine.  
 
 
 
 
Time 
(min) 
                         
Conc. of cocaine (µg in 250 ml of primary sludge) 
 
 
Conc. of cocaine (µg in 250 ml of SAF-1 sludge) 
COC 
soluble 
COC 
sorbed 
COC 
degraded 
Kd
*
 Removal 
(%) 
COC 
soluble 
COC 
sorbed 
COC 
degraded 
Kd
*
 Removal 
(%) 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
586.5 
433.3 
435.0 
425.8 
371.6 
225.3 
221.3 
195.8 
158.1 
122.1 
82.6 
46.0 
144.5 
186.2 
94.5 
87.9 
110.6 
80.8 
63.3 
50.3 
53.2 
38.0 
22.8 
9.5 
11769.0 
11880.5 
11970.5 
11986.3 
12017.8 
12193.9 
12215.5 
12253.8 
12288.6 
12339.9 
12394.6 
12444.5 
3.2 
5.6 
2.8 
2.7 
3.8 
4.6 
3.7 
3.3 
4.4 
4.0 
3.6 
2.7 
95.3 
96.5 
96.5 
96.6 
97.0 
98.2 
98.2 
98.4 
98.7 
99.0 
99.3 
99.6 
4619.4 
4198.6 
3367.1 
3405.2 
3003.1 
2553.9 
1722.5 
1413.1 
1155.2 
658.3 
502.4 
306.2 
3983.6 
3635.0 
3151.9 
2384.7 
2109.6 
1391.4 
853.9 
1018.8 
659.1 
579.1 
311.1 
229.1 
3897.0 
4666.4 
5981.0 
6710.0 
7387.3 
8554.7 
9923.6 
10068.1 
10685.8 
11262.6 
11686.6 
11964.6 
12.2 
12.2 
13.2 
9.9 
9.9 
7.7 
7.0 
10.2 
8.1 
12.4 
8.8 
10.6 
63.0 
66.4 
73.1 
72.8 
76.0 
79.6 
86.2 
88.7 
90.8 
94.7 
96.0 
97.6 
88 
 
Table 22: Degradation of BZE in PS and SAF-1 sludge batch tests at 19 ± 0.5oC (Data derived from Table 15 
& 17 in Appendix 5) 
 
Though many of the biological wastewater units have different characteristics, yet most compounds 
tend to exhibit general tendencies to accumulate to solids and sediments. But the removal rate of 
morphine appears to be related to degradation processes and less of sorption.  Gradual removal rate of 
morphine in both primary and secondary sewage with the decline in the concentration of morphine 
may be due to bio-degradation mechanism.  
In this current work, comparable removals of benzoylecgonine with cocaine infer that sorption may 
not be the only removal mechanisms.  Gradual decline in the concentration profile of benzoylecgonine 
(Table 22), morphine (Table 23), 6-MAM (Table 24) and diazepam (Table 26) were apparent but 
degradation producs of the two compounds could not be identified in both primary and SAF-1. 
However, the measurement of the degradation products of heroin (morphine and 6-MAM) provided 
evidence of degradation as presented in the Appendix 4 (Table 36b, 36c, 37b, 37c and 38b) in PS and 
SAF-1. Again, degradation products occurring simultaneously limited the accurate measurements of 
all metabolites as the degradation was going on. 
 
 
 
 
 
 
 
 
 
Time 
(min) 
                         
Conc. of BZE (µg in 250 ml of primary sludge) 
 
 
Conc. of BZE (µg in 250 ml of SAF-1 sludge) 
BZE 
soluble 
BZE 
sorbed 
BZE 
degraded 
Kd 
Removal 
(%) 
BZE 
soluble 
BZE 
sorbed 
BZE 
degraded 
Kd 
Removal 
(%) 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
406.3 
355.4 
319.4 
288.7 
240.9 
206.2 
166.3 
119.4 
101.9 
77.3 
43.3 
25.6 
89.8 
110.1 
88.4 
88.8 
141.8 
126.7 
136.4 
119.3 
123.2 
113.0 
86.1 
63.3 
12003.9 
12034.5 
12092.2 
12122.5 
12117.3 
12167.2 
12197.2 
12261.3 
12274.9 
12309.8 
12370.6 
12411.1 
2.9 
4.0 
3.6 
4.0 
7.6 
7.9 
10.6 
12.9 
15.6 
18.9 
25.7 
31.9 
96.7 
97.2 
97.4 
97.7 
98.1 
98.4 
98.7 
99.0 
99.2 
99.4 
99.7 
99.8 
6117.5 
3919.4 
3112.9 
2615.1 
2495.2 
2069.2 
1746.9 
1505.9 
1256.0 
912.6 
600.8 
364.8 
2824.4 
1755.7 
1175.1 
1656.0 
1443.9 
1183.1 
1033.7 
856.9 
692.7 
519.9 
368.3 
211.3 
3558.1 
6824.9 
8211.9 
8228.8 
8561.0 
9247.7 
9719.4 
10137.2 
10551.4 
11067.5 
11530.9 
11923.8 
6.5 
6.3 
5.3 
9.0 
8.2 
8.1 
- 
- 
- 
- 
8.7 
8.2 
51.1 
68.6 
75.1 
79.1 
80.0 
83.4 
86.0 
88.0 
90.0 
92.7 
95.2 
97.1 
89 
 
Table 23: Degradation of Morphine in PS and SAF-1 sludge batch tests at 19 ± 0.5oC (Data derived from 
Table 22 & 24 in Appendix 5) 
 
Another human metabolite of heroin studied in both primary and secondary treatment sludge was 6-
monoacetylmorphine (6-MAM) and results presented in Table 24. The idea was to observe the 6-
MAM trend of degradation to know its final fate.  Unlike the four compounds studied earlier, i 6-
ACM showed similar degradation in the primary sludge with corresponding low sorption potential (Kd 
< 9) and removal efficiency of between 98 – 100 % in PS, but removal rates were relatively slower 
after 2h of exposure in SAF-1 (19 – 86 %) from the result shown.  In real time, after 2h treatment 
there are possibilities of most compounds in aqueous phase to pass on to the next treatment tank due 
to the average 2 HRT for RAF Molesworth. However, the observed variability in degradationpattern 
may likely make the removal of 6-MAM faster in primary sludge than in SAF-1. Heroin and 
diazepam in Table 25 and 26 follow the pattern observed in cocaine. The heroin has over 96% 
removal in both sludges, but in Table 26, diazepam showed more removal in primary sludge. 
 
 
 
 
 
 
 
 
Time 
(min) 
                         
Conc. of  MOR (µg in 250 mL of primary sludge) 
 
 
Conc. of  MOR (µg in 250 mL of SAF-1 sludge) 
MOR 
soluble 
MOR 
sorbed 
MOR 
degraded 
Kd 
Removal 
(%) 
MOR 
soluble 
MOR 
sorbed 
MOR. 
degraded 
Kd 
Removal 
(%) 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1901.8 
1678.9 
1434.8 
1178.4 
1029.2 
843.7 
641.7 
486.8 
399.3 
287.4 
163.7 
58.3 
429.3 
430.0 
361.7 
355.8 
398.2 
304.1 
283.1 
192.3 
207.9 
146.2 
125.3 
73.8 
10168.9 
10391.1 
10703.5 
10965.8 
11072.6 
11352.2 
11575.2 
11820.9 
11892.8 
12066.4 
12211.0 
12367.9 
3.1 
3.9 
3.7 
3.3 
5.1 
6.6 
6.2 
6.4 
5.0 
7.4 
6.7 
4.6 
84.8 
86.6 
88.5 
90.6 
91.8 
93.3 
94.9 
96.1 
96.8 
97.7 
98.7 
99.5 
698.7 
411.2 
363.2 
329.0 
248.9 
210.5 
171.2 
145.3 
87.7 
41.7 
24.1 
13.7 
98.6 
128.4 
116.0 
91.0 
68.6 
62.2 
63.3 
60.5 
40.7 
36.1 
25.9 
15.3 
11702.7 
11960.4 
12020.8 
12080.0 
12182.5 
12227.4 
12265.5 
12294.1 
12371.6 
12422.2 
12449.9 
12471.0 
3.3 
4.2 
4.0 
3.6 
5.6 
7.2 
7.4 
7.9 
5.5 
8.1 
7.3 
5.1 
94.4 
96.7 
97.1 
97.4 
98.0 
98.3 
98.6 
98.8 
99.3 
99.7 
99.8 
99.9 
90 
 
Table 24: Degradation of 6-MAM in PS and SAF-1 sludge batch tests at 19 ± 0.5oC (Data derived from Table 
29 & 31 in Appendix 5) 
 
 
 
Table 25: Degradation of Heroin in PS and SAF-1 sludge batch tests at 19 ± 0.5oC (Data derived from Table  
36A & 38A in Appendix 5) 
 
 
 
 
Time 
(min) 
                         
Conc. of  6-ACM (µg in 250 mL of primary sludge) 
 
 
Conc. of 6-ACM (µg in 250 mL of SAF-1 sludge) 
6MAM 
soluble 
6MAM 
sorbed 
6MAM. 
degraded 
Kd 
Removal 
(%) 
6MAM 
soluble 
6MAM 
sorbed 
6MAM. 
degraded 
Kd 
Removal 
(%) 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
213.7 
160.8 
123.8 
101.6 
70.3 
60.1 
59.8 
47.0 
24.8 
18.9 
13.4 
6.2 
14.9 
13.4 
11.1 
9.1 
9.2 
8.4 
10.0 
7.9 
7.6 
7.1 
5.1 
3.3 
12271.4 
12325.8 
12365.1 
12389.3 
12420.6 
12431.5 
12430.2 
12445.0 
12467.6 
12474.0 
12481.5 
12490.5 
1.6 
1.3 
1.2 
1.2 
2.5 
1.9 
3.3 
3.0 
2.2 
3.1 
5.1 
7.1 
98.3 
98.7 
99.0 
99.2 
99.4 
99.5 
99.5 
99.6 
99.8 
99.8 
99.9 
100.0 
10135.8 
7091.8 
6023.9 
6195.8 
5234.1 
3724.6 
2302.7 
1750.4 
1360.5 
1042.2 
799.2 
394.6 
1693.6 
1045.0 
1043.5 
916.8 
668.1 
663.9 
896.1 
754.9 
606.9 
517.3 
292.4 
148.8 
670.6 
4363.2 
5432.6 
5387.4 
6597.8 
8111.5 
9301.3 
9994.7 
10532.6 
10940.4 
11408.4 
11956.6 
2.3 
2.7 
2.5 
2.6 
1.8 
2.5 
5.2 
6.3 
5.4 
7.0 
5.3 
5.2 
18.9 
43.3 
51.8 
50.4 
58.1 
70.2 
81.6 
86.0 
89.1 
91.7 
93.6 
96.8 
 
Time 
(min) 
                         
Conc. of  HER (µg in 250  mL of primary sludge) 
 
 
Conc. of HER (µg in 250 mL of SAF-1 sludge) 
HER 
soluble 
HER 
sorbed 
HER. 
degraded 
Kd 
Removal 
 (%) 
HER 
soluble 
HER 
sorbed 
 HER. 
degraded 
Kd 
Removal 
(%) 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
480.0 
414.1 
286.3 
276.4 
204.2 
167.7 
140.3 
80.4 
61.0 
34.7 
24.0 
14.7 
677.0 
652.6 
459.4 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
11343.0 
11433.3 
11754.3 
12223.6 
12295.8 
12332.3 
12359.7 
12419.6 
12439.0 
12465.3 
12476.0 
12485.3 
18.2 
20.4 
20.8
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
96.2 
96.7 
97.7 
97.8 
98.4 
98.7 
98.9 
99.4 
99.5 
99.7 
99.8 
99.9 
55.4 
46.0 
47.1 
36.3 
33.4 
27.8 
21.6 
17.7 
16.2 
9.2 
7.0 
4.6 
80.0 
72.5 
64.8 
62.4 
38.0 
38.9 
28.6 
17.3 
21.4 
15.9 
6.3 
3.4 
12364.6 
12381.4 
12388.1 
12401.3 
12428.6 
12433.3 
12449.9 
12465.0 
12462.4 
12474.9 
12486.7 
12492.0 
9.7 
26.1 
19.4 
26.9 
16.1 
19.8 
18.7 
12.0 
18.7 
24.4 
12.8 
15.1 
99.6 
99.6 
99.6 
99.7 
99.7 
99.8 
99.8 
99.9 
99.9 
99.9 
99.9 
100.0 
91 
 
Table 26: Degradation of Diazepam in PS and SAF-1 sludge batch tests at 19 ± 0.5oC (Data derived from 
Table 43A & 45 in Appendix 5) 
 
4.2.2.1. Removal of drugs during primary sewage treatment:  
Figure 23 further demonstrates the degradation as a removal mechanism for all drugs at different rates 
with decline in various compounds concentrations distributed between aqueous and solid phases.  
 
 Figure 23: Degradation of compounds in primary sludge at time (A) 15 min and (B) 3h, demonstrating the 
change in distribution/partitioning as drugs degrade at 19± 0.5
o
C. (Data derived from Table 19 - 24) 
 
 
Time 
(min) 
                         
Conc. of  DIAZ (µg in 250 mL of primary sludge) 
 
 
Conc. of DIAZ (µg in 250 mL of SAF-1 sludge) 
DIAZ 
soluble 
DIAZ 
sorbed 
DIAZ. 
degraded 
Kd 
Removal 
(%) 
DIAZ 
soluble 
DIAZ 
sorbed 
DIAZ. 
degraded 
Kd 
Removal 
(%) 
    15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
2015.7 
1547.0 
1401.2 
1093.9 
979.9 
653.6 
597.8 
439.4 
307.7 
190.8 
118.8 
37.0 
4919.3 
4504.2 
2933.2 
3229.7 
3028.4 
2690.2 
2104.9 
1887.4 
1506.1 
1301.3 
883.8 
508.1 
5565.1 
6448.8 
8165.6 
8176.4 
8491.7 
9156.2 
9797.3 
10173.2 
10686.2 
11008.0 
11497.4 
11954.9 
10.5 
12.6 
10.0 
10.7 
13.3 
17.6 
15.2 
18.6 
21.2 
29.5 
32.2 
66.7 
83.9 
87.6 
88.8 
91.2 
92.2 
94.8 
95.2 
96.5 
97.5 
98.5 
99.0 
99.7 
131.2 
120.7 
106.5 
93.8 
83.3 
71.0 
60.5 
50.5 
36.8 
28.6 
11.8 
6.9 
447.1 
400.3 
349.3 
281.6 
254.8 
208.8 
168.8 
142.3 
112.8 
84.8 
58.4 
33.1 
11921.7 
11979.0 
12044.1 
12124.6 
12161.8 
12220.2 
12270.7 
12307.2 
12350.4 
12386.6 
12429.8 
12460.0 
26.5 
- 
46.4 
36.8 
31.8 
41.6 
51.5 
46.0 
43.4 
46.1 
69.9 
68.1 
99.0 
99.0 
99.1 
99.2 
99.3 
99.4 
99.5 
99.6 
99.7 
99.8 
99.9 
99.9 
92 
 
In Figure 24, it can also be seen that all drug concentrations falls rapidly within the first hour of 
exposure to sewage with significant removals within the time of contact but slows down as 
biodegradation advances. Diazepam showed slower degradation but greater pattern of distribution in 
the aqueous phase as biodegradation progressed over 3 hour periods.  
 
Figure 24: Plot showing combined concentrations of drugs in aqueous and solid phases in primary sewage 
sludge at 19± 0.5
o
C. (Data derived from Table 19 - 24) 
The concentration of compounds decreases with concurrent accumulation of metabolites such as 
ecgoninemethylester, benzoyecgonine and cocaethylene for cocaine, morphine and 6-
monoacetylmorphine for heroin and nordiazepam for diazepam which were in turn being further 
biodegraded. A second experiment to evaluate the significance of adsorption or degradation on 
retention time and its effects on removal rates was carried out. The results in Figure 25 below shows 
the removal rates of different compounds due to their different association with primary sewage solids 
(suspended solids concentration of 77387 mg L
-1
) and different degradation rates.  The two 
mechanisms were significant in the removal of compounds in the primary sedimentation unit over the 
range of retention times with more than 80% removal achieved within the first hour of contact. 
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Figure 25: The effect of retention time on the removal of compounds during primary treatment processes. 
(Data derived from Table 19 - 24) 
4.2.2.2. Removal of drugs during secondary sewage treatment:  All six compounds exhibited 
significant but different removal rates over 3h retention time and the results are presented in Figure 
26.  
 
Figure 26:  Degradation of compounds in SAF-1 sludge at time (A) 15 min and (B) 3h, demonstrating the 
change in distribution/partitioning as drugs degrade at 19± 0.5
o
C.  (Data derived from Table 19 - 24)   
The illustration of combined concentrations of drugs in aqueous and solid phases in the same 
secondary sewage sample at 19± 0.5
o
C is shown in Figure 27. Most compounds expectedly showed 
greater degradation in biological secondary sewage compared to the pattern observed in primary 
sludge in Figure 24. 
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Figure 27. Plot showing combined concentrations of drugs in aqueous and solid phases in secondary sewage 
sludge (SAF-1) at 19± 0.5
o
C. 
 
In Figure 28, the effect of retention time on the removal of compounds during the secondary sewage 
processes can be seen with 6-monacetylmorphine, benzoylecgonine and cocaine showing average 
removal rate in the first hour of contact. Since others exhibited maximum removals at the same period 
of exposure, it was found that the removal of compounds at 19± 0.5
o
C was favourable being the 
normal operational temperature of most STWs. 
 
Figure 28: The effect of retention time on the removal of compounds during secondary treatment. (Data 
derived from Table 19 - 24) 
4.2.3. Comparison of Kd values to LogKow data. 
The octanol-water partition coefficient (Log Kow) is a laboratory-measured property of a substance 
that is recognized and are used extensively in environmental chemistry as it provides a 
thermodynamic measure of the tendency of the substance to prefer a non-aqueous or oily phase rather 
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than water (i.e. its hydrophilic/lipophilic balance).  But the water-solid partition coefficient (Kd) 
measured for the selected illicit drugs and abused pharmaceuticals in the current work were generally 
higher compare with literature Log Kow data range of 1.6 – 2.9 in Table 10 as against 1.2 – 69.9. in 
Table 27 for the drugs. Again, calculating of Kd changes at the timed interval of 15 minutes for 3h 
could introduce uncertainties as the values would be higher with higher recoveries from the sludge 
types. However, Table 27 below generally show the relatively higher Kd values in secondary sludge 
compare to primary sludge with diazepam showing greater values in both sludge types. 
Table 27:  Data of water-solid distribution coefficients of drugs in both PS and SAF at 19± 0.5oC (Kd, Kg/L). 
4.2.4. Evaluation of biotic versus abiotic degradation. 
Further batch tests to evaluate biotic and abiotic degradation were carried out with a 250 mL of 
unfiltered primary sludge samples of the same suspended solids concentration (77387 mgL
-1
) 
measured in a flask, refrigerated at 4 ± 0.5
o
C for 30 min to inhibit biological activity before the 
sample was spiked with drugs. Both biologically active and inactive samples were taken at 15 min for 
3h. Table 28 below shows the cocaine faster degradation process at biotic temperature of 19 ± 0.5
o
C 
and a relatively slowly abiotic process at 4± 0.5
o
C were observed. The low temperature inhibited the 
biological process as gradual transformation of initial compound concentration to degradation 
products at the low temperature have demonstrated biodegradation process and chemical hydrolysis as 
two major removal mechanism, as there is no loss through volatilisation [188]. Since gradual decline 
in the levels of cocaine were observed in spite of microbial inhibition, therefore it was correct to 
 
Time 
(min) 
                                Primary sludge (PS) Submerged aerated filter (SAF) 
 
COC 
 
BZE 
 
HER 
 
6MAM MOR 
 
DIAZ 
 
COC 
 
BZE        HER       6MAM       MOR        DIAZ 
 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
3.2 
5.6 
2.8 
2.7 
3.8 
4.6 
3.7 
3.3 
4.4 
4.0 
3.6 
     2.7 
2.9 
4.0 
3.6 
4.0 
7.6 
7.9 
10.6 
12.9 
15.6 
18.9 
25.7 
31.9 
18.2 
20.4 
20.8 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
 
0.0 
1.6 
1.3 
1.2 
1.2 
2.5 
1.9 
3.3 
3.0 
2.2 
3.1 
5.1 
7.1 
3.1 
3.9 
3.7 
3.3 
5.1 
6.6 
6.2 
6.4 
5.0 
7.4 
6.7 
4.6 
10.5 
12.6 
10.0 
10.7 
13.3 
17.6 
15.2 
18.6 
21.2 
29.5 
32.2 
66.7 
12.2 
12.2 
13.2 
9.9 
9.9 
7.7 
7.0 
10.2 
8.1 
12.4 
8.8 
 10.6 
6.5 
5.3 
9.0 
8.2 
8.1 
- 
- 
- 
- 
8.7 
8.2 
6.3 
9.7 
26.1 
19.4 
26.9 
16.1 
19.8 
18.7 
12.0 
18.7 
24.4 
12.8 
15.1 
2.3 
2.7 
2.5 
2.6 
1.8 
2.5 
5.2 
6.3 
5.4 
7.0 
5.3 
5.2 
3.3 
4.2 
4.0 
3.6 
5.6 
7.2 
7.4 
7.9 
5.5 
8.1 
7.3 
5.1 
26.5 
- 
46.4 
36.8 
31.8 
41.6 
51.5 
46.0 
43.4 
46.1 
69.9 
68.1 
96 
 
assume that bio-degradation was part of the removal processes and not only chemical degradation and 
reported in the performance differences of both activated sludge and trickling filters experiment [261].  
Several reports of  biological degradations such as the fate and behaviour of endocrine disrupters in 
wastewaters treatment processes in which the degradation of nonylphenolic surfactants in activated 
sludge batch tests and their removals were not by biological processes alone  have been shown [238]. 
In the behaviour of the s-triazine herbicides, atrazine and simazine, during primary and secondary 
biological waste water treatment [281], the removal of s-triazine was also not by bio-degradation as 
the primary degradation products in the two experiments were not obvious hence their removal was 
sorption to the solids. However, the observed rapid abiotic removal of cocaine was in contrast to the 
observation of Gheorghe et al (132) in their “analysis of cocaine and its principal metabolites in waste 
and surface water using solid-phase extraction and liquid chromatography-ion trap tandem mass 
spectrometry” where cocaine was reported to be stable for 5 days at 20 oC. Stability of cocaine and 
benzoylecgonine may be influenced by matrices due to difference in bacteria population that may aid 
bio-degradation. Apart from chemical hydrolysis of cocaine to benzoylecgonine, another bio-
degradation product of cocaine is ecgonine methylester at pH = 2 and its formation may or may not be 
as rapid depending on the matrice composition. However, significant removal of cocaine and other 
compounds may still not indicate complete degradation as some might undergo partitioning into solid 
phase. Since the recovery experiment for the solid phase was not separately conducted and this may 
have introduced uncertainty. Further study is therefore needed to confirm set conclusions to fully 
understand the partition of cocaine especially in primary sludge [261]”. 
Table 28: Degradation of cocaine in PS at biotic (19 ± 0.5oC) and abiotic (4 ± 0.5oC) temperature (Data 
derived from Table 1A & 2A in Appendix 5) 
 
Time 
(min) 
 
Conc. of  cocaine (µg in 250 mL of  PS) at 19 ± 0.5oC 
 
 
Conc. of  cocaine (µg in 250 mL of  PS) at 4 ± 0.5oC 
  
COC 
soluble 
COC 
sorbed 
COC 
degraded 
Kd
*
 Removal 
(%) 
COC 
soluble 
COC 
sorbed 
   COC 
degraded 
Kd
*
 Removal 
(%) 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
586.5 
433.3 
435.0 
425.8 
371.6 
225.3 
221.3 
195.8 
158.1 
122.1 
82.6 
46.0 
144.5 
186.2 
94.5 
87.9 
110.6 
80.8 
63.3 
50.3 
53.2 
38.0 
22.8 
9.5 
11769.0 
11880.5 
11970.5 
11986.3 
12017.8 
12193.9 
12215.5 
12253.8 
12288.6 
12339.9 
12394.6 
12444.5 
3.2 
5.6 
2.8 
2.7 
3.8 
4.6 
3.7 
3.3 
4.4 
4.0 
3.6 
2.7 
95.3 
96.5 
96.5 
96.6 
97.0 
98.2 
98.2 
98.4 
98.7 
99.0 
99.3 
99.6 
3430.2 
3114.0 
2924.7 
2235.4 
1689.5 
1442.8 
1197.9 
941.1 
733.4 
518.7 
365.5 
125.2 
205.9 
193.3 
175.2 
165.0 
148.0 
177.5 
191.4 
140.6 
165.0 
126.23 
132.7 
74.2 
8863.9 
9192.7 
9400.1 
10099.6 
10662.4 
10879.7 
11110.6 
11418.3 
11601.6 
11885.1 
12001.8 
12300.6 
0.8 
0.8 
0.8 
1.0 
1.1 
1.6 
2.1 
1.9 
4.3 
6.0 
4.7 
5.3 
72.6 
75.1 
76.6 
82.1 
86.5 
88.5 
90.4 
92.5 
94.1 
95.9 
97.1 
99.0 
97 
 
Nevertheless, treatment processes may use temperature strategy to optimise the removal of 
compounds from convectional sewage works during degradation.  
Table 29: Degradation of BZE in PS at biotic (19 ± 0.5oC) and abiotic (4 ± 0.5oC) temperature (Data derived 
from Table 14 & 15 in Appendix 5) 
 
Table 30: Degradation of Morphine in PS at biotic (19 ± 0.5oC) and abiotic (4 ± 0.5oC) temperature (Data 
derived from Table 21 & 22 in Appendix 5) 
 
 
Time 
(min) 
 
Conc. of  BZE (µg in 250 mL of  PS) at 19 ± 0.5oC 
 
 
Conc. of  BZE (µg in 250 mL of  PS) at 4 ± 0.5oC 
  
BZE 
soluble 
BZE 
sorbed 
BZE. 
degraded 
Kd 
Removal 
(%) 
BZE 
soluble 
BZE 
sorbed 
BZE. 
degraded 
Kd 
Removal 
(%) 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
406.3 
355.4 
319.4 
288.7 
240.9 
206.2 
166.3 
119.4 
101.9 
77.3 
43.3 
25.6 
89.8 
110.1 
88.4 
88.8 
141.8 
126.7 
136.4 
119.3 
123.2 
113.0 
86.1 
63.3 
12003.9 
12034.5 
12092.2 
12122.5 
12117.3 
12167.2 
12197.2 
12261.3 
12274.9 
12309.8 
12370.6 
12411.1 
2.9 
4.0 
3.6 
4.0 
7.6 
7.9 
10.6 
12.9 
15.6 
18.9 
25.7 
31.9 
96.7 
97.2 
97.4 
97.7 
98.1 
98.4 
98.7 
99.0 
99.2 
99.4 
99.7 
99.8 
6101.6 
2914.3 
2619.1 
2367.2 
1975.5 
1690.4 
1364.0 
979.1 
835.9 
633.5 
354.8 
210.1 
736.7 
902.6 
725.0 
728.2 
1162.9 
1038.7 
1118.8 
978.5 
1009.9 
926.5 
705.9 
518.8 
5661.8 
8683.2 
9155.8 
9404.6 
9361.6 
9770.9 
10017.1 
10542.4 
10654.2 
10940.0 
11439.3 
11771.1 
1.6 
4.0 
3.6 
4.0 
7.6 
7.9 
10.6 
12.9 
15.6 
18.9 
25.7 
31.9 
51.2 
76.7 
79.0 
81.1 
84.2 
86.5 
89.1 
92.2 
93.3 
94.9 
97.2 
98.3 
 
Time 
(min) 
 
Conc. of  MOR (µg in 250 mL of  PS) at 19 ± 0.5oC 
 
 
Conc. of  MOR (µg in 250 mL of  PS) at 4 ± 0.5oC 
  
MOR 
soluble 
MOR 
sorbed 
MOR. 
degraded 
Kd 
Removal 
(%) 
MOR 
soluble 
MOR 
sorbed 
MOR. 
degraded 
 
Kd 
Removal 
(%) 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1901.8 
1678.9 
1434.8 
1178.4 
1029.2 
843.7 
641.7 
486.8 
399.3 
287.4 
163.7 
58.3 
429.3 
430.0 
361.7 
355.8 
398.2 
304.1 
283.1 
192.3 
207.9 
146.2 
125.3 
73.8 
10168.9 
10391.1 
10703.5 
10965.8 
11072.6 
11352.2 
11575.2 
11820.9 
11892.8 
12066.4 
12211.0 
12367.9 
3.1 
3.9 
3.7 
3.3 
5.1 
6.6 
6.2 
6.4 
5.0 
7.4 
6.7 
4.6 
84.8 
86.6 
88.5 
90.6 
91.8 
93.3 
94.9 
96.1 
96.8 
97.7 
98.7 
99.5 
9716.4 
8764.9 
7773.9 
5801.2 
6057.4 
3927.8 
4158.5 
3504.3 
2835.5 
1976.5 
1485.7 
804.6 
137.0 
121.6 
120.5 
108.5 
108.9 
91.1 
80.3 
66.0 
62.0 
49.6 
35.8 
23.1 
2646.6 
3613.5 
4605.6 
6590.2 
6333.7 
8481.1 
8261.2 
8929.7 
9602.5 
10473.9 
10978.5 
11672.3 
0.2 
0.1 
0.2 
0.5 
1.9 
1.7 
0.8 
0.5 
0.4 
1.1 
1.4 
1.6 
22.3 
29.9 
37.8 
53.6 
51.5 
68.6 
66.7 
72.0 
77.3 
84.2 
88.1 
93.6 
98 
 
Table 31: Degradation of 6-MAM in PS at biotic (19 ± 0.5oC) and abiotic (4 ± 0.5oC) temperature (Data 
derived from Table 28 & 29 in Appendix 5) 
 
 
Table 32: Degradation of Heroin in PS at biotic (19 ± 0.5oC) and abiotic (4 ± 0.5oC) temperature (Data derived 
from Table 35A & 36A in Appendix 5) 
 
 
 
 
Time 
(min) 
 
Conc. of  6-MAM  (µg in 250 mL of  PS) at 19 ± 0.5oC 
 
 
Conc. of  6-MAM (µg in 250 mL of  PS) at 4 ± 0.5oC 
  
6MAM 
soluble 
6MAM 
sorbed 
6MAM. 
degraded 
Kd 
Removal 
(%) 
6MAM 
soluble 
6MAM 
sorbed 
6MAM. 
degraded 
Kd 
Removal 
(%) 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
213.7 
160.8 
123.8 
101.6 
70.3 
60.1 
59.8 
47.0 
24.8 
18.9 
13.4 
6.2 
14.9 
13.4 
11.1 
9.1 
9.2 
8.4 
10.0 
7.9 
7.6 
7.1 
5.1 
3.3 
12271.4 
12325.8 
12365.1 
12389.3 
12420.6 
12431.5 
12430.2 
12445.0 
12467.6 
12474.0 
12481.5 
12490.5 
1.6 
1.3 
1.2 
1.2 
2.5 
1.9 
3.3 
3.0 
2.2 
3.1 
5.1 
7.1 
98.3 
98.7 
99.0 
99.2 
99.4 
99.5 
99.5 
99.6 
99.8 
99.8 
99.9 
100.0 
572.5 
616.3 
564.4 
463.4 
373.7 
282.0 
243.2 
214.5 
113.1 
85.2 
61.3 
39.2 
69.8 
62.7 
52.1 
42.6 
50.9 
39.2 
61.3 
49.2 
35.5 
33.1 
23.9 
15.6 
11857.6 
11820.9 
11883.5 
11994.0 
12075.4 
12178.8 
12195.6 
12236.3 
12351.4 
12381.6 
12414.8 
12445.2 
1.6 
1.3 
1.2 
1.2 
2.5 
1.9 
3.3 
3.0 
2.2 
3.1 
5.1 
7.1 
95.4 
95.1 
95.5 
96.3 
97.0 
97.7 
98.1 
98.3 
99.1 
99.3 
99.5 
99.7 
 
Time 
(min) 
 
Conc. of  HER (µg in 250 mL of  PS) at 19 ± 0.5oC 
 
 
Conc. of  HER (µg in 250 mL of  PS) at 4 ± 0.5oC 
  
HER 
soluble 
HER 
sorbed 
HER. 
degraded 
Kd 
Removal 
 (%) 
HER 
soluble 
HER 
sorbed 
HER. 
degraded 
 
Kd 
Removal 
(%) 
    15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
480.0 
414.1 
286.3 
276.4 
204.2 
167.7 
140.3 
80.4 
61.0 
34.7 
24.0 
14.7 
677.0 
652.6 
459.4 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
11343.0 
11433.3 
11754.3 
12223.6 
12295.8 
12332.3 
12359.7 
12419.6 
12439.0 
12465.3 
12476.0 
12485.3 
18.2 
20.4 
20.8
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
96.2 
96.7 
97.7 
97.8 
98.4 
98.7 
98.9 
99.4 
99.5 
99.7 
99.8 
99.9 
1665.4 
1444.5 
1030.3 
1068.9 
908.5 
608.6 
476.6 
278.6 
208.0 
154.2 
110.8 
66.4 
2382.9 
2293.3 
1612.4 
1345.2 
1155.6 
803.3 
530.3 
301.4 
238.7 
186.4 
133.0 
90.0 
8451.7 
8762.3 
9857.3 
10085.9 
10435.9 
11088.1 
11493.1 
11920.1 
12053.3 
12159.4 
12256.2 
12343.6 
18.5 
20.5 
20.2 
16.3 
16.5 
17.1 
14.4 
14.0 
29.9 
20.2 
15.5 
17.5 
86.7 
88.4 
91.8 
91.4 
92.7 
95.1 
96.2 
97.8 
98.3 
98.8 
99.1 
99.5 
99 
 
Table 33: Degradation of Diazepam in PS at biotic (19 ± 0.5oC) and abiotic (4 ± 0.5oC) temperature (Data 
derived from Table 42A & 43 in Appendix 5) 
*Kd is solid-water partition coefficient. 
Figure 29 further demonstrates the results presented in Table 26 – 31, showing how microbial 
inactivity has slowed down metabolic processes with obvious relative slower changes in 
concentrations observed indicating the degradation of compounds were both biological and chemical 
with an increase degradation products and greater partitioning in solid phases. 
 
Figure 29:  Degradation of compounds in primary sludge at abiotic conditions (4± 0.5oC) demonstrating the 
change in distribution/partitioning at time (A) 15 min and (B) 3h. (Data derived from Table 25 - 30) 
 
Time 
(min) 
 
Conc. of  DIAZ (µg in 250 mL of  PS) at 19 ± 0.5oC 
 
 
Conc. of  DIAZ (µg in 250 mL of  PS) at 4 ± 0.5oC 
  
DIAZ 
soluble 
DIAZ 
sorbed 
DIAZ. 
degraded 
Kd 
Removal 
(%) 
DIAZ 
soluble 
DIAZ 
sorbed 
DIAZ. 
degraded 
Kd 
Removal 
(%) 
    15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
2015.7 
1547.0 
1401.2 
1093.9 
979.9 
653.6 
597.8 
439.4 
307.7 
190.8 
118.8 
37.0 
4919.3 
4504.2 
2933.2 
3229.7 
3028.4 
2690.2 
2104.9 
1887.4 
1506.1 
1301.3 
883.8 
508.1 
5565.1 
6448.8 
8165.6 
8176.4 
8491.7 
9156.2 
9797.3 
10173.2 
10686.2 
11008.0 
11497.4 
11954.9 
10.5 
12.6 
10.0 
10.7 
13.3 
17.6 
15.2 
18.6 
21.2 
29.5 
32.2 
66.7 
83.9 
87.6 
88.8 
91.2 
92.2 
94.8 
95.2 
96.5 
97.5 
98.5 
99.0 
99.7 
914.2 
832.3 
741.2 
687.2 
294.9 
266.3 
229.7 
193.0 
149.8 
120.6 
77.6 
41.5 
3866.1 
3878.6 
3983.4 
3677.1 
3317.1 
2958.0 
2603.8 
2203.2 
1860.0 
1446.7 
1065.5 
643.5 
7719.6 
7789.1 
7775.5 
8135.7 
8888.0 
9275.7 
9666.5 
10103.8 
10490.1 
10932.7 
11356.8 
11815.0 
50.6 
40.9 
50.5 
49.3 
99.6 
97.3 
75.7 
85.6 
93.0 
73.2 
91.8 
91.8 
92.7 
93.3 
94.1 
94.5 
97.6 
97.9 
98.2 
98.5 
98.8 
99.0 
99.4 
99.7 
100 
 
Figure 30 below further confirmed the degradations were temperature independent as chemical 
hydrolysis did occur for all compounds at low temperature.  
 
Figure 30: Plot showing combined concentrations of compounds in aqueous and solid phases in abiotic 
conditions (4± 0.5oC). (Data derived from Table 25 - 30) 
Inhibition of the biological activities in the samples was expected at 4 ± 0.5
o 
C to slow the metabolic 
processes.  Observed changes in the concentration indicating that the degradation was chemical with 
possible biological processes may be involved. No changes in the concentrations would have been 
observed if degradation were only biological, but that was not the case here as metabolic processes 
though were slowed down compared to degradation at 19± 0.5
o
C. The changes suggest chemical 
degradation of compounds indicating that the degradation was both biological and chemical. The 
temperature change affects the rate of removal of compounds with the Kd values of diazepam, 
heroin, morphine and benzoylecgonine showing greater sorption at 19± 0.5oC while 6 
monoacetylmorphine and cocaine were better sorped at 4± 0.5
o
C.  
4.2.5 Evaluation of suspended solids on the removal of compounds 
High removals of organic compounds during primary treatment have largely depended on water-solid 
partition coefficient (Kd) values which normally determine the degree of partitioning of compounds 
between aqueous and solid phases [290]. One of the major removal mechanisms of compounds is the 
association with the suspended and settleable solids which are removed in sludge after sedimentation 
in the primary sludge. In the secondary treatment processes, transformation or accumulation of 
organic pollutant onto the sewage sludge matrix depends on factors like: 
i. Sorption onto the surfaces of the biological solids or association with fats and oils 
ii. Chemical degradation such as hydrolysis 
iii. Biodegradation 
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iv. Volatilisation  
In the current work, the effect of suspended solids on the removal of compounds was done by 
evaluating the levels of compounds adsorbed onto the solids in primary sludge at 19±0.5
o
C.  
The results in Table 34 indicate  that in PS, 0.08% of cocaine was sorbed onto solids, further showing 
adsorption as one of the removal mechanisms with significant removal of diazepam in both primary 
and secondary sewage samples, compared  to cocaine, benzoylecgonine and 6-monoacetylmorphine 
removals in secondary sludge. Heroin and morphine exhibited negligible associations with the 
suspended solids and therefore have minimal removals in both primary and secondary sludge samples.  
Table 34: Adsorption of compounds onto sludge of different suspended solids concentration (%) in 3h. 
 
 
 
 
Compounds 
                                  Suspended solids (mg L
-1
) 
 
77386.5  (PS) 
 
70793.5 (SAF-1) 
 
8465.0 (MSAF) 
 
3563.5 (HS) 
Cocaine 0.08 1.83 0.17 0.09 
Benzoylecgonine 0.51 1.69 0.59 0.73 
Heroin 0.0 0.03 0.01 0.38 
Morphine 0.59 0.12 0.31 0.02 
6-monoacetylmorphine 0.03 1.19 0.02 0.0 
Diazepam 4.06 0.26 3.07 0.15 
 
Further comparison of the effects of adsorption on the removal of compounds at abiotic (4±0.5
o
C) and 
biotic (19±0.5
o
C) temperatures exhibited similar adsorption pattern (Fig. 31). However, heroin, 
cocaine and benzoylecgonine showed greater adsorption at chilling temperature whereas morphine 
and diazepam exhibited better adsorption at biotic temperature. The sorption by organic compounds 
has therefore be reported with log Kow < 2.5 (low sorption potential), log Kow > 2.5 and < 4.0 (medium 
sorption potential) and log Kow > 4.0 (high sorption potential) for chemicals that partition to organic 
phases to estimate a clear relationship with the degree of partitioning of contaminants during 
treatment [111]. 
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Figure 31: Effect of adsorption on the removal of compounds in primary sludge at (A) 4±0.5oC (B) 19±0.5oC. 
(Data derived from Table 31 - 36) 
 The solid-water partition coefficients (Kd) in the current study were in the range for cocaine (0.2 – 
0.9), benzoylecgonine (0.2 – 2.5), morphine (0.2 – 1.3), 6-monoacetylmorphine (0.1 – 0.5), heroin 
(0.7 -1.7) and diazepam (2.1–13.7). The association of diazepam with biological solids may have 
exhibited adsorption as an important removal mechanism during primary and secondary wastewater 
treatment while other drugs have no significant adsorption. Also, removal efficiencies above 75 % in 
primary sludge and biological secondary sludge for all the compounds were observed. The Kd values 
of compounds studied in this work showed positive correlation with their removal efficiencies as 
reported for ten quinolone and fluoroquinolone antibiotics in sludge samples [290]. 
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4.2.6. Effect of nature of sludge on degradation. 
Table 35 – 40 below compares the effects of degradation of compounds with respect to the nature of 
sludge sample. Therein are results obtained from the primary sludge samples collected at Molesworth 
and Stoke Bardolph Nottingham STWs.  
Table 35: Degradation of cocaine in primary sludge from Molesworth and Stoke Bardolph 
Nottingham STWs (19 ± 0.5
o
C) (Data derived from Table 2A & 13A in Appendix 5) 
 
 
 
 
 
 
 
 
 
 
 
Table 36: Degradation of BZE in primary sludge from Molesworth and Stoke Bardolph 
Nottingham STWs (19 ± 0.5
o
C) (Data derived from Table 15 & 20 in Appendix 5) 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
PS (Molesworth STW)                          PS (Nottingham) 
 
COC. 
soluble 
COC. 
degraded 
Removal 
(%) 
COC. 
soluble 
COC. 
degraded 
Removal 
(%) 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
731.0 
619.5 
529.5 
513.7 
482.2 
306.1 
284.5 
246.2 
211.4 
160.1 
105.4 
55.5 
11769.0 
11880.5 
11970.5 
11986.3 
12017.8 
12193.9 
12215.5 
12253.8 
12288.6 
12339.9 
12394.6 
12444.5 
95.3                                  
96.5 
96.5 
96.6 
97.0 
98.2 
98.2 
98.4 
98.7 
99.0 
99.3 
99.6 
468.7
394.8 
321.9 
268.7 
215.5 
172.8 
146.5 
121.9 
99.4 
76.0 
54.3 
31.6 
12031.3 
12105.2 
12178.1 
12231.3 
12284.5 
12327.2 
12353.5 
12378.1 
12400.6 
12424.0 
12445.7 
12468.4 
96.3 
96.8 
97.4 
97.9 
98.3 
98.6 
98.8 
99.0 
99.2 
99.4 
99.6 
99.7 
 
Time 
(min) 
 
PS (Molesworth STW)                            PS (Nottingham) 
 
BZE 
soluble 
BZE. 
degraded 
Removal 
(%) 
BZE 
soluble 
BZE 
degraded 
Removal 
(%) 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
496.1 
465.5 
407.8 
377.5 
382.7 
332.8 
302.8 
238.7 
225.1 
190.2 
129.4 
88.9 
12003.9 
12034.5 
12092.2 
12122.5 
12117.3 
12167.2 
12197.2 
12261.3 
12274.9 
12309.8 
12370.6 
12411.1 
96.7 
97.2 
97.4 
97.7 
98.1 
98.4 
98.7 
99.0 
99.2 
99.4 
99.7 
99.8 
1660.2 
1291.2 
1131.7 
1164.2 
1053.4 
831.9 
731.5 
596.6 
539.7 
414.1 
287.7 
164.2 
10839.8 
11208.8 
11368.3 
11335.8 
11446.6 
11668.1 
11768.5 
11903.4 
11960.3 
12085.9 
12212.3 
12335.8 
86.7 
89.7 
90.9 
90.7 
91.6 
93.3 
94.1 
95.2 
95.7 
96.7 
97.7 
98.7 
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Table 37:  Degradation of Morphine in primary sludge from Molesworth and Stoke Bardolph 
Nottingham STWs (19 ± 0.5
o
C) (Data derived from Table 22 & 27 in Appendix 5) 
 
 
 
 
 
 
 
 
 
 
Table 38: Degradation of 6-MAM in primary sludge from Molesworth and Stoke Bardolph 
 Nottingham STWs (19 ± 0.5
o
C) (Data derived from Table 29 & 34 in Appendix 5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
PS (Molesworth STW)                           PS (Nottingham)   
 
MOR 
soluble 
MOR. 
degraded 
Removal 
(%) 
MOR 
soluble 
MOR. 
degraded 
Removal 
(%) 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
2331.1 
2108.9 
1796.5 
1534.2 
1427.4 
1147.8 
924.8 
679.1 
607.2 
433.6 
289.0 
132.1 
10168.9 
10391.1 
10703.5 
10965.8 
11072.6 
11352.2 
11575.2 
11820.9 
11892.8 
12066.4 
12211.0 
12367.9 
84.8 
86.6 
88.5 
90.6 
91.8 
93.3 
94.9 
96.1 
96.8 
97.7 
98.7 
99.5 
9897.3 
8915.8 
6472.2 
6126.5 
5237.1 
4599.3 
3377.3 
1376.2 
1127.8 
875.9 
598.9 
362.8 
2602.7 
3584.2 
6027.8 
6373.5 
7262.9 
7900.7 
9122.7 
11123.8 
11372.2 
11624.1 
11901.1 
12137.2 
20.8 
28.7 
48.2 
51.0 
58.1 
63.2 
73.0 
89.0 
91.0 
93.0 
95.2 
97.1 
 
Time 
(min) 
 
PS (Molesworth STW)                           PS (Nottingham) 
 
6MAM 
soluble 
6MAM. 
degraded 
Removal 
(%) 
6MAM 
soluble 
6MAM. 
degraded 
Removal 
(%) 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
228.6 
174.2 
134.9 
110.7 
79.4 
68.5 
69.8 
55.0 
32.4 
26.0 
18.5 
9.5 
12271.4 
12325.8 
12365.1 
12389.3 
12420.6 
12431.5 
12430.2 
12445.0 
12467.6 
12474.0 
12481.5 
12490.5 
98.3 
98.7 
99.0 
99.2 
99.4 
99.5 
99.5 
99.6 
99.8 
99.8 
99.9 
100.0 
133.7 
129.8 
108.5 
88.5 
74.1 
45.8 
36.0 
24.4 
18.1 
12.2 
9.2 
5.2 
12366.3 
12370.2 
12391.5 
12411.5 
12425.9 
12454.2 
12464.0 
12475.6 
12481.9 
12487.8 
12490.8 
12494.8 
98.9 
99.0 
99.1 
99.3 
99.4 
99.6 
99.7 
99.8 
99.9 
99.9 
99.9 
100.0 
105 
 
Table 39: Degradation of Heroin in primary sludge from Molesworth and Stoke Bardolph  
 Nottingham STWs (19 ± 0.5
o
C) (Data derived from Table 36A & 41A in Appendix 5) 
 
 
 
 
 
 
 
 
 
 
 
Table 40: Degradation of Diazepam in primary sludge from Molesworth and Stoke Bardolph 
 Nottingham STWs (19 ± 0.5
o
C) (Data derived from Table 43 & 48 in Appendix 5) 
 
 
 
 
 
 
 
 
 
 
The ability of sewage treatment works to design removal processes that enable interactions with 
natural solid particles (sediments, microorganisms, clay) and added materials (coagulants, active 
 
Time 
(min) 
 
PS (Molesworth STW)                            PS (Nottingham) 
 
HER 
soluble 
HER. 
degraded 
Removal 
(%) 
HER 
soluble 
HER. 
degraded 
Removal 
(%) 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1157.0 
1066.7 
745.7 
276.4 
204.2 
167.7 
140.3 
80.4 
61.0 
34.7 
24.0 
14.7 
11343.0 
11433.3 
11754.3 
12223.6 
12295.8 
12332.3 
12359.7 
12419.6 
12439.0 
12465.3 
12476.0 
12485.3 
96.2 
96.7 
97.7 
97.8 
98.4 
98.7 
98.9 
99.4 
99.5 
99.7 
99.8 
99.9 
1836.0 
1657.5 
1261.4 
943.2 
840.6 
767.8 
597.3 
506.5 
377.8 
271.6 
175.8 
97.8 
10664.0 
10842.5 
11238.6 
11556.8 
11659.4 
11732.2 
11902.7 
11993.5 
12122.2 
12228.4 
12324.2 
12402.2 
85.3 
86.7 
89.9 
92.5 
93.3 
93.9 
95.2 
95.9 
97.0 
97.8 
98.6 
99.2 
 
Time 
(min) 
 
PS (Molesworth STW)                            PS (Nottingham) 
 
DIAZ 
soluble 
DIAZ. 
degraded 
Removal 
(%) 
DIAZ 
soluble 
DIAZ. 
degraded 
Removal 
(%) 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
6934.9 
6051.2 
4334.4 
4323.6 
4008.3 
3343.8 
2702.7 
2326.8 
1813.8 
1492.0 
1002.6 
545.1 
5565.1 
6448.8 
8165.6 
8176.4 
8491.7 
9156.2 
9797.3 
10173.2 
10686.2 
11008.0 
11497.4 
11954.9 
83.9 
87.6 
88.8 
91.2 
92.2 
94.8 
95.2 
96.5 
97.5 
98.5 
99.0 
99.7 
11970.5 
9533.0 
8060.3 
7131.4 
6317.9 
5433.0 
4709.3 
4024.3 
3313.0 
2589.0 
1774.2 
1043.4 
529.5 
2967.0 
4439.7 
5368.6 
6182.1 
7067.0 
7790.7 
8475.7 
9187.0 
9911.0 
10725.8 
11456.6 
4.2 
23.7 
35.5 
42.9 
49.5 
56.5 
62.3 
67.8 
73.5 
79.3 
85.8 
91.7 
106 
 
carbon) in facilitating the physical-chemical removals of compounds by flotation, settling or by 
biodegradation are disimilar. Even difference in bacteria population and diversity could exist in 
different municipal treatment works giving rise to different degradation rates. Municipal treatment 
works vary in design capacity and location and this has almost certainly resulted in variations in 
degree of degradation (Figure 32).  
 
Figure 32: Degradation of cocaine in (a) Molesworth and (b) Nottingham STWs, comparing reductions in 
parent drug over 3h as drugs degrade at 19± 0.5o. (Data derived from Table 38 - 43) 
The similarity in degradation and removal profiles as shown from the two STWs where samples were 
collected surprisingly showed no significant effects of nature of primary sludge samples on 
degradation, the only difference is the morphine data. Both have high values after 15 mins, and low 
values after 3hours. Variability in the values of TSS and COD as shown in the characterization (Table 
16) is based on Stoke Bardolph STW Nottingahm and Molesworth STWs suggesting many treatment 
processes exist with different requirements based on peculiar inflow variability to solve problematic 
situation by adjusting operating conditions.  
The degradation products (metabolites) found for cocaine were benzoylecgonine, ecgonine methyl 
ester and cocaethene and heroin produced morphine and 6-monoacetylmorphine. Attempt to quantify 
these products were difficult due to their diffuse nature as these compounds were futher being 
degraded simultaneously as they were been generated from initial corresponding drugs. While other 
polar degradation products could also not be detected and accurately measured possibly due to the 
method of analysis or incomplete derivatisation, duplicate measurement of the concentration levels of 
drugs dissolved in aqueous phase and those sorbed to solid phase were removed from initial 
concentration to obtain degradation levels. 
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Finally, benzoylecgonine, morphine and diazepam showed relatively higher degradations in sludge-
samples from Molesworth compared to Stoke Bardolph STW Nottingham samples. But as part of the 
operational challenges encountered as mentioned above, inability to obtain extensive samples from 
different processing units of the Stoke Bardolph STW, Nottingham limited the empirical comparison 
between the STWs to only TSS and COD contents. The primary wastewater effluent from primary 
sedimentation tank was the only access we had due to site restrictions.  
Developments on different aspects of drug’s transformations in the environment that appeared 
recently in the chemical literature includes occurrence and fate, treatability by conventional and non-
conventional processes, and several miscellaneous others [317-33, 335-339]. There was no 
information to our knowledge in the literature on the laboratory studies of fate and behaviour of illcit 
drug using different sewage types.  Also not very clear was the use of mass balance calculations to 
assess degradation and removal patterns of organic compounds from the removal rate data obtained 
from batch experiments. Therefore, using the current work to provide this important information from 
the batch studies as presented in Chapter 4 in order to generate mass balance calculations and to 
estimate influent concentrations of compounds was the main objective duly completed. 
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5. Mass Balance of Compounds in a Sewage Treatment Work 
 
5.1 Introduction 
There appears to be limited published work on the mass balances for illicit drugs. However, a review 
of many reported approaches of heavy metals in full-scale sewage treatment has been undertaken to 
demonstrate mass balance calculation and highlight assumptions inherent in these [264, 344-348]. 
Herein are some approaches to highlight the merits and demerits often associated with the mass 
balances of this nature and then offer alternative methods based on the present batch studies.  
To estimate the levels of cocaine in wastewaters, Zuccato et al [124] first related the concentration of  
benzoylecgonine (BZE), a  main metabolite of cocaine to estimate the loads of parent cocaine in 
effluent wastewater and this was later applied by other researchers  [131, 134]. In their approach, 
certain assumptions were made: (i) a total of 45% of ingested cocaine dose is excreted as BZE, (ii) no 
loss or leakage of wastewater along the sewage system, (iii) no accidental discharge or ‘dumping’ of 
large quantities of BZE into the sewage system and (iv) the main source of cocaine and metabolites 
comes from the human urination and the metabolite used in back calculation is the major product.  
Also they proposed some parameters relevant to the calculations including (i) the concentration of the 
main metabolite be ng L
-1
, (ii) the ratio of the molecular masses of the parent drug and metabolites 
(e.g. BZE/COC), (iii) the influent flow rate (m
3
 sec
-1
), (iv) the population size that are served by the 
STW, (v) the percentages of  drug dose excreted as major metabolites, (iv) correction factor  and (v) 
proven stability of the main metabolite (BZE) with respect to pH and temperature. In calculating the 
load (g day
-1
); the concentration of BZE (ng L
-1
), flow rate and molar fraction of cocaine and BZE as 
well as their molar mass ratio were estimated.  Zuccato used the approach to estimate the community 
consumption of cannabinoids, opiates and cocaine per day/1000 people but the percentage of drug 
dose excreted as drug target residue (DTR) and correction factor must be known. Bones et al [265] 
used 10% as a percentage of parent cocaine excreted to estimate the level of cocaine consumed with 
the assumption that cocaine was more stable in aqueous media and found in greater quantity than its 
main metabolite, benzoylecgonine. It appears the literature differs on the actual percentage of excreted 
cocaine and BZE from cocaine dose and more information is therefore required to address 
discrepancies in the literature. 
In 2007, mass balances of pharmaceutical products were undertaken at the Soseigawa Municipal 
STW, Japan. Grab samples were taken 11 times from the effluents from grit chamber, the effluent 
from secondary sedimentation basin and the effluents from the two pilots scale-submerged MBRs of 
175 L effective volume installed at the STW, operated at the same membrane flux and HRT of 6.7 h 
as this study and the result are presented in Table 41. Simple mass balances were estimated by  
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Table 41: Average concentrations and mass balances of pharmaceuticals in the WWTP and MBRs as found in 
Soseigawa Municipal STW, Japan [240] 
 
Water flow (m
3
/day) 
Excess sludge (kg/day) 
WWTP 
125 000 
7865 
MBR-A 
0.624 
0.035 
MBR-B 
0.624 
0.033 
Influent concentration
b
 (ngL
-1
, n=11) 
Clofibric acid 28 ± 8   
Diclofenac 251 ± 100   
Ketoprofen 979 ± 237   
Ibuprofen 1966 ± 662   
Mafanamic acid 221 ± 62   
naproxen 276 ± 115  
Effluent concentration
b
 (ngL
-1
, n=11) 
Clofibric acid 14 ± 4 14 ± 5 5 ± 4 
Diclofenac 145 ± 32 124 ± 29 46 ± 17 
Ketoprofen 445 ± 121 171 ± 60 <20
c
 
Ibuprofen 40 ± 32 106  ± 68 35 ± 32 
Mafanamic acid 62 ± 23 51 ± 1 15 ± 6 
naproxen 99 ± 18 11 ± 12 <10
c
 
Amount of  pharmaceuticals adsorbed on sludge
b
 (ng/g of TSS
d
, n=4) 
Clofibric acid <4
c
 <4
c
 <4
c
 
Diclofenac 35 ± 7 135 ± 200 31 ± 7 
Ketoprofen <40c <40 <40c 
Ibuprofen 51 ± 8 26 ± 8 18 ± 6 
Mafanamic acid 130 ± 71 111 ± 27 92 ± 29 
naproxen <20c <20c <20c 
Total elimination during wastewater treatment [g/day (WWTP) or ug/day (MBR)] 
Clofibric acid 1.75 8.74 14.4 
Diclofenac 13.3 79.2 128 
Ketoprofen 66.8 504 598 
Ibuprofen 241 1160 1200 
Mafanamic acid 19.9 106 129 
naproxen 22.1 165 >166 
Elimination due to sorption [g/day (WWTP) or ug/day (MBR)] 
Clofibric acid <0.031 <0.14 <0.13 
Diclofenac 0.28 4.7 1.0 
Ketoprofen <0.31 <1.4 <1.3 
Ibuprofen 0.40 0.91 0.59 
Mafanamic acid 1.0 3.9 3.0 
naproxen <0.16 <0.70 <0.66 
Sorption vs Elimination (%) 
Clofibric acid <2 <2 <0.9 
Diclofenac 2 6 0.8 
Ketoprofen <0.5 <0.3 <0.3 
Ibuprofen 0.2 0.1 0.05 
Mafanamic acid 5 4 2 
naproxen <0.7 <0.4 <0.4 
aAmount of sludge extracted from each process to maintain a target concentration of biomass, b Data are shown with standard 
deviations. cConcentrations were always <LOQ. d Dry weight is represented by grams of TSS 
inflow concentration minus outflow concentration. However, the problems of representative 
samplings and effect of rainfall were not taken into account as sampling was in summer at low 
rainfall, this meant the dilution of the effluent was minimal and for this reason the errors often 
encountered as a result of rain dilution have been eliminated. Also, the presence of conjugates were 
110 
 
overlooked but it has been reported that pharmaceuticals that enter the STWs are significantly 
underestimated in studies as dilution of influent wastewater in STW would have occurred and result  
is an overestimate of performance. 
A detailed study of the occurrence and removal of selected pharmacuticals compounds in a sewage 
treatment works utilising activated sludge treatment was undertaken by Jones et al [78] in England, 
UK.  The mass balance was completed using municipal sewage samples collected over four days 
sampling periods for the study. The example of the simple mass balance of the flow through the 
works was consistent with the large amount of data as presented in Table 42. To calculate a simple 
mass balance of the flow of pharmaceuticals along the sewage works processes, Jones et al used the 
formula:                                                 Mrem = min - mout                                                                    [eqn. 9] 
Where, Mrem= mass removed by the activated sludge, min = mass  of compound from settled sewage 
and mout= total mass leaving the works in the final effluent. The main error were from the returned 
activated sludge, RAS which was mixed with the settled sewage before entering the  
Table 42: Mass balance (g/d) of  pharmaceuticals over 4 day sampling period in England, UK  [78] (Note the 
contrasting approaches to mass balance calculation as compared to Table 44). 
Compounds Day    Removal 
rate (%) Min Mout (Min-Mout) 
Ibuprofen 1 4.82 8.38 46.44 84.71 
 2 40.89 8.06 32.84 80.29 
 3 47.58 5.67 41.91 88.08 
 4 45.54 4.27 41.27 90.62 
 Mean 47.21 6.60 40.61 86.03 
      
Paracetamol 1 28.37 3.77 24.60 86.71 
 2 27.72 2.10 25.62 92.42 
 3 24.92 1.23 23.70 95.08 
 4 24.17 1.57 22.60 93.51 
 Mean 26.30 2.17 24.13 91.93 
      
Salbutamol 1 35.93 2.94 32.99 9183 
 2 32.23 3.09 29.13 90.40 
 3 44.13 2.11 42.02 95.21 
 4 53.81 0.82 52.98 98.47 
 Mean 41.52 2.24 39.28 94.60 
      
Melfenamic acid 1 51.72 4.83 46.89 90.66 
 2 60.36 5.40 54.96 91.05 
 3 42.87 5.62 37.25 86.89 
 4 47.79 1.31 46.48 97.25 
 Mean 50.69 4.26 46.40 91.54 
 
activated sludge unit and this was assumed to be ‘locked in the system’ and removal of selected 
compounds during primary sedimentation ought to have been carried out in primary tanks prior to the 
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experiment to completely eliminate bias, but this may be insignificant as the study was limited to 
activated sludge.As a useful tool in allowing the fate of drugs to be accounted for, as well as assessing 
analytical quality mass balance calculation is important wherever the data is available. It appears the 
problems due to sampling logistics and desludging process often introduce high errors in the mass 
balances of heavy metals through sewage works and these make methods and methodology of 
reporting mass balances vary considerably [264]. Therefore more work is required to address the 
discrepancies in the literature, which the current study hopes to provide. 
5.2 Mass balance calculation from batch studies data with Molesworth sewage samples 
The site flow data for the last 24 months in RAF Molesworth shown in Figures 33 and 34 gives 
indication of the average flows and the range. A meter measures and records the flow to the primary 
tank. The data is logged and recorded by site operatives. For performance assessment the maximum 
flow has been taken as the consented 360 m
3
/d (0.10 Mgal/d), while the average volume treated by the 
works is approximately 78.4 m
3
/d (0.02 Mgal/d). The hydraulic retention time (HRT) and average 
time the flow spends in each treatment unit is a function of the average flow as calculated in equation 
11. The process calculation of each process unit including the volume is presented in Appendix D 
[292]: 
Hydraulic Loading Rate  (m/h) = flow to tanks (m3/h) / total surface area (m2)   [eqn 10] 
Hydraulic Retention Time (h) = flow to tanks (m3/h) / total volume of tanks (m3)   [eqn 11] 
             Therefore, HRT    = 360 m
3
/d (15 m
3
/h) / 78.4 x 3 m
3
/d (9.81 m
3
/h) 
                                               = ~ 1.5 hr 
For mass balances, duplicate samples were collected every 15 minutes over 3h to provide composite 
batch samples for each process stage. The samples were taken through the process at the following 
four locations: (1) primary effluent (2) submerged aerated filter-1, (3) mixed submerged aerated 
filterand & (4) humus tanks effluent. RAF Molesworth currently operates no base housing, so the 
wastewater composition does not conform to typical ranges and conditions for wastewater. However, 
the actual TSS and COD were easy to assess as the primary effluent did not include the recirculation 
flow which would have diluted the concentration by the recirculation flow. The plastic media filter 
has been replaced by the SAF (a COPA CB750, which has a process volume of 40 cubic meters) 
hence; this recirculation pumping system has not been used. It was installed to ensure the required 
wetting rate of the plastic media filter was maintained. In a SAF, the filter is entirely submerged and 
mechanically aeration is provided.  
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                                                 Figure 33:  RAF Molesworth - Waste Water Flow Data for Year 10-11 
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Figure 34:  RAF Molesworth - Waste Water Flow Data for Year 11-12 
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5.2.1. Procedures used in mass balance calculation:  
1.  In these batch studies, the removal of compounds was through adsorption to solids and 
degradation and data table of different sludge experiments are presented in the Appendix 4 as 
listed below. 
A. partition/degradation of cocaine in all  the four sewage types– Tables: 2A, 5A, 8A, 11A 
B. partition/degradation of benzoylecgonine in the four sewage types – Tables: 15, 17, 18, 19 
C. partition/degradation of morphine in the four sewage types – Tables: 22, 24, 25, 26 
D. partition/degradation of 6-ACM in the four sewage types - Tables: 29, 31, 32, 33 
E. partition/degradation of heroin in the four sewage types – Tables: 36A, 38A, 39A, 40A 
F. partition/degradation of diazepam in the four sewage types – Tables: 43, 45, 46, 47 
2. The percent removal rate data used are taken from Table 21 – 40 using equation 8: 
% removal = 100 ([initial drug] – [final drug in aqueous phase]) 
[Initial drug] 
obtained from different sludge of STW units are summarised below in the following order: 
Table 43 (cocaine) 
Table 44 (benzoylecgonine) 
Table 45 (morphine) 
Table 46 (6-monoacetylmorphine) 
Table 47 (heroin) and  
Table 48 (diazepam)  
 
3. The STW process at Molesworth goes through terminal pumping station, screens (no grit 
trap), primary tank, submerged aerated filter (SAF), humus tank, reed bed, and finally to the 
outfall chamber. Each dissolved compound in effluent of an STW unit is passed on to the next 
unit where the compound would again partition into aqueous-solid layers and the new 
partitioning concentration calculated as presented in Table 43 – 48. The successive 
partitioning of compound along through STW indicate the measure of mass balance of 
individual drug through different STW units using equation 10 below: 
   Conc. of drug in effluent of each unit = (% removal rate) x [dissolved drug]                        [eqn. 10] 
                                                                                                                                                       
4.  The final effluent (µg in 250 ml) was then multiplied by 4 and converted to final 
concentration expressed in µgL
-1
 
5. Back-calculation assessment is to cross-check and account for all the masses through the 
STW bringing the total mass-flow to original batch concentration (12.5 mg in 250 mL).            
Conc. of drug in effluent of each unit ÷ (% removal rate) = [dissolved drug]                      [eqn. 11] 
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Mass balance modelling calculation: 
Note:  The percent removal rates data of compounds from all sewage types were used in 
the mass balance modelling work as presented below in Table 43 – 48. 
For example, mass balance in the first row of Table 43 after 15 min degradation goes thus: 
Removal rate of cocaine by sorption & degradation from 12500 µg of cocaine in 250 mL flask: 
 
First PS row = 12500 µg x 95.3% (0.953) = 11912.5 µg (removed by sorption/degradation) 
                    = 12500 µg x 4.7% (0.047) = 587.5 µg (dissolved in aqueous phase) → 
 
Second SAF row = 587.5 µg (dissolved in aqueous) x 63% (0.63) = 370.13 µg (removed/sorbed) 
                           = 587.5 µg x 37% (0.370) = 217.4 µg (dissolved in aqueous phase) → 
 
Third MSAF row = 217.4 µg (dissolved in aqueous) x 94.9 % (0.949) = 206.31 µg (removed) 
                            = 217.4 µg x 5.1% (0.051) = 11.09 µg (dissolved in aqueous phase) → 
 
Fourth HS row = 11.09 µg (dissolved in aqueous phase) x 81.0% (0.810) = 8.98 µg 
                           = 11.09 µg x 19.0% (0.019) = 2.11 µg (dissolved in aqueous phase) → to effluent 
 
Total removed by degradation & sorption = 11912.5 + 370.13 + 206.31 + 8.98  
                                                                  = 12497.89 µg 
Final effluent (L) = 2.11 in 250 mL x 4 = 8.43 (µg L
-1
)   
(Note: Above calculation applies to all compounds passing the columns from 15 min to 180 min) 
In Table 43, the concentration of cocaine from the batch studies experiment using primary (PS), 
submerged aerated filter-1 (SAF-1), mixed submerged aerated filter (MSAF) and humus sludge are 
shown.  Data derived from Table 2A, 5A, 8A & 11A (Appendix 4) were used to calculate the removal 
rates of drugs as illustrated above (Section 5.2.1). The removal rates are in RED (sorbed & degraded) 
and amount dissolved in aqueous phase are in BLACK for every 15 min timescale. In a STW with a 
HRT of 2 – 3 hours, for a mass balance the initial concentration goes through the STW, using the 
corresponding removal rates and the percent dissolved in the aqueous phase to estimate the 
concentration of drugs that moves through the processing units of STW, and then measured the 
effluent.  
The final effluent concentrations (µg L
-1
) were calculated in the last column by multiplying the final 
measured drugs by 4 (concentration in µgL
-1
) since the initial batch concentration was 12500 µg in 
250 mL. We then used the data to estimate the mass balance calculation and this similarly applies to 
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benzoylecgonine, morphine, 6 – monoacetylmorphine, heroin and diazepam in Table 43 -48, 
respectively.  
Table 43: Concentration and mass balances of cocaine from the batch studies experiment using primary (PS), 
submerged aerated filter-1 (SAF-1), mixed submerged aerated filter (MSAF) and humus sludge and showing  
the removal rate of drugs in RED (sorbed & degraded) and amount dissolved in aqueous phase in BLACK.  
(Data derived from Table 2A, 5A, 8A & 11A in Appendix 4). 
 
 
 
 
   Time 
  (min) 
 
 
Removal rate (%) from each STW 
units 
 
 
Cocaine partition in aqueous and solid phases 
 (µg in 250 mL) 
 
 
 
Final 
Effluent   
(µg L-1) 
 
PS 
 
SAF 
 
MSAF 
 
HS 
 
PS 
 
SAF 
 
MSAF 
 
HS 
Total 
degraded & 
sorbed 
Mass 
Balance 
15 
 
 
 
30 
 
 
 
45 
 
 
 
60 
 
 
 
75 
 
 
 
90 
 
 
 
105 
 
 
 
120 
 
 
 
135 
 
 
 
150 
 
 
 
165 
 
 
 
180 
4.7 
95.3 
3.5 
96.5 
3.5 
96.5 
3.4 
96.6 
3.0 
97.0 
1.8 
98.2 
1.8 
98.2 
1.6 
98.4 
1.3 
98.7 
1.0 
99.0 
0.7 
99.3 
0.4 
99.6 
37.0 
63.0 
33.6 
66.4 
26.9 
73.1 
27.2 
72.8 
24.0 
76.0 
20.4 
79.2 
13.8 
86.2 
11.3 
88.7 
9.2 
90.8 
5.3 
94.7 
4.0 
96.0 
2.4 
97.6 
5.1 
94.9 
4.1 
95.9 
3.6 
96.4 
1.8 
98.2 
1.4 
98.6 
1.3 
98.7 
1.2 
98.8 
1.3 
98.7 
0.9 
99.1 
0.6 
99.4 
0.4 
99.6 
0.2 
99.8 
19.0 
81.0 
16.5 
83.5 
14.8 
85.2 
16.8 
83.2 
15.1 
84.9 
12.5 
87.5 
10.7 
89.3 
9.0 
91.0 
7.9 
92.1 
5.9 
94.1 
2.7 
97.3 
1.4 
98.6 
587.50 
11912.50 
437.50 
12062.50 
437.50 
12062.50 
425.00 
12075.00 
375.00 
12125.00 
225.00 
12275.00 
225.00 
12275.00 
200.00 
12300.00 
162.50 
12337.50 
125.00 
12375.00 
87.50 
12412.50 
50.00 
12450.00 
217.38 
370.13 
147.00 
290.50 
117.69 
319.81 
115.60 
309.40 
90.00 
285.00 
45.90 
179.10 
31.05 
193.95 
22.60 
177.40 
14.95 
147.55 
6.63 
118.38 
3.50 
84.00 
1.20 
48.80 
11.09 
206.29 
6.03 
140.97 
4.24 
113.45 
2.08 
113.52 
1.26 
88.74 
0.60 
45.30 
0.37 
30.68 
0.29 
22.31 
0.13 
14.82 
0.04 
6.59 
0.01 
3.49 
0.00 
1.20 
2.11 
8.98 
0.99 
5.03 
0.63 
3.61 
0.35 
1.73 
0.19 
1.07 
0.07 
0.52 
0.04 
0.33 
0.03 
0.27 
0.01 
0.12 
0.00 
0.04 
0.00 
0.01 
0.00 
0.00 
 
12497.89 
 
12499.01 
 
12499.37 
 
12499.65 
 
12499.81 
 
12499.93 
 
12499.96 
 
12499.97 
 
12499.99 
 
12500.00 
 
12500.00 
 
12500.00 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
8.43 
 
3.98 
 
2.51 
 
1.40 
 
0.76 
 
0.30 
 
0.16 
 
0.11 
 
0.04 
 
0.01 
 
0.00 
 
0.00 
 
*Black figure = dissolved (aqueous phase); Red figure = sorbed & degraded 
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Table 44: Concentration and mass balance of benzoylecgonine from the batch studies experiment using 
primary (PS), submerged aerated filter-1 (SAF-1), mixed submerged aerated filter (MSAF) and humus sludge 
and showing  the removal rate of drugs in RED (sorbed & degraded) and amount dissolved in aqueous phase in 
BLACK. (Data derived from Table 15, 17, 18 & 19 in Appendix 4) 
 
 
 
 
   Time 
  (min) 
 
 
Removal rate (%) from each STW 
units 
 
 
Benzoylecgonine partition in aqueous and solid phases 
 (µg in 250 mL) 
 
 
 
Final 
Effluent   
(µg L-1) 
 
PS 
 
SAF 
 
MSAF 
 
HS 
 
PS 
 
SAF 
 
MSAF 
 
HS 
Total 
degraded & 
sorbed 
Mass 
Balance 
15 
 
 
 
30 
 
 
 
45 
 
 
 
60 
 
 
 
75 
 
 
 
90 
 
 
 
105 
 
 
 
120 
 
 
 
135 
 
 
 
150 
 
 
 
165 
 
 
 
180 
3.3 
96.7 
2.8 
97.2 
2.6 
97.4 
2.3 
97.7 
1.9 
98.1 
1.6 
98.4 
1.3 
98.7 
1.0 
99.0 
0.8 
99.2 
0.6 
99.4 
0.3 
99.7 
0.2 
99.8 
48.9 
51.1 
31.4 
68.6 
24.9 
75.1 
20.9 
79.1 
20.0 
80.0 
16.6 
83.4 
14.0 
86.0 
12.0 
88.0 
10.0 
90.0 
7.3 
92.7 
4.8 
95.2 
2.9 
97.1 
51.9 
48.1 
49.0 
51.0 
38.9 
61.1 
38.9 
61.1 
32.8 
67.2 
26.6 
73.4 
18.6 
81.4 
12.2 
87.8 
10.8 
89.2 
8.2 
91.8 
6.6 
93.4 
4.3 
95.7 
30.9 
69.1 
19.6 
80.4 
17.4 
82.6 
16.2 
83.8 
15.8 
84.2 
12.9 
87.1 
11.3 
88.7 
9.4 
90.6 
7.0 
93.0 
5.4 
94.6 
3.5 
96.5 
2.1 
97.9 
412.50 
12087.50 
350.00 
12150.00 
325.00 
12175.00 
287.50 
12212.50 
237.50 
12262.50 
200.00 
12300.00 
162.50 
12337.50 
125.00 
12375.00 
100.00 
12400.00 
75.00 
12425.00 
37.50 
12462.50 
25.00 
12475.00 
201.71 
210.79 
109.90 
240.10 
80.93 
244.08 
60.09 
227.41 
47.50 
190.00 
33.20 
166.80 
22.75 
139.75 
15.00 
110.00 
10.00 
90.00 
5.48 
69.53 
1.80 
35.70 
0.73 
24.28 
104.69 
97.02 
53.85 
56.05 
31.48 
49.45 
23.37 
36.71 
15.58 
31.92 
8.83 
24.37 
4.23 
18.52 
1.83 
13.17 
1.08 
8.92 
0.45 
5.03 
0.12 
1.68 
0.03 
0.69 
32.35 
72.34 
10.55 
43.30 
5.48 
26.00 
3.79 
19.59 
2.46 
13.12 
1.14 
7.69 
0.48 
3.75 
0.17 
1.66 
0.08 
1.00 
0.02 
0.42 
0.00 
0.11 
0.00 
0.03 
 
12467.65 
 
12489.45 
 
12494.52 
 
12496.21 
 
12497.54 
 
12498.86 
 
12499.52 
 
12499.83 
 
12499.92 
 
12499.98 
 
12500.00 
 
12500.00 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
129.40 
 
42.22 
 
21.91 
 
15.15 
 
9.85 
 
4.56 
 
1.91 
 
0.69 
 
0.30 
 
0.10 
 
0.02 
 
0.00 
*Black figure = dissolved (aqueous phase); Red figure = sorbed & degraded 
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Table 45: Concentration and mass balance of  morphine from the batch studies experiment using primary 
(PS), submerged aerated filter-1 (SAF-1), mixed submerged aerated filter (MSAF) and humus sludge and 
showing  the removal rate of drugs in RED (sorbed & degraded) and amount dissolved in aqueous phase in 
BLACK.  (Data derived from Table 22, 24, 25 & 26 in Appendix 4) 
 
 
 
 
   Time 
  (min) 
 
 
Removal rate (%) from each STW 
units 
 
 
Morphine partition in aqueous and solid phases 
 (µg in 250 mL) 
 
 
 
Final 
Effluent   
(µg L-1) 
 
PS 
 
SAF 
 
MSAF 
 
HS 
 
PS 
 
SAF 
 
MSAF 
 
HS 
Total 
degraded & 
sorbed 
Mass 
Balance 
15 
 
 
 
30 
 
 
 
45 
 
 
 
60 
 
 
 
75 
 
 
 
90 
 
 
 
105 
 
 
 
120 
 
 
 
135 
 
 
 
150 
 
 
 
165 
 
 
 
180 
15.2 
84.8 
13.4 
86.6 
11.5 
88.5 
9.4 
90.6 
8.2 
91.8 
6.7 
93.3 
5.1 
94.9 
3.9 
96.1 
3.2 
96.8 
2.3 
97.7 
1.3 
98.7 
0.5 
99.5 
5.6 
94.4 
3.3 
96.7 
2.9 
97.1 
2.6 
97.4 
2.0 
98.0 
1.7 
98.3 
1.4 
98.6 
1.2 
98.8 
0.7 
99.3 
0.3 
99.7 
0.2 
99.8 
0.1 
99.9 
35.3 
64.7 
24.0 
76.0 
22.0 
78.0 
18.6 
81.4 
14.8 
85.2 
12.5 
87.5 
10.9 
89.1 
9.1 
90.9 
7.6 
92.4 
5.7 
94.3 
4.0 
96.0 
2.4 
97.6 
1.0 
99.0 
0.7 
99.3 
0.6 
99.4 
0.5 
99.5 
0.5 
99.5 
0.3 
99.7 
0.3 
99.7 
0.3 
99.7 
0.3 
99.7 
0.2 
99.8 
0.2 
99.8 
0.1 
99.9 
1900.00 
10600.00 
1675.00 
10825.00 
1437.50 
11062.50 
1175.00 
11325.00 
1025.00 
11475.00 
837.50 
11662.50 
637.50 
11862.50 
487.50 
12012.50 
400.00 
12100.00 
287.50 
12212.50 
162.50 
12337.50 
62.50 
12437.50 
106.40 
1793.60 
55.28 
1619.73 
41.69 
1395.81 
30.55 
1144.45 
20.50 
1004.50 
14.24 
823.26 
8.93 
628.58 
5.85 
481.65 
2.80 
397.20 
0.86 
286.64 
0.33 
162.18 
0.06 
62.44 
37.56 
68.84 
13.27 
42.01 
9.17 
32.52 
5.68 
24.87 
3.03 
17.47 
1.78 
12.46 
0.97 
7.95 
0.53 
5.32 
0.21 
2.59 
0.05 
0.81 
0.01 
0.31 
0.00 
0.06 
0.38 
37.18 
0.09 
13.17 
0.06 
9.12 
0.03 
5.65 
0.02 
3.02 
0.01 
1.77 
0.00 
0.97 
0.00 
0.53 
0.00 
0.21 
0.00 
0.05 
0.00 
0.01 
0.00 
0.00 
 
12499.62 
 
12499.91 
 
12499.95 
 
12499.97 
 
12499.98 
 
12499.99 
 
12500.00 
 
12500.00 
 
12500.00 
 
12500.00 
 
12500.00 
 
12500.00 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
1.50 
 
0.37 
 
0.22 
 
0.11 
 
0.06 
 
0.02 
 
0.01 
 
0.01 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
*Black figure = dissolved (aqueous phase); Red figure = sorbed & degraded 
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Table 46: Concentration and mass balances of 6-monoacetylmorphine from the batch studies experiment 
using primary (PS), submerged aerated filter-1 (SAF-1), mixed submerged aerated filter (MSAF) and humus 
sludge and showing  the removal rate of drugs in RED (sorbed & degraded) and amount dissolved in aqueous 
phase in BLACK.. (Data derived from Table 29, 31, 32 & 33 in Appendix 4) 
 
 
 
 
   Time 
  (min) 
 
 
Removal rate (%) from each STW 
units 
 
 
6MAM  partition in aqueous and solid phases 
 (µg in 250 mL) 
 
 
 
Final 
Effluent   
(µg L-1) 
 
PS 
 
SAF 
 
MSAF 
 
HS 
 
PS 
 
SAF 
 
MSAF 
 
HS 
Total 
degraded & 
sorbed 
Mass 
Balance 
15 
 
 
 
30 
 
 
 
45 
 
 
 
60 
 
 
 
75 
 
 
 
90 
 
 
 
105 
 
 
 
120 
 
 
 
135 
 
 
 
150 
 
 
 
165 
 
 
 
180 
1.7 
98.3 
1.3 
98.7 
1.0 
99.0 
0.8 
99.2 
0.6 
99.4 
0.5 
99.5 
0.5 
99.5 
0.4 
99.6 
0.2 
99.8 
0.2 
99.8 
0.1 
99.9 
0.0 
100.0 
81.1 
18.9 
56.7 
43.3 
48.2 
51.8 
49.6 
50.4 
41.9 
58.1 
29.8 
70.2 
18.4 
81.6 
14.0 
86.0 
10.9 
89.1 
8.3 
91.7 
6.4 
93.6 
3.2 
96.8 
13.3 
86.7 
11.6 
88.4 
10.1 
89.9 
9.0 
91.0 
7.5 
92.5 
6.1 
93.9 
5.2 
94.8 
4.4 
95.6 
3.6 
96.4 
2.9 
97.1 
2.0 
98.0 
1.1 
98.9 
33.6 
66.4 
29.1 
70.9 
23.3 
76.7 
14.2 
85.8 
10.9 
89.1 
9.9 
90.1 
8.2 
91.8 
6.7 
93.3 
5.0 
95.0 
3.4 
96.6 
2.4 
97.6 
1.4 
98.6 
212.50 
12287.50 
162.50 
12337.50 
125.00 
12375.00 
100.00 
12400.00 
75.00 
12425.00 
62.50 
12437.50 
62.50 
12437.50 
50.00 
12450.00 
25.00 
12475.00 
25.00 
12475.00 
12.50 
12487.50 
0.00 
12500.00 
172.34 
40.16 
92.14 
70.36 
60.25 
64.75 
49.60 
50.40 
31.43 
43.58 
18.63 
43.88 
11.50 
51.00 
7.00 
43.00 
2.73 
22.28 
2.08 
22.93 
0.80 
11.70 
0.00 
0.00 
22.92 
149.42 
10.69 
81.45 
6.09 
54.16 
4.46 
45.14 
2.36 
29.07 
1.14 
17.49 
0.60 
10.90 
0.31 
6.69 
0.10 
2.63 
0.06 
2.01 
0.02 
0.78 
0.00 
0.00 
7.70 
15.22 
3.11 
7.58 
1.42 
4.67 
0.63 
3.83 
0.26 
2.10 
0.11 
1.02 
0.05 
0.55 
0.02 
0.29 
0.00 
0.09 
0.00 
0.06 
0.00 
0.02 
0.00 
0.00 
 
12492.30 
 
12496.89 
 
12498.58 
 
12499.37 
 
12499.74 
 
12499.89 
 
12499.95 
 
12499.98 
 
12500.00 
 
12500.00 
 
12500.00 
 
12500.00 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
30.81 
 
12.44 
 
5.67 
 
2.54 
 
1.03 
 
0.45 
 
0.20 
 
0.08 
 
0.02 
 
0.01 
 
0.00 
 
0.00 
*Black figure = dissolved (aqueous phase); Red figure = sorbed & degraded 
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Table 47: Concentration and mass balances of heroin from the batch studies experiment using primary (PS), 
submerged aerated filter-1 (SAF-1), mixed submerged aerated filter (MSAF) and humus sludge and showing  
the removal rate of drugs in RED (sorbed & degraded) and amount dissolved in aqueous phase in BLACK.. 
(Data derived from Table 36A, 38A, 39A & 40A in Appendix 4) 
 
 
 
 
   Time 
  (min) 
 
 
Removal rate (%) from each STW 
units 
 
 
Heroin partition in aqueous and solid phases 
 (µg in 250 mL) 
 
 
 
Final 
Effluent   
(µg L-1) 
 
PS 
 
SAF 
 
MSAF 
 
HS 
 
PS 
 
SAF 
 
MSAF 
 
HS 
Total 
degraded & 
sorbed 
Mass 
Balance 
15 
 
 
 
30 
 
 
 
45 
 
 
 
60 
 
 
 
75 
 
 
 
90 
 
 
 
105 
 
 
 
120 
 
 
 
135 
 
 
 
150 
 
 
 
165 
 
 
 
180 
3.8 
96.2 
3.3 
96.7 
2.3 
97.7 
2.2 
97.8 
1.6 
98.4 
1.3 
98.7 
1.1 
98.9 
0.6 
99.4 
0.5 
99.5 
0.3 
99.7 
0.2 
99.8 
0.1 
99.9 
0.4 
99.6 
0.4 
99.6 
0.4 
99.6 
0.3 
99.7 
0.3 
99.7 
0.2 
99.8 
0.2 
99.8 
0.1 
99.9 
0.1 
99.9 
0.1 
99.9 
0.1 
99.9 
0.0 
100.0 
0.4 
99.6 
0.4 
99.6 
0.3 
99.7 
0.3 
99.7 
0.2 
99.8 
0.2 
99.8 
0.2 
99.8 
0.1 
99.9 
0.1 
99.9 
0.1 
99.9 
0.1 
99.9 
0.0 
100.0 
12.3 
87.7 
8.9 
91.1 
7.3 
92.7 
6.3 
93.7 
4.5 
95.5 
3.0 
97.0 
2.5 
97.5 
2.1 
97.9 
1.1 
98.9 
0.9 
99.1 
0.9 
99.1 
0.5 
99.5 
475.00 
12025.00 
412.50 
12087.50 
287.50 
12212.50 
275.00 
12225.00 
200.00 
12300.00 
162.50 
12337.50 
137.50 
12362.50 
75.00 
12425.00 
62.50 
12437.50 
37.50 
12462.50 
25.00 
12475.00 
12.50 
12487.50 
1.90 
473.10 
1.65 
410.85 
1.15 
286.35 
0.83 
274.18 
0.60 
199.40 
0.33 
162.18 
0.28 
137.23 
0.08 
74.93 
0.06 
62.44 
0.04 
37.46 
0.03 
24.98 
0.00 
12.50 
0.0076 
1.8924 
0.0066 
1.6434 
0.0035 
1.1465 
0.0025 
0.8225 
0.0012 
0.5988 
0.0007 
0.3243 
0.0006 
0.2744 
0.0001 
0.0749 
0.0001 
0.0624 
0.0 
0.0375 
0.0 
0.0250 
0.0 
0.0 
0.0009 
0.0067 
0.0006 
0.006 
0.0003 
0.0032 
0.0002 
0.0023 
0.0001 
0.0011 
0.0 
0.0007 
0.0 
0.0006 
0.0 
0.0001 
0.0 
0.0001 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
0.0037 
 
0.0023 
 
0.0010 
 
0.0006 
 
0.0002 
 
0.0001 
 
0.0001 
 
0.0000 
 
0.0000 
 
0.0000 
 
0.0000 
 
0.0000 
*Black figure = dissolved (aqueous phase); Red figure = sorbed & degraded 
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Table 48: Concentration and mass balances of diazepam. from the batch studies experiment using primary 
(PS), submerged aerated filter-1 (SAF-1), mixed submerged aerated filter (MSAF) and humus sludge and 
showing  the removal rate of drugs in RED (sorbed & degraded) and amount dissolved in aqueous phase in 
BLACK.   (Data derived from Table 43, 45, 46 & 47 in Appendix 4) 
 
 
 
 
   Time 
  (min) 
 
 
Removal rate (%) from each STW 
units 
 
 
Diazepam partition in aqueous and solid phases 
 (µg in 250 mL) 
 
 
 
Final 
Effluent   
(µg L-1) 
 
PS 
 
SAF 
 
MSAF 
 
HS 
 
PS 
 
SAF 
 
MSAF 
 
HS 
Total 
degraded & 
sorbed 
Mass 
Balance 
15 
 
 
 
30 
 
 
 
45 
 
 
 
60 
 
 
 
75 
 
 
 
90 
 
 
 
105 
 
 
 
120 
 
 
 
135 
 
 
 
150 
 
 
 
165 
 
 
 
180 
16.1 
83.9 
12.4 
87.6 
11.2 
88.8 
8.8 
91.2 
7.8 
92.2 
5.2 
94.8 
4.8 
95.2 
3.5 
96.5 
2.5 
97.5 
1.5 
98.5 
1.0 
99.0 
0.3 
99.7 
1.0 
99.0 
1.0 
99.0 
0.9 
99.1 
0.8 
99.2 
0.7 
99.3 
0.6 
99.4 
0.5 
99.5 
0.4 
99.6 
0.3 
99.7 
0.2 
99.8 
0.1 
99.9 
0.1 
99.9 
14.5 
85.5 
11.1 
88.9 
9.9 
90.1 
8.6 
91.4 
6.5 
93.5 
4.4 
95.6 
4.2 
95.8 
3.5 
96.5 
2.0 
98.0 
1.2 
98.8 
0.8 
99.2 
0.6 
99.4 
0.5 
99.5 
0.5 
99.5 
0.5 
99.5 
0.4 
99.6 
0.4 
99.6 
0.3 
99.7 
0.3 
99.7 
0.3 
99.7 
0.3 
99.7 
0.2 
99.8 
0.2 
99.8 
0.2 
99.8 
2012.50 
10487.50 
1550.00 
10950.00 
1400.00 
11100.00 
1100.00 
11400.00 
975.00 
11525.00 
650.00 
11850.00 
600.00 
11900.00 
437.50 
12062.50 
312.50 
12187.50 
187.50 
12312.50 
125.00 
12375.00 
37.50 
12462.50 
20.13 
1992.38 
15.50 
1534.50 
12.60 
1387.40 
8.80 
1091.20 
6.83 
968.18 
3.90 
646.10 
3.00 
597.00 
1.75 
435.75 
0.94 
311.56 
0.38 
187.13 
0.13 
124.88 
0.04 
37.46 
2.9181 
17.2069 
1.7205 
13.7795 
1.2474 
11.3526 
0.7568 
8.0432 
0.4436 
6.3814 
0.1716 
3.7284 
0.1260 
2.8740 
0.0613 
1.6887 
0.0187 
0.9188 
0.0045 
0.3705 
0.0010 
0.1240 
0.0002 
0.0373 
0.0146 
2.9035 
0.0086 
1.7119 
0.0062 
1.2412 
0.0030 
0.7538 
0.0018 
0.4418 
0.0005 
0.1711 
0.0004 
0.1256 
0.0002 
0.0611 
0.0001 
0.0186 
0.0000 
0.0045 
0.0000 
0.0010 
0.0000 
0.0002 
 
12499.99 
 
12499.99 
 
12499.99 
 
12500.00 
 
12500.00 
 
12500.00 
 
12500.00 
 
12500.00 
 
12500.00 
 
12500.00 
 
12500.00 
 
12500.00 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
0.0584 
 
0.0344 
 
0.0249 
 
0.0121 
 
0.0071 
 
0.0021 
 
0.0015 
 
0.0007 
 
0.0002 
 
0.0000 
 
0.0000 
 
0.0000 
*Black figure = dissolved (aqueous phase); Red figure = sorbed & degraded 
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5.3 Back-calculation assessment of compounds. 
In Table 49, the result of back-calculation to estimate initial concentration of analytes in raw influent 
wastewaters using their respective removal rates in reversed order from Table 43 as shown below and 
arriving back at initial influent concentration of 12500 µg L
-1
. This confirms or checks the mass 
balance calculation operation has been done correctly.  
Table 49: Mass Balance back-calculation in reversed order in humus sludge (HS), mixed submerged aerated 
filter (MSAF), submerged aerated filter-1 (SAF-1) and primary sludge (PS), showing  the removal rate of drugs 
in RED (sorbed & degraded) and amount dissolved in aqueous phase in BLACK.  (Data from Table 44) 
 
 
 
 
   
Time 
  (min) 
 
 
Removal rate (%) from each STW 
units 
 
 
Cocaine partition in aqueous and solid phases 
 (µg in 250 mL) 
 
 
HS 
 
MSAF 
 
SAF 
 
PS 
 
HS 
 
MSAF 
 
SAF 
 
PS 
Total 
degraded & 
sorbed 
Batch 
Conc. (µg 
in 250ml) 
15 
 
 
 
30 
 
 
 
45 
 
 
 
60 
 
 
 
75 
 
 
 
90 
 
 
 
105 
 
 
 
120 
 
 
 
135 
 
 
 
150 
 
 
 
165 
 
 
 
180 
19.0 
81.0 
16.5 
83.5 
14.8 
85.2 
16.8 
83.2 
15.1 
84.9 
12.5 
87.5 
10.7 
89.3 
9.0 
91.0 
7.9 
92.1 
5.9 
94.1 
2.7 
97.3 
1.4 
98.6 
5.1 
94.1 
4.1 
95.9 
3.6 
96.4 
1.8 
98.2 
1.4 
98.6 
1.3 
98.7 
1.2 
98.8 
1.3 
98.7 
0.9 
99.1 
0.6 
99.4 
0.4 
99.6 
0.2 
99.8 
37.0 
63.0 
33.6 
66.4 
26.9 
73.1 
27.2 
72.8 
24.0 
76.0 
20.4 
79.2 
13.8 
86.2 
11.3 
88.7 
9.2 
90.8 
5.3 
94.7 
4.0 
96.0 
2.4 
97.6 
4.7 
95.3 
3.5 
96.5 
3.5 
96.5 
3.4 
96.6 
3.0 
97.0 
1.8 
98.2 
1.8 
98.2 
1.6 
98.4 
1.3 
98.7 
1.0 
99.0 
0.7 
99.3 
0.4 
99.6 
2.11 
8.98 
0.99 
5.03 
0.63 
3.61 
0.35 
1.73 
0.19 
1.07 
0.07 
0.52 
0.04 
0.33 
0.03 
0.27 
0.01 
0.12 
0.00 
0.04 
0.00 
0.01 
0.00 
0.00 
11.09 
206.29 
6.03 
140.97 
4.24 
113.45 
2.08 
113.52 
1.26 
88.74 
0.60 
45.30 
0.37 
30.68 
0.29 
25.34 
0.13 
14.82 
0.04 
6.59 
0.01 
3.49 
0.00 
1.20 
217.38 
370.13 
147.00 
290.50 
117.69 
319.81 
115.60 
309.40 
90.00 
285.00 
45.90 
179.10 
31.05 
193.95 
25.64 
201.26 
14.95 
147.55 
6.63 
118.38 
3.50 
84.00 
1.20 
48.80 
587.50 
11912.50 
437.50 
12062.50 
437.50 
12062.50 
425.00 
12075.00 
375.00 
12125.00 
225.00 
12275.00 
225.00 
12275.00 
226.90 
12273.08 
162.50 
12337.50 
125.00 
12375.00 
87.50 
12412.50 
50.00 
12450.00 
 
12497.89 
 
12499.01 
 
12499.37 
 
12499.65 
 
12499.81 
 
12499.93 
 
12499.96 
 
12499.92 
 
12499.99 
 
12500.00 
 
12500.00 
 
12500.00 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
 
12500 
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5.4 Application of mass balance to calculate influent concentration of analytes from 
Nottingham STW effluent. 
In this section (Table 50), we applied back-calculation for the selected analytes from Stoke Bardolph 
STW Nottingham effluent to estimate influent concentrations.  In using the removal rates (%) 
obtained from batch studies data using sewage samples collected from Molesworth STW and applying 
it to the Stoke Bardolph STW Nottingham  to estimate influent (ng L
-1
)  in back calculation.  The 
following assumptions that may influence the removal rate (%) and its application in the back-
calculation were made: 
1. Operational design and treatment policy for Stoke Bardolph Nottingham and Molesworth 
STWs are assumed to be similar. There was no recirculation section in Molesworth STW 
and no submerged aerated filter (SAF) processing unit at Stoke Bardolph STW Nottingham. 
2. The nature of sewage and its characteristics were assumed to be the representative of most 
municipal sewage types. 
3. The STWs hydraulic retention times were assumed to be the same (though a total of 8 HRT in 
Molesworth and 16 HRT including recycling process in Stoke Bardolph STW Nottingham). 
4. The batch experiments data obtained with the real sewage samples collected from each 
processing units of the Molesworth STW were assumed to be representative of real-time 
STW runs, the real time pilot run in the STW was not possible due to site restrictions. 
Table 50: Estimation of analytes from effluents concentration at 2 HRT using the percent removal rates for 
Cocaine (Table 43) and Benzoylecgonine (Table 44) in back calculation to estimate influent concentration. 
(Note the reverse order of sewage sludges: HS →MSAF→SAF-1→PS) 
Analyte  
Analytes (%) in aqueous phase of 
each STW units. 
 
Concentration of analytes (ng L-1) in STW 
units. 
 
Estimated 
influent 
(µg L-1) 
HS MSAF SAF-1 PS HS MSAF SAF-1 PS 
COC 9.0 
91.0 
1.3 
98.7 
11.3 
88.7 
1.6 
98.4 
1.9 
19.2 
21.1 
1602.8 
1623.9 
12747.2 
14371.1 
 
14.3 
 
BZE 9.4 
90.6 
12.2 
87.8 
12.0 
88.0 
1.0 
99.0 
32.9 
317.1 
350.0 
2518.9 
2868.9 
21038.2 
23907.1 
 
23.9 
 
           *Black = dissolved (aqueous phase); Red = sorbed & degraded. 
Using the concentration of drugs found from Stoke Bardolph STW Nottingham effluent in Table 18 
and applying the percent removal rates of drugs (cocaine, benzoylecgonine and morphine) at 2h 
timescale for back- calculation as shown in Table 50: 
The First HS row: = 1.9 ng L
-1
 of COC (effluent) 
Dissolved rate = 1.9 ÷ 9.0% (0.09) = 21.1 ng (dissolved in aqueous phase that goes to MSAF) → 
Removal rate = 91.0% = 19.2 ng (removed by sorption/degradation) 
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Second MSAF row: 
Dissolved rate = 21.1ng ÷ 1.3% (0.013) = 1623.9 ng (dissolved in aqueous that goes to SAF-1) → 
Removal rate = 98.7% = 1602.8 ng (removed by sorption/degradation) 
 
Third SAF row:  
Dissolved rate = 1623.9 ÷ 0.113 ng = 14371.1 ng (dissolved in aqueous phase that goes to PS) → 
Removal rate = 88.7% = 12747.2 ng (removed by sorption/degradation) 
 
Fourth PS row: 
Dissolved rate = 14371.1 ng (influent) 
Removal rate = 98.4% = 883882.7 ng (removed by sorption/degradation) 
 
Table 55 below, makes it easy to compare data of the effluents concentations of cocaine and 
benzoylecgonine obtained from Stoke Bardolph STW Nottingham with the back calculated influent 
concentrations for cocaine (14371.1 ng L-
1
) and benzoylecgonine 23907.1 (ng L-
1
). 
Table 51: Comparing literature influent measurements of drugs  
 
 
Our calculated values though seem very high results – (1000s ng L-1) may possibly be due to 
uncertainty in primary removal in our batch studies as no recovery values from the solid 
phase were used [354], compared with those quoted in other places (Table 4 in Chapter 1).  
However, the capabilities of the current experimental batch data in generating removal rates 
        
 
Influent measurements of cocaine and benzoylecgonine  
quoted from other places (Table 4 in Chapter 1) 
 
Calculated influent 
based on back 
calculations from 
effluent using batch 
study removal rates    
Analytes Matrix Measured 
Influent (ng L-1 ) 
 (µg L-1 ) 
 
Cocaine 
 
5 STPs, Spain 
 
225.0  
  
14.3 
 5 STPs,  Belgium 22 -678   
 37 STPs, Belgium 32 – 753   
 5 STPs, Ireland, UK 489 ±  117   
 Eastern Spain 370 – 1000.24   
 30 STPs, Belgium 9 – 683   
 2 STPs, Italy 218.4 – 421.4    
 42 STPs, NE Spain 4 – 4700   
 Barcelona, Spain 2.40    
Benzoylecgonine 5 STPs,  Spain 2307.0  23.9 
 5 STPs,  Belgium 82 – 1898   
 37 STPs, Belgium 46 –2258   
 5 STPs, Ireland UK 290 ± 11   
 Eastern  Spain 150 – 1000.5   
 30 STPs, Belgium 37 – 1550   
 2 STPs, Italy 547.4 -197.2    
 42 STPs, NE Spain 9 – 7500   
  Barcelona, Spain 5.24   
 12 STPs, Germany 65 ± 5   
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as used in our current mass balance approach have improved on the complications associated 
with assumptions of Zuccato et al [124] in their use of 45% of total ingested cocaine dose to 
calculate the concentration of excreted as BZE and Bones et al [265] used 10%. The literature 
apparent differences on the actual percentage of excreted cocaine and BZE from cocaine dose 
coupled with the problems due to sampling logistics and desludging as experienced by prior 
studies have made methodologies of reporting mass balances varied considerably and this is 
what the present new approach has addressed.  
The removal rates of COC (91.0%), BZE (90.6%), HER (97.9%), (MOR (99.7%), 6MAM (93.3%) 
and DIAZ (99.7%) in total of 8 HRT compare to the removal efficiencies of some pharmaceuticals 
like ciprofloxacin (37-86%), ofloxacin (33-66%), norfloxacin (58-87%) and Iomefloxacin (21-72%) 
are presented, respectively [290].  
Clear and simple steps in mass balance calculation of compounds in STWs has been 
presented in the current work and with some refinement, the conceptual approach may be 
useful. 
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CHAPTER 6: Conclusions 
 In the current work, six representative compounds of classes of illicit drugs (cocaine, 
benzoylecgonine, heroin, 6 monoacetyl morphine, morphine and diazepam  (pharmaceutical) were 
studied and these drugs exhibited comparable removals when in contact with both primary and 
biological secondary treatment sludge during the batch studies of 3h exposure time. The compounds 
were comparably dissolved, degraded, adsorbed and distributed between both solid and aqueous 
phases in a pattern that reflects their hydrophobic nature as degradation progressed. Observed rapid 
removals were exhibited in the first few minutes of contact with both primary and secondary sewage 
samples with  increase in the degradation products as compounds exposed to microbial and chemical 
hydrolysis but the rate slows down as availability of nutrient source reduces. Elements of this work 
reaffirm existing knowledge and data derived from batch studies, removal rates and their application 
to Molesworth and Stoke Bardolph STWs are the novel aspects of this thesis.  The main conclusions 
for the novel work are presented in 8 bullet points: 
 Methods were developed for the determination of a range of drugs in wastewaters and sludge 
samples, which were applied to samples from two sewage treatment works of RAF 
Molesworth and Stoke Bardolph, Nottingham, UK. This stage of my work confirmed 
analytical methodologies had necessary capabilities for the work undertaken. 
 The present study concentrations of analytes found were between 1.9 and 3147 ng L-1 in 
effluents of Stoke Bardolph STW with the percentage recoveries ranged from 74.5 – 109.6%, 
 with the instrumental limits of detection (LODs) ranges of 0.2 – 12.7 ng L-1, and relative 
standard deviation (RSD) values of 0.6 – 4.7% for all the compounds were achieved. 
Procaine, bromacil, codeine, lidocaine, ibruprofen, caffeine, nicotine and diazepam were the 
most abundant compounds with concentrations of 99.2, 1806.8, 33.5, 71.8, 3147, 213.4, 252.5 
and 105.2 ng L
-1
, respectively, and the results were in line with values reported by other 
workers for such analyses. 
 A number of degradation batch studies of cocaine, benzoylecgonine, heroin, morphine, 6-
monoacetylmorphine and diazepam on sludge samples at two different temperatures showed 
consistent duplicates results with the degradation of compounds at 19 ± 0.5
o
 C relatively 
greater but still occurred slowly at 4 ± 0.5
o 
C, demonstrating that degradation was both biotic 
and abiotic but the degradation of compounds at 19 ± 0.5
o
 C was faster than at 4 ± 0.5
o 
C, by 
between 5 and 10%. Both biological and chemical degradations affects the removal of 
compounds in different rates at 4 ± 0.5 
o
C, the degradation/partitioning is therefore 
temperature dependent.  
 Optimal experimental strategy with refinement can be developed by incorporating good 
temperature process variables with knowledge of individual’s compound degradation and 
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possible transport occurring in the STWs to achieve complete removals as demonstrated in 
the batch studies. 
 Compounds removal by biodegradation, chemical degradation and sorption were the 
dominant removal processes (volatilization is unlikely) with removal rates of cocaine 
(91.0%), benzoylecgonine (90.6%), heroin (97.9%), morphine (99.7%), 6 
monoacetylmorphine (93.3%) and diazepam (99.7%) having corresponding partitioning 
coefficients (Kd) ranged from 1.2 – 68.1 Kg L
-1
for the same 8 HRT. Diazepam has the highest 
sorption removal in both primary and secondary sludge treatments and its exhibited 
tendencies of accumulating in sediments with identical Kd values in all sludge types could 
possibly provide empirical relationship between drug removal and HRT.  
 The characterization of the sewage sludge of RAF Moleswoth and Stoke Bardolph STW, 
Nottingham demonstrated strong variation in concentration strengths of TSS, CODs and 
occasional pH changes. In the RAF Molesworth STW, the TSS was 36243.0 mg L
-1
 (influent) 
and 5.5 mg L
-1
 (effluent), while Stoke Bardolph had 797.9 mg L
-1
 (influent) and 8.6 mg L
-1
 
(effluent). The COD at RAF Molesworth was 216.8 mgdm
-3
O2   (influent) and 1.8 mgdm
-3
O2 
(effluent), while Stoke Bardolph had 36.0 mgdm
-3
O2  (influent) and 3.6 mgdm
-3
O2 (effluent). 
The pH ranges of 7.8 and 8.4 were found between the influent and effluent wastewaters of the 
two STWs. Also, the average ash and organic carbon contents of the sewage samples were 
0.94 g/g and 0.06 g/g, respectively.  
 The measurements made from batch studies allowed for the development of a mass balance 
which indicates that 110.0 ng L
-1
 (cocaine), 690.0 ng L
-1
 (benzoylecgonine), 10.0 ng L
-1
 
(morphine), 80.0 ng L
-1
 (6-monoacetylmorphine), 0.0 ng L
-1
 (heroin) and 0.7 ng L
-1
 
(diazepam) remained in humus sludge that are passed into effluent in total of 8 HRT from an 
initial influent concentration of 12500 ng L
-1
. Projected influent concentrations of cocaine 
(14, 471 ng L
-1
) and benzoylecgonine (23, 907.1 ng L
-1
) at Stoke Bardolph were derived from 
back-calculating measued final effluent concentrations using this same mass balance 
approach. 
 Influent concentrations of cocaine (14. 4 µg L-1) and benzoylecgonine (23.9 µg L-1) were 
obtained from effluent concentrations in back-calculation of removal rates to demonstrate the 
application of mass balance approach in simple and clear steps. However, the uncertainties as 
highlighted in section 4.2.1 may be an important impacting factor on our eventual removal 
rate calculations. 
Work encompassed directly measures illicit drug removal rates in laboratory studies for the first time 
and improvement over prior study where assumptions on removal rates were made. With refinement, 
the capabilities of the current experimental batch data in generating removal rates of drugs have 
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however been clearly demonstrated and applied, the conceptual approach developed may be very 
useful to obtain influent information of any organic compounds in real life (STWs) situations. 
 
Future Research 
1. More work is required for batch experiments of other classes of illicit drugs using many 
STWs at different location. Complete transformation processes of the compounds should 
be further studied to provide additional exposure data for environmental scientists.  
2. Mass balance calculations should be further applied using other STWs and composite 
sludge samples from all the major processing units be obtained to eliminate erroneous 
calculation of drug levels based on analytes found in surface water.  
3. With approval from the relevant environmental agency, real-life pilot runs through some 
STWs to monitor degradation processes and assess removal efficiencies would be 
advantageous. 
4. Chemical screening of phytotoxicity potential of these drugs and their active metabolites 
in the environment may be insufficient until the analysis of sediments and fruits grown in 
sewage – amended soils are investigated. It might give further information about possible 
transports of these residues to humans through organic foodstuffs. Understanding the 
adverse effects of other compounds would be a right step towards the development of 
safer sewage management practices.  
 
 
 
 Supplementary data for calibration, wastewater sampling analysis, batch studies and 
RAF process unit calculation are provided in the appendices. 
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Appendix 1: Reference Mass Spectra of Selected Compounds from 
GC NIST Library 
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2. Examples of GC TIC traces of analytes from wastewater samples: 
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Appendix 2A– Linear Calibration Data and Graphs for Analysed 
Wastewaters: 
 
 
Compounds Calibration equations Coefficient of 
variations 
 
Ibuprofen y = 7192673.8091x       R
2 
= 0.9914 
Benzocaine   y = 12643449.0909x     R
2 
= 0.9898 
Caffeine y = 3624740.0364x      R
2 
= 0.9914 
Lidocaine   y = 5972102.5364x      R
2 
= 0.9956 
Cocaine    y = 6695077.2818x      R
2 
= 0.9964 
Codeine y = 26382267.9909x     R
2 
= 0.9914 
Amphetamine  y = 2603437.4545x      R
2 
= 0.9719 
Metamphetamine y = 3936488.1455x      R
2 
= 0.9534 
Ecgonine methyl ester     y = 9712404.1364x      R
2 
= 0.9850 
Methadone      y = 8283520.2818x      R
2 
= 0.9978 
6- acetylcodeine             y = 363398.0455x        R
2 
= 0.9950 
6- acetylmorphine           y = 968887.8455x       R
2 
= 0.9956 
Diacetylmorphine   y = 4861518.1909x      R
2 
= 0.9671 
Diazepam y = 7186720.3364x      R
2 
= 0.9768 
Procaine   y = 1562839.1455x      R
2 
= 0.9852 
Aspirin    y = 3317023.0818x       R
2 
= 0.9647 
Bromacil y = 1351922.4355x       R
2
 = 0.9947 
Benzoylecgonine y= 113780x                 R
2
 = 0.9989 
Morphine y= 2380012.11x           R
2
 = 1.00 
Ephedrine y= 1335354.68x           R
2
 = 0.9902 
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Diacetylmorphine peak area versus concentration 
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Appendix 2B– Linear Calibration Data and Graphs for Batch Studies: 
 
Cocaine: (y) =13223636.07x     R2  = 1.00   
Ecgoninemethylester :(y) =101000x    R2  = 0.9877 
Cocaethene:   (y) =103540x    R2  = 0.9947. 
Benzoylecgonine:(y) =113780x    R2  = 0.9989 
Morphine:(y) =2380012.11x    R2  = 1.00 
6-monoacetylmorphine: (y) =878750x    R2  = 0.9940 
Heroin: (y) =106632x    R2  = 0.998 
Diazepam: (y) =78682x    R2  = 0.9989 
Nordazepam:  (y) =348405x    R2  = 0.999 
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Appendix 3: GC TIC data for analysis of Stoke Bardolph, Nottingham 
STW wastewaters  
 
 
 
 
Compounds                                            Water Sampling dates and TIC area 
Mon; 
22/02/10 
Thur; 
25/02/10 
Thur; 
04/03/10 
Thur; 
11/03/10 
Mon; 
15/03/10 
Thur; 
18/03/10 
Fri; 
23/04/10 
Sat; 
24/04/10 
Cocaine 129537 
131538 
       
Benzoylecgonine-O-
TMS 
   125648 
124070 
905197 
964038 
930387 
456995 
474036 
453764 
  
Codeine-O-TMS 2843877 
2828066 
1265427 
1203968 
857768 
859669 
7750259 
7588535 
8116051 
8958348 
8716846 
6694918 
6590851 
4740367 
1980035 4649455 
4603701 
4458251 
Diazepam 288823 
284285 
  3090946 
2901362 
4193148 
4342158 
4167055 
7525654 
7593518 
  
Morphine-bis- O-
TMS 
   380541 
393180 
    
Ephedrine- O-TMS   70455      
Dihydrocodeine-O-
TMS 
   1223462 
4230932 
2433785 
6829090 
2741835   
Dihydromorphine-O-
TMS 
   1843927  8602830   
Lidocaine 2236362 
2224158 
4554012 
4581522 
 1355039 1289848 
1276897 
1246592 
 
938076 
947060 
 
 
4264405 
4157302 
 
2586923 
2604099 
 
Diacetylmorphine 
(Heroin) 
   2385847 
2388462 
    
Ibruprofen--O-TMS    8317097 
8857220 
    
Bromacil 4989517 
5285145 
 634139 
636344 
 1421622 
1024792 
861113 
872471 
5655181 
5525176 
8167878 
8116136 
Procaine 2583272 
2478914 
   1564681 
1534684 
   
Amphetamine       100296  
Ecgonine methyl 
ester 
      785137  
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Appendix 4 – Concentration Data of Sewage Batch Studies 
Batch Studies Data Table 
Table 1a. Partition/Degradation of cocaine in primary sludge batch tests (4± 0.5
o
C)
 
 
 
Table 1b. Partition/Degradation of ecgonine methyl ester in primary sludge batch tests (4± 0.5
o
C)
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
cocaine 
 
 
% 
COC 
 
 
 
 
% 
removal 
 
EME, CE 
& 
Residual 
products 
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
3420.3 
3114.1 
2923.2 
2234.1 
1690.0 
1446.1 
1210.0 
940.3 
732.9 
518.3 
365.6 
125.0 
3440.2 
3113.8 
2926.1 
2236.7 
1689.0 
1439.5 
1185.9 
941.8 
733.8 
519.1 
365.4 
125.3 
3430.2 
3114.0 
2924.7 
2235.4 
1689.5 
1442.8 
1197.9 
941.1 
733.4 
518.7 
365.5 
125.2 
201.4 
193.3 
170.4 
166.3 
141.6 
177.5 
192.7 
140.5 
166.7 
126.9 
133.0 
74.3 
210.4 
193.3 
180.0 
163.8 
154.5 
177.4 
190.2 
140.7 
163.3 
125.5 
132.3 
74.2 
205.9 
193.3 
175.2 
165.0 
148.0 
177.5 
191.4 
140.6 
165.0 
126.23 
132.7 
74.2 
3636.1 
3307.3 
3099.9 
2400.4 
1837.6 
1620.3 
1389.4 
1081.7 
898.4 
644.9 
498.2 
199.4 
29.1 
26.5 
24.8 
19.2 
14.7 
13.0 
11.1 
8.7 
7.2 
5.2 
4.0 
1.6 
72.6 
75.1 
76.6 
82.1 
86.5 
88.5 
90.4 
92.5 
94.1 
95.9 
97.1 
99.0 
8863.9 
9192.7 
9400.1 
10099.6 
10662.4 
10879.7 
11110.6 
11418.3 
11601.6 
11885.1 
12001.8 
12300.6 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total EME 
 
 
 
 
 
CE & other 
Residual 
products 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1800 
1702 
1449 
1121 
1241 
1140 
962 
792 
666 
588 
425 
267 
 
1800 
1725 
1470 
1121 
1224 
1155 
949 
803 
657 
581 
430 
270 
 
1800 
1725 
1470 
1121 
1241 
1140 
962 
803 
684 
588 
425 
267 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
1800 
1725 
1470 
1121 
1241 
1140 
962 
803 
684 
588 
425 
267 
 
7063.9 
7467.7 
7930.1 
8978.6 
9421.4 
9739.7 
10148.6 
10615.3 
10917.6 
11297.1 
11576.8 
12033.6 
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Table 1c. Partition/Degradation of cocaethylene in primary sludge batch tests (4± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2a. Partition/Degradation of cocaine in primary sludge batch tests (19± 0.5
o
C) 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
CE 
 
 
CE & other 
Residual 
products 
 
Sample 
1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
 
650 
644 
525 
475 
442 
450 
312 
264 
216 
189 
115 
96 
625 
621 
546 
418 
442 
450 
312 
264 
216 
189 
115 
96 
650 
644 
546 
456 
442 
450 
312 
264 
216 
189 
115 
96 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
650 
644 
546 
456 
442 
450 
312 
264 
216 
189 
115 
96 
6413.9 
6823.7 
7384.1 
8522.6 
8979.4 
9289.7 
9836.6 
10351.3 
10701.6 
11108.1 
11461.8 
11937.6 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
cocaine 
 
 
% 
COC 
 
 
 
 
% 
removal 
 
EME, CE 
& 
Residual 
products 
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
583.7 
430.3 
435.0 
424.4 
372.0 
225.0 
224.2 
196.4 
157.6 
121.0 
82.5 
46.2 
589.3 
436.3 
435.0 
427.3 
371.2 
225.5 
218.3 
195.2 
158.6 
123.1 
82.7 
45.9 
586.5 
433.3 
435.0 
425.8 
371.6 
225.3 
221.3 
195.8 
158.1 
122.1 
82.6 
46.0 
142.8 
184.6 
91.1 
82.0 
109.6 
81.7 
63.4 
48.8 
52.5 
38.0 
22.3 
9.4 
146.2 
187.8 
97.9 
93.7 
111.5 
80.0 
63.1 
51.9 
54.0 
38.0 
23.3 
9.6 
144.5 
186.2 
94.5 
87.9 
110.6 
80.8 
63.3 
50.3 
53.2 
38.0 
22.8 
9.5 
731.0 
619.5 
529.5 
513.7 
482.2 
306.1 
284.5 
246.2 
211.4 
160.1 
105.4 
55.5 
5.8 
5.0 
4.2 
4.1 
3.9 
2.4 
2.3 
2.0 
1.7 
1.3 
0.8 
0.4 
95.3 
96.5 
96.5 
96.6 
97.0 
98.2 
98.2 
98.4 
98.7 
99.0 
99.3 
99.6 
11769.0 
11880.5 
11970.5 
11986.3 
12017.8 
12193.9 
12215.5 
12253.8 
12288.6 
12339.9 
12394.6 
12444.5 
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                     Table 2b. Partition/Degradation of ecgonine methyl ester in primary sludge batch tests  (19± 
0.5
o
C)
 
 
Time 
(min) 
 
aqueous phase (ug in10 mL) 
 
 
solid phase (ug in10 mL) 
 
 
 
Total 
EME 
 
 
Other 
residuals  
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
25 
23 
84 
76 
85 
75 
65 
88 
63 
49 
30 
18 
25 
23 
63 
76 
85 
75 
78 
88 
63 
42 
25 
18 
25 
23 
74 
76 
85 
75 
65 
88 
63 
46 
30 
18 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
25 
23 
74 
76 
85 
75 
65 
88 
63 
46 
30 
18 
11744 
11857.5 
11886.5 
11910.3 
11932.8 
12118.9 
12150.5 
12165.8 
12225.6 
12290.9 
12364.6 
12426.5 
Table 2c. Partition/Degradation of cocaethylene in primary sludge batch tests  (19± 0.5
o
C)
 
 
Time 
(min) 
 
aqueous phase (ug ) 
 
 
solid phase (ug) 
 
 
 
Total CE 
 
 
Other 
Residual 
products 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
150 
184 
147 
152 
119 
135 
91 
66 
54 
63 
50 
27 
150 
184 
147 
152 
136 
135 
104 
77 
54 
63 
50 
27 
150 
184 
147 
152 
119 
135 
91 
66 
54 
63 
50 
27 
225 
184 
168 
114 
153 
105 
91 
55 
72 
28 
40 
30 
200 
184 
168 
133 
119 
105 
91 
55 
72 
28 
40 
24 
225 
184 
168 
114 
136 
105 
91 
77 
72 
28 
40 
27 
375 
368 
315 
266 
255 
240 
182 
121 
126 
98 
90 
54 
11394 
11512.5 
11655.5 
11720.3 
11762.8 
11953.9 
12033.5 
12132.8 
12162.6 
12241.9 
12304.6 
12390.5 
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Table 3a. Total cocaine degradation in primary sludge (filtered) batch tests (19 ± 0.5
o
C) 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
            Table 3b. Total cocaethylene degradation in primary sludge (filtered) batch tests (19 ± 0.5oC) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
cocaine (ug 
) 
  
 
 
% 
COC 
 
  
% 
Removal 
 
 
CE & 
Residual 
products 
 
 
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1393.0 
1153.8 
976.2 
822.4 
803.5 
695.0 
587.3 
485.3 
357.5 
243.2 
114.9 
62.5 
1373.1 
1152.9 
985.5 
823.1 
805.7 
705.3 
578.7 
482.0 
358.0 
243.4 
115.3 
62.7 
1383.1 
1153.3 
980.8 
822.8 
804.6 
700.1 
583.0 
483.6 
357.7 
243.3 
115.1 
62.6 
11.1 
9.2 
7.8 
6.6 
6.4 
5.6 
4.7 
3.9 
2.9 
1.9 
0.9 
0.5 
88.9 
90.8 
92.2 
93.4 
93.6 
94.4 
95.3 
96.1 
97.1 
98.1 
99.1 
99.5 
11116.9 
11346.7 
11519.2 
11677.2 
11695.4 
11799.9 
11917.0 
12016.4 
12142.3 
12256.7 
12384.9 
12437.4 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total CE 
(ug) 
  
 
 
 
Residual 
products 
 
Sample 1 
 
Sample 2 
    15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
 
275 
276 
462 
437 
425 
375 
351 
308 
270 
203 
145 
114 
275 
276 
441 
437 
425 
375 
364 
297 
261 
203 
150 
111 
275 
276 
462 
437 
425 
375 
364 
308 
261 
203 
145 
111 
10841.9 
11070.7 
11057.2 
11240.2 
11270.4 
11424.9 
11553 
11708.4 
11881.3 
12053.7 
12239.9 
12326.4 
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Table 4a. Partition/Degradation of cocaine in SAF-1 batch tests (4 ± 0.5
o
C) 
 
 
 
 
 
Table 4b. Partition/Degradation of cocaethylene in SAF-1 sludge batch tests (4± 0.5
o
C)
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
cocaine 
 
 
% 
COC 
 
 
 
% 
removal 
 
  
CE & 
Residual 
products  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
3934.1 
3438.0 
2113.6 
1888.0 
1600.1 
1143.8 
888.0 
663.3 
440.0 
388.0 
259.0 
134.7 
3911.0 
3375.6 
2080.0 
1875.5 
1584.0 
1135.1 
880.8 
661.0 
500.0 
369.9 
243.3 
135.8 
3922.5 
3406.8 
2096.8 
1881.7 
1592.1 
1139.4 
884.4 
662.1 
470.0 
378.9 
251.1 
135.2 
4252.4 
4038.3 
4637.2 
4289.6 
4078.2 
3445.2 
2901.1 
2505.5 
1997.1 
1545.2 
1092.8 
633.2 
4265.3 
4053.3 
4691.6 
4321.6 
4046.2 
3453.3 
2930.3 
2529.7 
2008.5 
1561.5 
1101.7 
627.0 
4258.9 
4045.8 
4664.4 
4305.6 
4062.2 
3449.3 
2915.7 
2517.6 
2002.8 
1553.3 
1097.3 
630.1 
8181.4 
7452.6 
6761.2 
6187.4 
5654.2 
4588.7 
3800.1 
3179.7 
2472.8 
1932.2 
1348.4 
765.4 
65.5 
59.6 
54.1 
49.5 
45.2 
36.7 
30.4 
25.4 
19.8 
15.5 
10.8 
6.1 
68.6 
72.7 
83.2 
84.9 
87.3 
90.9 
92.9 
94.7 
96.2 
97.0 
98.0 
98.9 
4318.6 
5047.4 
5738.8 
6312.6 
6845.8 
7911.3 
8699.9 
9320.3 
10027.2 
10567.8 
11151.6 
11734.6 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total CE 
 
 
Other 
Residual 
products 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
400 
506 
420 
361 
340 
300 
260 
220 
180 
161 
120 
93 
400 
506 
420 
361 
357 
300 
260 
220 
180 
154 
110 
93 
400 
506 
420 
361 
357 
300 
260 
220 
180 
161 
115 
93 
400 
368 
294 
494 
425 
360 
195 
198 
234 
175 
120 
66 
400 
368 
294 
475 
425 
345 
195 
198 
234 
175 
130 
66 
400 
368 
294 
494 
425 
345 
195 
198 
234 
175 
125 
66 
800 
874 
714 
855 
765 
660 
455 
429 
414 
336 
240 
159 
3518.6 
4173.4 
5024.8 
5457.6 
6080.8 
7251.3 
8244.9 
8891.3 
9613.2 
10231.8 
10911.6 
11575.6 
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Table 5a. Partition/Degradation of cocaine in SAF-1 sludge batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
Table 5b. Partition/Degradation of ecgonine methyl ester  in SAF-1 sludge batch tests  (19± 0.5
o
C)
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
cocaine 
 
 
% 
COC 
 
 
 
% 
removal 
 
 EME, 
CE & 
Residual   
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
4600.1 
4227.3 
3388.7 
3386.7 
3025.0 
2564.9 
1730.5 
1403.3 
1144.3 
666.9 
514.9 
306.5 
4638.8 
4169.9 
3345.4 
3423.8 
2981.3 
2542.8 
1714.4 
1423.0 
1166.0 
649.8 
489.9 
305.9 
4619.4 
4198.6 
3367.1 
3405.2 
3003.1 
2553.9 
1722.5 
1413.1 
1155.2 
658.3 
502.4 
306.2 
3975.0 
3665.6 
3130.2 
2404.5 
2123.9 
1422.8 
862.1 
1011.3 
658.2 
574.2 
312.9 
230.7 
3992.2 
3604.4 
3173.6 
2365.0 
2095.3 
1360.1 
845.8 
1026.2 
659.9 
584.0 
309.3 
227.6 
3983.6 
3635.0 
3151.9 
2384.7 
2109.6 
1391.4 
853.9 
1018.8 
659.1 
579.1 
311.1 
229.1 
8603.0 
7833.6 
6519.0 
5790.0 
5112.7 
3945.3 
2576.4 
2431.9 
1814.2 
1237.4 
813.4 
535.4 
68.8 
62.7 
52.2 
46.3 
40.9 
31.6 
20.6 
19.5 
14.5 
9.9 
6.5 
4.3 
63.0 
66.4 
73.1 
72.8 
76.0 
79.6 
86.2 
88.7 
90.8 
94.7 
96.0 
97.6 
3897.0 
4666.4 
5981.0 
6710.0 
7387.3 
8554.7 
9923.6 
10068.1 
10685.8 
11262.6 
11686.6 
11964.6 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total EME 
 
 
CE & 
other 
residuals 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
275 
207 
63 
133 
102 
75 
52 
88 
90 
28 
35 
18 
275 
207 
63 
133 
102 
75 
52 
88 
99 
28 
35 
18 
275 
207 
63 
133 
102 
75 
52 
88 
99 
28 
35 
18 
125 
184 
252 
152 
238 
120 
234 
110 
108 
77 
60 
48 
125 
230 
252 
152 
255 
120 
247 
110 
108 
70 
60 
48 
125 
207 
252 
152 
255 
120 
247 
110 
108 
77 
60 
48 
400 
414 
315 
285 
357 
195 
208 
198 
207 
105 
95 
66 
3497 
4252.4 
5666 
6425 
7030.3 
8359.7 
9715.6 
9870.1 
10478.8 
11157.6 
11591.6 
11898.6 
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Table 5c. Partition/Degradation of cocaethylene in SAF-1 batch tests (19 ± 0.5
o
C)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6a. Total cocaine degradation in (filtered) SAF-1 sludge batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total CE 
 
 
other 
residuals  
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
350 
322 
294 
266 
238 
195 
169 
143 
108 
84 
60 
42 
350 
345 
294 
266 
221 
195 
169 
132 
108 
84 
60 
42 
350 
345 
294 
266 
238 
195 
169 
132 
108 
84 
60 
42 
150 
138 
126 
152 
119 
90 
117 
110 
99 
70 
90 
54 
150 
115 
126 
152 
119 
90 
91 
121 
99 
70 
85 
54 
150 
138 
126 
152 
119 
90 
104 
110 
99 
70 
85 
54 
500 
460 
420 
437 
357 
270 
260 
253 
216 
154 
145 
96 
2997 
3792.4 
5246 
5988 
6673.3 
8089.7 
9455.6 
9617.1 
10262.8 
11003.6 
11446.6 
11802.6 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
cocaine (ug 
) 
  
 
 
% 
COC 
 
  
% 
Removal 
 
 
CE & 
Residual 
 
 
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
6089.3 
5435.2 
4883.2 
4581.4 
3791.0 
3233.4 
2810.5 
2241.9 
1633.9 
1202.0 
803.4 
429.0 
6101.2 
5440.0 
4706.1 
4599.4 
3773.4 
3258.8 
2774.7 
2311.6 
1596.6 
1208.2 
832.9 
428.5 
6095.2 
5437.6 
4794.6 
4590.4 
3782.2 
3246.1 
2792.6 
2276.8 
1615.2 
1205.1 
818.1 
428.7 
48.8 
43.5 
38.4 
36.7 
30.3 
26.0 
22.3 
18.2 
12.9 
9.6 
6.5 
3.4 
51.2 
56.5 
61.6 
63.3 
69.7 
74.0 
77.7 
81.8 
87.1 
90.4 
93.5 
96.6 
6404.8 
7062.4 
7705.4 
7909.6 
8717.8 
9253.9 
9707.4 
10223.2 
10884.8 
11294.9 
11681.9 
12071.3 
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Table 6b. Total cocaethylene degradation (filtered) SAF-1 sludge batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7a. Partition/Degradation of cocaine in MSAF-1 sludge batch tests (4± 0.5
o
C) 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total CE 
(ug) 
  
 
 
 
Residuals   
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
 
3125 
2829 
2583 
2451 
2397 
2310 
2002 
1760 
1449 
1106 
810 
477 
3125 
2852 
2625 
2299 
2397 
2310 
1976 
1760 
1458 
1106 
795 
480 
3125 
2829 
2604 
2375 
2397 
2310 
1989 
1760 
1449 
1106 
800 
480 
3279.8 
4210.4 
5080.4 
5610.6 
6320.8 
6943.9 
7731.4 
8463.2 
9426.8 
10188.9 
10886.9 
11591.3 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
cocaine 
 
 
% 
COC 
 
 
 
% 
removal 
 
 EME, 
CE & 
Residual   
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
5488.0 
5176.5 
4877.7 
3832.8 
3812.6 
3536.8 
3046.4 
2300.8 
1884.6 
1409.3 
985.3 
608.6 
5458.8 
5182.0 
4863.0 
4141.0 
3784.3 
3554.3 
3035.5 
2301.8 
1877.9 
1416.9 
992.8 
607.6 
5473.4 
5179.3 
4870.3 
3986.9 
3798.5 
3545.5 
3040.9 
2301.3 
1881.2 
1413.1 
989.1 
608.1 
418.0 
391.0 
355.5 
355.5 
372.1 
276.5 
250.2 
277.4 
167.9 
136.8 
112.1 
67.9 
442.2 
448.2 
374.0 
360.6 
385.8 
288.7 
257.2 
277.2 
167.8 
139.5 
117.4 
67.1 
430.1 
419.6 
364.7 
358.0 
378.9 
282.6 
253.7 
277.3 
167.8 
138.1 
114.7 
67.5 
5903.5 
5598.9 
5235.0 
4344.9 
4177.4 
3828.2 
3294.6 
2578.5 
2049.1 
1551.2 
1103.8 
675.6 
47.2 
44.8 
41.9 
34.8 
33.4 
30.6 
26.4 
20.6 
16.4 
12.4 
8.8 
5.4 
56.2 
58.6 
61.0 
68.1 
69.6 
71.6 
75.7 
81.6 
85.0 
88.7 
92.1 
95.1 
6596.5 
6901.1 
7265.0 
8155.1 
8322.6 
8671.8 
9205.4 
9921.5 
10450.9 
10948.8 
11396.2 
11824.4 
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Table 7b. Partition/Degradation of cocaethylene in MSAF batch tests (4± 0.5
o
C) 
 
 
 
 
Table 8a. Partition/Degradation of cocaine in MSAF batch tests (19± 0.5
o
C) 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total CE 
 
 
other 
residuals  
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
2600 
2369 
2163 
1957 
1853 
1515 
1417 
1331 
1161 
959 
765 
447 
2575 
2415 
2205 
1976 
1870 
1560 
1430 
1276 
1170 
952 
755 
444 
2575 
2392 
2184 
1976 
1853 
1545 
1430 
1298 
1170 
959 
760 
444 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
2575 
2392 
2184 
1976 
1853 
1545 
1430 
1298 
1170 
959 
760 
444 
4021.5 
4509.1 
5081 
6179.1 
6469.6 
7126.8 
7775.4 
8623.5 
9280.9 
9989.8 
10636.2 
11380.4 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
cocaine 
 
 
% 
COC 
 
 
 
% 
removal 
 
 EME, 
CE & 
Residual   
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
647.7 
509.4 
446.6 
231.9 
179.2 
162.1 
146.4 
160.8 
114.3 
74.5 
47.5 
28.7 
635.9 
510.9 
456.0 
230.0 
179.5 
163.4 
146.4 
161.7 
115.9 
74.8 
47.4 
29.9 
641.8 
510.1 
451.3 
231.0 
179.4 
162.7 
146.4 
161.2 
115.1 
74.7 
47.4 
29.3 
90.7 
115.4 
101.1 
93.5 
77.4 
68.5 
65.3 
55.3 
43.1 
35.9 
30.2 
21.9 
93.1 
113.9 
99.0 
92.3 
77.5 
68.2 
65.1 
55.4 
42.1 
35.1 
30.4 
21.6 
91.9 
114.7 
100.1 
92.9 
77.5 
68.4 
65.2 
55.4 
42.6 
35.5 
30.3 
21.7 
733.7 
624.8 
551.4 
323.9 
256.8 
231.1 
211.6 
216.6 
157.7 
110.2 
77.7 
51.0 
5.9 
5.0 
4.4 
2.6 
2.1 
1.8 
1.7 
1.7 
1.3 
0.9 
0.6 
0.4 
94.9 
95.9 
96.4 
98.2 
98.6 
98.7 
98.8 
98.7 
99.1 
99.4 
99.6 
99.8 
11858.2 
11989.9 
12048.7 
12269.0 
12320.6 
12337.3 
12353.6 
12338.8 
12384.9 
12425.3 
12452.6 
12470.7 
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Table 8b. Partition/Degradation of ecgonine methyl ester  in MSAF-1 sludge batch tests  (19± 0.5
o
C)
 
 
 
 
 
Table 8c. Partition/Degradation of cocaethylene  in MSAF-1 sludge batch tests  (19± 0.5
o
C)
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total EME 
(ug) 
 
CE & other  
Metabolites 
 (ug) 
 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
0 
0 
0 
114 
102 
45 
39 
33 
45 
21 
15 
24 
0 
0 
0 
114 
102 
45 
39 
33 
45 
21 
15 
24 
0 
0 
0 
114 
102 
45 
39 
33 
45 
21 
15 
24 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
0 
0 
0 
114 
102 
45 
39 
33 
45 
21 
15 
24 
11858.2 
11989.9 
12048.7 
12155 
12218.6 
12292.3 
12314.6 
12305.8 
12339.9 
12404.3 
12437.6 
12446.7 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total CE 
(ug) 
 
 
Other 
metabolites   
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
200 
184 
147 
133 
136 
90 
78 
88 
90 
91 
65 
36 
225 
184 
147 
133 
119 
90 
78 
88 
81 
98 
65 
33 
225 
184 
147 
133 
119 
90 
78 
88 
81 
98 
65 
33 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
225 
184 
147 
133 
119 
90 
78 
88 
81 
98 
65 
33 
11633.2 
11805.9 
11901.7 
12022 
12099.6 
12202.3 
12236.6 
12217.8 
12258.9 
12306.3 
12372.6 
12413.7 
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Table 9a. Total cocaine degradation in MSAF sludge (filtered) batch tests (19± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 9b. Total cocaethylene degradation in MSAF sludge (filtered) batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
cocaine 
(ug) 
  
 
 
% 
COC 
 
  
% 
Removal 
 
 
CE & 
Residual 
 
 
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
995.3 
898.8 
838.9 
782.0 
670.0 
552.0 
452.2 
369.2 
264.9 
187.9 
132.8 
73.1 
1002.2 
889.6 
841.2 
789.5 
674.6 
550.9 
447.8 
365.7 
262.4 
177.8 
133.3 
71.1 
998.7 
894.2 
840.0 
785.8 
672.3 
551.5 
450.0 
367.5 
263.7 
182.9 
133.1 
72.1 
8.0 
7.2 
6.7 
6.3 
5.4 
4.4 
3.6 
2.9 
2.1 
1.5 
1.1 
0.6 
92.0 
92.8 
93.3 
93.7 
94.6 
95.6 
96.4 
97.1 
97.9 
98.5 
98.9 
99.4 
11501.3 
11605.8 
11660.0 
11714.2 
11827.7 
11948.5 
12050.0 
12132.5 
12236.3 
12317.1 
12366.9 
12427.9 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total CE 
(ug) 
  
  
Other 
metabolites  
(ug )  
Sample 1 
 
Sample 2 
 
 
    15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
 
525 
506 
462 
418 
442 
315 
299 
242 
198 
175 
135 
78 
525 
506 
483 
380 
425 
315 
286 
253 
207 
175 
140 
81 
525 
506 
483 
399 
425 
315 
286 
242 
207 
175 
135 
81 
 10976.3 
11099.8 
11177 
11315.2 
11402.7 
11633.5 
11764 
11890.5 
12029.3 
12142.1 
12231.9 
12346.9 
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 Table 10a. Partition/Degradation of cocaine in Humus sludge batch tests (4± 0.5oC) 
 
 
 
 
Table 10b. Partition/Degradation of cocaethylene in Humus sludge batch tests  (4± 0.5
o
C)
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
cocaine 
 
 
% 
COC 
 
 
 
% 
removal 
 
 EME, 
CE & 
Residual   
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
5099.7 
4686.5 
4374.4 
3602.3 
3596.7 
3204.3 
2122.8 
1939.3 
1311.5 
1111.0 
856.6 
430.1 
5053.2 
4640.7 
4221.2 
3766.6 
3626.4 
3154.3 
2178.2 
1888.9 
1335.9 
1117.1 
864.4 
430.9 
5076.5 
4663.6 
4297.8 
3684.4 
3611.6 
3179.3 
2150.5 
1914.1 
1323.7 
1114.1 
860.5 
430.5 
2355.7 
2065.8 
1914.9 
1558.3 
1463.9 
1213.5 
1027.7 
711.6 
573.5 
438.8 
315.0 
181.8 
2351.3 
2010.5 
1883.8 
1555.3 
1436.9 
1173.6 
1056.8 
703.8 
569.1 
439.3 
314.3 
182.0 
2353.5 
2038.2 
1899.4 
1556.8 
1450.4 
1193.5 
1042.3 
707.7 
571.3 
439.0 
314.6 
181.9 
7429.9 
6701.7 
6197.1 
5241.2 
5062.0 
4372.9 
3192.7 
2621.8 
1895.0 
1553.1 
1175.1 
612.4 
59.4 
53.6 
49.6 
41.9 
40.5 
35.0 
25.5 
21.0 
15.2 
12.4 
9.4 
4.9 
59.4 
62.7 
65.6 
70.5 
71.1 
74.6 
82.8 
84.7 
89.4 
91.1 
93.1 
96.6 
5070.1 
5798.3 
6302.9 
7258.8 
7438.0 
8127.1 
9307.3 
9878.2 
10605.0 
10946.9 
11324.9 
11887.6 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total CE 
(ug) 
 
BZE & 
other 
metabolites   
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
 
400 
230 
252 
323 
272 
285 
260 
176 
189 
196 
135 
72 
350 
230 
252 
285 
272 
270 
208 
187 
207 
196 
135 
75 
375 
230 
252 
304 
272 
270 
234 
176 
198 
196 
135 
72 
450 
575 
441 
342 
340 
240 
299 
253 
198 
175 
90 
60 
450 
368 
441 
361 
340 
255 
299 
253 
198 
175 
95 
57 
450 
460 
441 
361 
340 
240 
299 
253 
198 
175 
95 
60 
825 
690 
693 
665 
612 
525 
533 
429 
396 
371 
225 
132 
4245.1 
5108.3 
5609.9 
6593.8 
6826 
7602.1 
8774.3 
9449.2 
10209 
10575.9 
11099.9 
11755.6 
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Table 10c. Partition/Degradation of benzoylecgonine in Humus sludge batch tests  (4± 0.5
o
C)
 
 
 
  
 
Table 11a. Partition/Degradation of cocaine in Humus sludge batch tests (19± 0.5
o
C) 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total BZE 
(ug) 
 
 
Other 
metabolites   
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
 
300 
299 
168 
171 
221 
135 
117 
77 
171 
126 
55 
72 
300 
299 
189 
171 
221 
135 
117 
77 
180 
140 
60 
72 
300 
299 
168 
171 
221 
135 
117 
77 
171 
133 
55 
72 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
300 
299 
168 
171 
221 
135 
117 
77 
171 
133 
55 
72 
3945.1 
4809.3 
5441.9 
6422.8 
6605 
7467.1 
8657.3 
9372.2 
10038 
10442.9 
11044.9 
11683.6 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
cocaine 
 
 
% 
COC 
 
 
 
% 
removal 
 
 EME, 
CE & 
Residual   
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
2393.2 
2092.9 
1856.8 
2085.3 
1890.2 
1570.1 
1350.8 
1128.5 
991.0 
740.7 
337.9 
170.3 
2365.0 
2042.7 
1848.3 
2107.3 
1897.2 
1551.9 
1333.9 
1131.0 
983.6 
738.2 
341.5 
168.9 
2379.1 
2067.8 
1852.6 
2096.3 
1893.7 
1561.0 
1342.4 
1129.7 
987.3 
739.4 
339.7 
169.6 
240.1 
207.9 
169.1 
114.2 
108.1 
107.3 
67.9 
65.4 
54.9 
35.1 
22.9 
10.6 
239.9 
202.8 
186.5 
113.2 
108.8 
108.1 
66.4 
65.5 
54.6 
35.8 
22.9 
10.5 
240.0 
205.3 
177.8 
113.7 
108.4 
107.7 
67.1 
65.4 
54.7 
35.4 
22.9 
10.6 
2619.1 
2273.1 
2030.4 
2210.0 
2002.1 
1668.7 
1409.5 
1195.2 
1042.1 
774.9 
362.6 
180.1 
21.0 
18.2 
16.2 
17.7 
16.0 
13.3 
11.3 
9.6 
8.3 
6.2 
2.9 
1.4 
81.0 
83.5 
85.2 
83.2 
84.9 
87.5 
89.3 
91.0 
92.1 
94.1 
97.3 
98.6 
9880.9 
10226.9 
10469.6 
10290.0 
10497.9 
10831.3 
11090.5 
11304.8 
11457.9 
11725.1 
12137.4 
12319.9 
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Table 11b. Partition/Degradation of ecgonine methyl ester in Humus sludge batch tests (19± 0.5
o
C)
 
 
 
 
 
Table 11c. Partition/Degradation of cocaethylene in Humus sludge batch tests  (19± 0.5
o
C)
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total EME 
(ug) 
 
 
CE & other 
metabolites   
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
 
1350 
1058 
945 
874 
544 
600 
507 
803 
630 
581 
410 
297 
1375 
1035 
945 
874 
544 
615 
494 
781 
630 
574 
410 
300 
1350 
1058 
945 
874 
544 
615 
494 
792 
630 
581 
410 
297 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
1350 
1058 
945 
874 
544 
615 
494 
792 
630 
581 
410 
297 
8530.9 
9168.9 
9524.6 
9416 
9953.9 
10216.3 
10596.5 
10512.8 
10827.9 
11144.1 
11727.4 
12022.9 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total CE 
(ug) 
 
 
Other 
metabolites   
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1625 
1909 
1722 
1045 
1190 
810 
858 
484 
900 
693 
615 
375 
1625 
1909 
1680 
1026 
1156 
825 
871 
484 
891 
686 
605 
357 
1625 
1909 
1701 
1026 
1173 
810 
858 
484 
900 
686 
610 
366 
1375 
897 
924 
665 
918 
765 
624 
352 
279 
210 
250 
174 
1375 
897 
987 
665 
935 
765 
650 
352 
279 
217 
245 
171 
1375 
897 
945 
665 
935 
765 
637 
352 
279 
210 
250 
171 
3000 
2806 
2646 
1710 
2091 
1575 
1495 
836 
1179 
903 
860 
537 
5530.9 
6362.9 
6878.6 
7706 
7862.9 
8641.3 
9101.5 
9676.8 
9648.9 
10241.1 
10867.4 
11485.9 
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Table 12a. Total cocaine degradation in (filtered) Humus sludge batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 12b. Total cocaethylene degradation in (filtered) Humus sludge batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
cocaine 
(ug) 
  
 
 
% 
COC 
 
  
% 
Removal 
 
 
CE & 
Residual 
 
 
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
3144.1 
2769.3 
2380.1 
2256.5 
1995.8 
1426.1 
1213.7 
1000.8 
841.6 
579.1 
352.9 
150.9 
3066.6 
2769.2 
2384.8 
2256.5 
2011.6 
1400.7 
1228.6 
1006.2 
832.8 
580.8 
349.9 
154.1 
3105.4 
2769.3 
2382.4 
2256.5 
2003.7 
1413.4 
1221.1 
1003.5 
837.2 
580.0 
351.4 
152.5 
24.8 
22.2 
19.1 
18.1 
16.0 
11.3 
9.8 
8.0 
6.7 
4.6 
2.8 
1.2 
75.2 
77.8 
80.9 
81.9 
84.0 
88.7 
90.2 
92.0 
93.3 
95.4 
97.2 
98.8 
9394.6 
9730.7 
10117.6 
10243.5 
10496.3 
11086.6 
11278.9 
11496.5 
11662.8 
11920.0 
12148.6 
12347.5 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total  CE 
(ug) 
  
  
 
Other 
metabolites  
(ug) 
 
Sample 1 
 
Sample 2 
 
 
    15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1400 
1472 
1449 
1292 
1326 
960 
1014 
1397 
1044 
840 
595 
636 
1400 
1518 
1407 
1311 
1139 
1020 
988 
1397 
1134 
826 
590 
621 
1400 
1495 
1428 
1292 
1224 
990 
1001 
1397 
1089 
833 
595 
630 
 7994.6 
8235.7 
8689.6 
8951.5 
9272.3 
10096.6 
10277.9 
10099.5 
10573.8 
11087 
11553.6 
11717.5 
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Table 13a. Total cocaine degradation in Stoke primary effluent batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 13b. Total ecgonine methylester degradation in Stoke primary effluent batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
cocaine (ug 
) 
  
 
 
% 
COC 
 
  
% 
Removal 
 
 
EME, CE 
& Residual 
 
 
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
468.0 
384.3 
320.6 
267.6 
216.3 
173.0 
146.8 
121.5 
99.7 
76.0 
54.3 
31.6 
469.5 
405.3 
323.3 
269.8 
214.7 
172.6 
146.1 
122.3 
99.1 
75.9 
54.4 
31.6 
468.7 
394.8 
321.9 
268.7 
215.5 
172.8 
146.5 
121.9 
99.4 
76.0 
54.3 
31.6 
3.7 
3.2 
2.6 
2.1 
1.7 
1.4 
1.2 
1.0 
0.8 
0.6 
0.4 
0.3 
96.3 
96.8 
97.4 
97.9 
98.3 
98.6 
98.8 
99.0 
99.2 
99.4 
99.6 
99.7 
12031.3 
12105.2 
12178.1 
12231.3 
12284.5 
12327.2 
12353.5 
12378.1 
12400.6 
12424.0 
12445.7 
12468.4 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total EME  
(ug) 
  
  
 
CE & other  
metabolites 
 (ug) 
 
Sample 1 
 
Sample 2 
 
    15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
125 
115 
105 
76 
85 
75 
52 
55 
54 
42 
40 
24 
125 
115 
105 
76 
68 
75 
52 
55 
54 
42 
40 
24 
125 
115 
105 
76 
77 
75 
52 
55 
54 
42 
40 
24 
 11781.3 
11875.2 
11968.1 
12079.3 
12131.5 
12177.2 
12249.5 
12268.1 
12292.6 
12340 
12365.7 
12420.4 
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Table 13c. Total cocaethylene degradation in Stoke primary effluent batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 14. Partition/Degradation of BZE in primary sludge batch tests (4 ± 0.5oC) 
 
  
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total CE 
(ug in10 
mL) 
  
  
 
Other 
metabolites  
(ug ) 
 
Sample 1 
 
Sample 2 
 
    15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
 
250 
230 
210 
152 
119 
105 
78 
66 
63 
42 
35 
18 
250 
230 
189 
171 
119 
105 
78 
66 
63 
42 
35 
18 
250 
230 
200 
162 
119 
105 
78 
66 
63 
42 
35 
18 
 11531 
11645 
11769 
11918 
12013 
12072 
12172 
12202 
12230 
12298 
12331 
12402 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
BZE 
 
 
% 
BZE 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
6112.8 
2924.3 
2624.2 
2367.3 
1972.0 
1688.8 
1366.5 
979.8 
830.4 
633.7 
356.2 
209.6 
6090.3 
2904.2 
2614.0 
2367.1 
1979.1 
1692.1 
1361.6 
978.4 
841.4 
633.3 
353.4 
210.7 
6101.6 
2914.3 
2619.1 
2367.2 
1975.5 
1690.4 
1364.0 
979.1 
835.9 
633.5 
354.8 
210.1 
736.5 
898.6 
723.9 
727.4 
1147.2 
1043.8 
1124.0 
983.2 
1010.0 
926.3 
704.4 
519.8 
736.8 
906.6 
726.1 
728.9 
1178.7 
1033.5 
1113.7 
973.7 
1009.8 
926.6 
707.4 
517.8 
736.7 
902.6 
725.0 
728.2 
1162.9 
1038.7 
1118.8 
978.5 
1009.9 
926.5 
705.9 
518.8 
6838.2 
3816.8 
3344.2 
3095.4 
3138.4 
2729.1 
2482.9 
1957.6 
1845.8 
1560.0 
1060.7 
728.9 
54.7 
30.5 
26.8 
24.8 
25.1 
21.8 
19.9 
15.7 
14.8 
12.5 
8.5 
5.8 
51.2 
76.7 
79.0 
81.1 
84.2 
86.5 
89.1 
92.2 
93.3 
94.9 
97.2 
98.3 
5661.8 
8683.2 
9155.8 
9404.6 
9361.6 
9770.9 
10017.1 
10542.4 
10654.2 
10940.0 
11439.3 
11771.1 
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Table 15. Partition/Degradation of BZE in primary sludge batch tests (19± 0.5
o
C) 
 
 
 
 
Table 16. Total degradation of BZE in filtered primary sludge batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
BZE 
 
 
% 
BZE 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
407.6 
356.6 
320.0 
288.7 
240.5 
205.9 
166.6 
119.5 
101.3 
77.3 
43.4 
25.6 
404.9 
354.2 
318.8 
288.7 
241.4 
206.4 
166.1 
119.3 
102.6 
77.2 
43.1 
25.7 
406.3 
355.4 
319.4 
288.7 
240.9 
206.2 
166.3 
119.4 
101.9 
77.3 
43.3 
25.6 
89.8 
109.6 
88.3 
88.7 
139.9 
127.3 
137.1 
119.9 
123.2 
113.0 
85.9 
63.4 
89.9 
110.6 
88.6 
88.9 
143.7 
126.0 
135.8 
118.7 
123.1 
113.0 
86.3 
63.1 
89.8 
110.1 
88.4 
88.8 
141.8 
126.7 
136.4 
119.3 
123.2 
113.0 
86.1 
63.3 
496.1 
465.5 
407.8 
377.5 
382.7 
332.8 
302.8 
238.7 
225.1 
190.2 
129.4 
88.9 
4.0 
3.7 
3.3 
3.0 
3.1 
2.7 
2.4 
1.9 
1.8 
1.5 
1.0 
0.7 
96.7 
97.2 
97.4 
97.7 
98.1 
98.4 
98.7 
99.0 
99.2 
99.4 
99.7 
99.8 
12003.9 
12034.5 
12092.2 
12122.5 
12117.3 
12167.2 
12197.2 
12261.3 
12274.9 
12309.8 
12370.6 
12411.1 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total  
BZE  
(ug) 
  
 
 
% 
BZE 
 
  
% 
Removal 
 
 
 Residual 
  
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
9363.3 
8136.2 
7056.3 
5896.4 
5101.4 
4085.7 
3235.3 
2676.0 
2216.6 
1650.3 
1220.5 
617.7 
9031.9 
8176.2 
7082.3 
5794.4 
4811.0 
4174.8 
3135.6 
2631.7 
2134.0 
1620.0 
1227.8 
622.4 
9197.6 
8156.2 
7069.3 
5845.4 
4956.2 
4130.3 
3185.5 
2653.9 
2175.3 
1635.2 
1224.2 
620.0 
73.6 
65.2 
56.6 
46.8 
39.6 
33.0 
25.5 
21.2 
17.4 
13.1 
9.8 
5.0 
26.4 
34.8 
43.4 
53.2 
60.4 
67.0 
74.5 
78.8 
82.6 
86.9 
90.2 
95.0 
3302.4 
4343.8 
5430.7 
6654.6 
7543.8 
8369.7 
9314.5 
9846.1 
10324.7 
10864.8 
11275.8 
11880.0 
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Table 17. Partition/Degradation of BZE in SAF-1 batch tests (19 ± 0.5
o
C) 
 
 
 
 
Table 18. Partition/Degradation of BZE in MSAF batch tests (19 ± 0.5
o
C) 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
BZE 
 
 
% 
BZE 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
6061.7 
3919.4 
3123.6 
2622.2 
2495.2 
2076.8 
1746.9 
1505.9 
1256.0 
912.6 
600.8 
364.8 
6173.2 
3919.4 
3102.3 
2608.1 
2495.2 
2061.7 
1746.9 
1505.9 
1256.0 
912.6 
600.8 
364.8 
6117.5 
3919.4 
3112.9 
2615.1 
2495.2 
2069.2 
1746.9 
1505.9 
1256.0 
912.6 
600.8 
364.8 
2824.4 
1755.7 
1175.1 
1656.0 
1443.9 
1183.1 
1032.4 
857.2 
693.6 
519.0 
368.3 
211.3 
2824.4 
1755.7 
1175.1 
1656.0 
1443.9 
1183.1 
1035.0 
856.6 
691.7 
520.9 
368.3 
211.3 
2824.4 
1755.7 
1175.1 
1656.0 
1443.9 
1183.1 
1033.7 
856.9 
692.7 
519.9 
368.3 
211.3 
8941.9 
5675.1 
4288.1 
4271.2 
3939.0 
3252.3 
2780.6 
2362.8 
1948.6 
1432.5 
969.1 
576.2 
71.5 
45.4 
34.3 
34.2 
31.5 
26.0 
22.2 
18.9 
15.6 
11.5 
7.8 
4.6 
51.1 
68.6 
75.1 
79.1 
80.0 
83.4 
86.0 
88.0 
90.0 
92.7 
95.2 
97.1 
3558.1 
6824.9 
8211.9 
8228.8 
8561.0 
9247.7 
9719.4 
10137.2 
10551.4 
11067.5 
11530.9 
11923.8 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
BZE 
 
 
% 
BZE 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
6478.7 
5830.2 
4858.2 
4184.7 
3503.1 
2321.1 
1491.2 
1354.3 
1022.6 
803.2 
541.4 
321.9 
6488.7 
6296.2 
4858.2 
4013.6 
3145.4 
2321.1 
1558.0 
1351.7 
1022.6 
843.0 
541.4 
321.9 
6483.7 
6063.2 
4858.2 
4099.1 
3324.2 
2321.1 
1524.6 
1353.0 
1022.6 
823.1 
541.4 
321.9 
1064.6 
873.3 
746.8 
663.0 
593.5 
519.7 
465.6 
394.8 
327.0 
251.2 
168.8 
73.5 
1071.9 
873.0 
740.1 
667.1 
616.0 
544.2 
458.1 
394.6 
326.4 
250.6 
171.3 
73.5 
1068.3 
873.1 
743.4 
665.1 
604.7 
532.0 
461.8 
394.7 
326.7 
250.9 
170.1 
73.5 
7551.9 
6936.4 
5601.6 
4764.2 
3929.0 
2853.1 
1986.5 
1747.8 
1349.3 
1074.0 
711.4 
395.4 
60.4 
55.5 
44.8 
38.1 
31.4 
22.8 
15.9 
14.0 
10.8 
8.6 
5.7 
3.2 
48.1 
51 
61.1 
61.1 
67.2 
73.4 
81.4 
87.8 
89.2 
91.8 
93.4 
95.7 
4948.1 
5563.6 
6898.4 
7735.8 
8571.0 
9646.9 
10513.5 
10752.2 
11150.7 
11426.0 
11788.6 
12104.6 
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Table 19. Partition/Degradation of BZE in HS batch tests (19 ± 0.5
o
C) 
 
 
 
Table 20. Total degradation of BZE in Stoke primary effluent batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
BZE 
 
 
% 
BZE 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
3844.8 
2434.1 
2178.4 
2024.8 
1972.4 
1614.9 
1413.8 
1169.9 
881.0 
680.8 
435.2 
266.3 
3874.0 
2453.5 
2173.5 
2024.8 
1978.7 
1608.2 
1403.1 
1167.8 
876.7 
678.4 
448.8 
266.3 
3859.4 
2443.8 
2175.9 
2024.8 
1975.5 
1611.6 
1408.5 
1168.8 
878.9 
679.6 
442.0 
266.3 
758.2 
699.1 
650.8 
518.7 
416.7 
372.1 
334.3 
276.8 
208.4 
166.3 
136.0 
91.1 
798.7 
699.1 
674.2 
518.7 
416.7 
367.0 
337.5 
276.8 
208.4 
164.5 
136.0 
91.1 
778.4 
699.1 
662.5 
518.7 
416.7 
369.6 
335.9 
276.8 
208.4 
165.4 
136.0 
91.1 
4637.8 
3142.9 
2838.4 
2543.5 
2392.2 
1981.1 
1744.4 
1445.6 
1087.2 
845.0 
578.0 
357.4 
37.1 
25.1 
22.7 
20.3 
19.1 
15.8 
14.0 
11.6 
8.7 
6.8 
4.6 
2.9 
69.1 
80.4 
82.6 
83.8 
84.2 
87.1 
88.7 
90.6 
93.0 
94.6 
96.5 
97.9 
7862.2 
9357.1 
9661.6 
9956.5 
10107.8 
10518.9 
10755.6 
11054.4 
11412.8 
11655.0 
11922.0 
12142.6 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total BZE 
(ug) 
  
 
 
% 
BZE 
 
  
% 
Removal 
 
 
 Residual 
  
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1662.5 
1288.5 
1129.4 
1174.0 
1051.3 
838.0 
730.9 
596.5 
539.9 
414.2 
288.3 
164.8 
1657.9 
1293.8 
1134.0 
1154.4 
1055.6 
825.8 
732.1 
596.8 
539.4 
414.0 
287.2 
163.5 
1660.2 
1291.2 
1131.7 
1164.2 
1053.4 
831.9 
731.5 
596.6 
539.7 
414.1 
287.7 
164.2 
13.3 
10.3 
9.1 
9.3 
8.4 
6.7 
5.9 
4.8 
4.3 
3.3 
2.3 
1.3 
86.7 
89.7 
90.9 
90.7 
91.6 
93.3 
94.1 
95.2 
95.7 
96.7 
97.7 
98.7 
10839.8 
11208.8 
11368.3 
11335.8 
11446.6 
11668.1 
11768.5 
11903.4 
11960.3 
12085.9 
12212.3 
12335.8 
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Table 21. Partition/Degradation of Morphine in Primary Sludge batch tests (4± 0.5
o
C)
 
 
 
 
Table 22. Partition/Degradation of Morphine in Primary Sludge batch tests (19± 0.5
o
C) 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
MOR 
 
 
% 
MOR 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
9713.2 
8784.6 
7729.0 
5789.3 
6048.0 
3914.4 
4165.4 
3504.0 
2862.9 
1979.3 
1490.5 
804.5 
9719.6 
8745.1 
7818.9 
5813.2 
6066.8 
3941.1 
4151.5 
3504.6 
2808.1 
1973.7 
1480.9 
804.6 
9716.4 
8764.9 
7773.9 
5801.2 
6057.4 
3927.8 
4158.5 
3504.3 
2835.5 
1976.5 
1485.7 
804.6 
137.1 
121.3 
120.4 
110.1 
109.0 
89.9 
77.4 
66.8 
61.4 
49.3 
36.2 
23.0 
136.8 
121.9 
120.6 
107.0 
108.7 
92.4 
83.2 
65.2 
62.5 
49.9 
35.5 
23.2 
137.0 
121.6 
120.5 
108.5 
108.9 
91.1 
80.3 
66.0 
62.0 
49.6 
35.8 
23.1 
9853.4 
8886.5 
7894.4 
5909.8 
6166.3 
4018.9 
4238.8 
3570.3 
2897.5 
2026.1 
1521.5 
827.7 
78.8 
71.1 
63.2 
47.3 
49.3 
32.2 
33.9 
28.6 
23.2 
16.2 
12.2 
6.6 
22.3 
29.9 
37.8 
53.6 
51.5 
68.6 
66.7 
72.0 
77.3 
84.2 
88.1 
93.6 
2646.6 
3613.5 
4605.6 
6590.2 
6333.7 
8481.1 
8261.2 
8929.7 
9602.5 
10473.9 
10978.5 
11672.3 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
MOR 
 
 
% 
MOR 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1891.9 
1692.3 
1411.7 
1178.2 
1065.4 
840.0 
634.9 
495.1 
399.2 
284.5 
162.4 
58.1 
1911.6 
1665.4 
1457.8 
1178.6 
993.0 
847.4 
648.5 
478.5 
399.4 
290.4 
165.0 
58.5 
1901.8 
1678.9 
1434.8 
1178.4 
1029.2 
843.7 
641.7 
486.8 
399.3 
287.4 
163.7 
58.3 
431.0 
428.5 
358.2 
351.7 
394.6 
303.1 
284.8 
194.0 
206.0 
145.6 
126.5 
73.8 
427.7 
431.5 
365.1 
359.8 
401.8 
305.1 
281.5 
190.5 
209.8 
146.7 
124.0 
73.7 
429.3 
430.0 
361.7 
355.8 
398.2 
304.1 
283.1 
192.3 
207.9 
146.2 
125.3 
73.8 
2331.1 
2108.9 
1796.5 
1534.2 
1427.4 
1147.8 
924.8 
679.1 
607.2 
433.6 
289.0 
132.1 
18.6 
16.9 
14.4 
12.3 
11.4 
9.2 
7.4 
5.4 
4.9 
3.5 
2.3 
1.1 
84.8 
86.6 
88.5 
90.6 
91.8 
93.3 
94.9 
96.1 
96.8 
97.7 
98.7 
99.5 
10168.9 
10391.1 
10703.5 
10965.8 
11072.6 
11352.2 
11575.2 
11820.9 
11892.8 
12066.4 
12211.0 
12367.9 
  
 190 
Table 23. Total degradation of Morphine in filtered primary sludge batch tests (19 ± 0.5
o
C)
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 24. Partition/Degradation of Morphine in SAF-1 sludge batch tests (19± 0.5
o
C) 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
MOR (ug) 
  
 
 
% 
MOR 
 
  
% 
Removal 
 
 
 Residual 
  
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
841.2 
713.0 
651.2 
593.5 
510.9 
456.7 
353.9 
297.6 
242.1 
179.9 
136.6 
77.1 
831.1 
721.5 
650.6 
600.1 
510.8 
457.2 
353.9 
294.8 
242.1 
179.9 
136.4 
77.1 
836.2 
717.3 
650.9 
596.8 
510.9 
457.0 
353.9 
296.2 
242.1 
179.9 
136.5 
77.1 
6.7 
5.7 
5.2 
4.8 
4.1 
3.7 
2.8 
2.4 
1.9 
1.4 
1.1 
0.6 
93.3 
94.3 
94.8 
95.2 
95.9 
96.3 
97.2 
97.6 
98.1 
98.6 
98.9 
99.4 
11663.8 
11782.7 
11849.1 
11903.2 
11989.1 
12043.0 
12146.1 
12203.8 
12257.9 
12320.1 
12363.5 
12422.9 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
MOR 
 
 
% 
MOR 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
696.5 
410.0 
360.9 
326.4 
247.7 
208.0 
170.8 
145.5 
89.3 
41.7 
24.2 
13.7 
700.8 
412.4 
365.5 
331.6 
250.0 
212.9 
171.5 
145.2 
86.0 
41.7 
24.0 
13.7 
698.7 
411.2 
363.2 
329.0 
248.9 
210.5 
171.2 
145.3 
87.7 
41.7 
24.1 
13.7 
98.5 
128.4 
115.9 
91.5 
70.1 
58.9 
63.6 
60.5 
40.3 
36.2 
25.8 
15.3 
98.7 
128.3 
116.1 
90.6 
67.0 
65.4 
63.1 
60.6 
41.1 
35.9 
26.0 
15.3 
98.6 
128.4 
116.0 
91.0 
68.6 
62.2 
63.3 
60.5 
40.7 
36.1 
25.9 
15.3 
797.3 
539.6 
479.2 
420.0 
317.5 
272.6 
234.5 
205.9 
128.4 
77.8 
50.1 
29.0 
6.4 
4.3 
3.8 
3.4 
2.5 
2.2 
1.9 
1.6 
1.0 
0.6 
0.4 
0.2 
94.4 
96.7 
97.1 
97.4 
98.0 
98.3 
98.6 
98.8 
99.3 
99.7 
99.8 
99.9 
11702.7 
11960.4 
12020.8 
12080.0 
12182.5 
12227.4 
12265.5 
12294.1 
12371.6 
12422.2 
12449.9 
12471.0 
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Table 25. Partition/Degradation of Morphine in MSAF-1 sludge batch tests (19± 0.5
o
C) 
 
 
 
 
Table 26. Partition/Degradation of Morphine in Humus sludge batch tests (19± 0.5
o
C) 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
MOR 
 
 
% 
MOR 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
4424.8 
3044.9 
2728.9 
2325.9 
1846.7 
1568.1 
1365.9 
1145.2 
941.4 
720.1 
498.1 
297.6 
4402.9 
2964.4 
2770.8 
2321.2 
1846.7 
1557.0 
1362.0 
1140.2 
948.7 
711.7 
494.9 
295.4 
4413.8 
3004.6 
2749.8 
2323.5 
1846.7 
1562.6 
1364.0 
1142.7 
945.1 
715.9 
496.5 
296.5 
221.6 
245.4 
186.1 
223.4 
242.8 
240.2 
191.6 
209.8 
147.4 
102.7 
66.9 
38.8 
215.3 
243.7 
184.6 
226.1 
244.7 
239.2 
192.8 
213.5 
148.1 
105.1 
67.1 
39.8 
218.4 
244.6 
185.3 
224.8 
243.8 
239.7 
192.2 
211.7 
147.7 
103.9 
67.0 
39.3 
4632.3 
3249.2 
2935.2 
2548.3 
2090.5 
1802.3 
1556.1 
1354.4 
1092.8 
819.8 
563.5 
335.8 
37.1 
26.0 
23.5 
20.4 
16.7 
14.4 
12.4 
10.8 
8.7 
6.6 
4.5 
2.7 
64.7 
76.0 
78.0 
81.4 
85.2 
87.5 
89.1 
90.9 
92.4 
94.3 
96.0 
97.6 
7867.7 
9250.8 
9564.8 
9951.7 
10409.5 
10697.7 
10943.9 
11145.6 
11407.2 
11680.2 
11936.5 
12164.2 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
MOR 
 
 
% 
MOR 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
119.8 
94.9 
78.0 
69.0 
61.3 
42.3 
39.6 
33.8 
42.2 
29.8 
19.1 
11.8 
120.8 
89.9 
76.9 
67.8 
61.4 
43.0 
39.0 
33.6 
42.6 
30.0 
19.0 
11.8 
120.3 
92.4 
77.5 
68.4 
61.3 
42.7 
39.3 
33.7 
42.4 
29.9 
19.0 
11.8 
14.2 
13.8 
12.7 
10.7 
9.9 
10.3 
12.3 
8.9 
6.9 
6.5 
3.8 
2.0 
14.8 
14.4 
13.0 
9.7 
9.7 
10.4 
12.0 
8.9 
7.0 
6.5 
3.8 
2.0 
14.5 
14.1 
12.8 
10.2 
9.8 
10.3 
12.1 
8.9 
7.0 
6.5 
3.8 
2.0 
134.8 
106.5 
90.3 
78.6 
71.1 
53.0 
51.4 
42.6 
49.4 
36.5 
22.9 
13.8 
1.1 
0.9 
0.7 
0.6 
0.6 
0.4 
0.4 
0.3 
0.4 
0.3 
0.2 
0.1 
99.0 
99.3 
99.4 
99.5 
99.5 
99.7 
99.7 
99.7 
99.7 
99.8 
99.8 
99.9 
12365.2 
12393.5 
12409.7 
12421.4 
12428.9 
12447.0 
12448.6 
12457.4 
12450.6 
12463.5 
12477.1 
12486.2 
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Table 27. Total degradation of Morphine in Stoke primary effluent batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 28. Partition/Degradation of 6-ACM in primary sludge batch tests (4± 0.5
o
C) 
 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
MOR  
(ug) 
  
 
 
% 
MOR 
 
  
% 
Removal 
 
 
 Residual 
  
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
9962.7 
8913.9 
6415.1 
6416.2 
5195.0 
4617.6 
3348.1 
1373.7 
1131.4 
875.8 
606.6 
362.9 
9831.8 
8917.8 
6529.2 
5836.8 
5279.3 
4581.0 
3406.5 
1378.8 
1124.3 
876.0 
591.3 
362.8 
9897.3 
8915.8 
6472.2 
6126.5 
5237.1 
4599.3 
3377.3 
1376.2 
1127.8 
875.9 
598.9 
362.8 
79.2 
71.3 
51.8 
49.0 
41.9 
36.8 
27.0 
11.0 
9.0 
7.0 
4.8 
2.9 
20.8 
28.7 
48.2 
51.0 
58.1 
63.2 
73.0 
89.0 
91.0 
93.0 
95.2 
97.1 
2602.7 
3584.2 
6027.8 
6373.5 
7262.9 
7900.7 
9122.7 
11123.8 
11372.2 
11624.1 
11901.1 
12137.2 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
6ACM 
 
 
% 
6ACM 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
570.4 
610.8 
559.5 
461.6 
376.9 
291.3 
252.4 
201.1 
113.8 
83.7 
60.0 
39.5 
574.7 
621.8 
569.3 
465.1 
370.5 
272.7 
233.9 
227.8 
112.3 
86.8 
62.5 
38.9 
572.5 
616.3 
564.4 
463.4 
373.7 
282.0 
243.2 
214.5 
113.1 
85.2 
61.3 
39.2 
69.7 
63.1 
51.8 
43.5 
50.5 
39.2 
61.3 
49.0 
35.7 
33.4 
24.2 
15.6 
69.7 
63.1 
51.8 
43.5 
50.5 
39.2 
61.3 
49.0 
35.7 
33.4 
24.2 
15.6 
69.8 
62.7 
52.1 
42.6 
50.9 
39.2 
61.3 
49.2 
35.5 
33.1 
23.9 
15.6 
642.4 
679.1 
616.5 
506.0 
424.6 
321.2 
304.4 
263.7 
148.6 
118.4 
85.2 
54.8 
5.1 
5.4 
4.9 
4.0 
3.4 
2.6 
2.4 
2.1 
1.2 
0.9 
0.7 
0.4 
95.4 
95.1 
95.5 
96.3 
97.0 
97.7 
98.1 
98.3 
99.1 
99.3 
99.5 
99.7 
11857.6 
11820.9 
11883.5 
11994.0 
12075.4 
12178.8 
12195.6 
12236.3 
12351.4 
12381.6 
12414.8 
12445.2 
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 Table 29. Partition/Degradation of 6-ACM in primary sludge batch tests (19± 0.5
o
C)
 
 
 
 
 
 
Table 30. Total degradation of 6-ACM in filtered primary sludge batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
6ACM 
 
 
% 
6ACM 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
213.3 
159.6 
122.7 
101.2 
71.0 
63.9 
59.7 
44.1 
25.0 
19.0 
13.2 
6.3 
214.2 
162.0 
124.8 
102.0 
69.6 
56.3 
59.9 
50.0 
24.6 
18.9 
13.7 
6.2 
213.7 
160.8 
123.8 
101.6 
70.3 
60.1 
59.8 
47.0 
24.8 
18.9 
13.4 
6.2 
15.3 
13.8 
11.4 
9.5 
9.6 
8.6 
10.3 
8.1 
7.8 
7.3 
5.3 
3.4 
14.5 
12.9 
10.9 
8.7 
8.7 
8.1 
9.7 
7.8 
7.3 
6.8 
4.9 
3.2 
14.9 
13.4 
11.1 
9.1 
9.2 
8.4 
10.0 
7.9 
7.6 
7.1 
5.1 
3.3 
228.6 
174.2 
134.9 
110.7 
79.4 
68.5 
69.8 
55.0 
32.4 
26.0 
18.5 
9.5 
1.8 
1.4 
1.1 
0.9 
0.6 
0.5 
0.6 
0.4 
0.3 
0.2 
0.1 
0.1 
98.3 
98.7 
99.0 
99.2 
99.4 
99.5 
99.5 
99.6 
99.8 
99.8 
99.9 
100.0 
12271.4 
12325.8 
12365.1 
12389.3 
12420.6 
12431.5 
12430.2 
12445.0 
12467.6 
12474.0 
12481.5 
12490.5 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
cocaine 
(ug) 
  
 
 
% 
6ACM 
 
  
% 
Removal 
 
 
 Residual 
  
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
55.9 
40.4 
38.5 
33.1 
23.8 
20.4 
17.3 
14.1 
11.1 
8.9 
5.6 
4.1 
56.4 
40.1 
38.4 
33.1 
23.7 
20.4 
17.1 
14.0 
11.1 
8.5 
5.6 
4.1 
56.2 
40.2 
38.5 
33.1 
23.8 
20.4 
17.2 
14.1 
11.1 
8.7 
5.6 
4.1 
0.4 
0.3 
0.3 
0.3 
0.2 
0.2 
0.1 
0.1 
0.1 
0.1 
0.0 
0.0 
99.6 
99.7 
99.7 
99.7 
99.8 
99.8 
99.9 
99.9 
99.9 
99.9 
100.0 
100.0 
12443.8 
12459.8 
12461.5 
12466.9 
12476.2 
12479.6 
12482.8 
12485.9 
12488.9 
12491.3 
12494.4 
12495.9 
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Table 31. Partition/Degradation of 6-ACM in SAF-1 sludge batch tests (19± 0.5
o
C) 
 
 
 
 
Table 32. Partition/Degradation of 6-ACM in MSAF sludge batch tests (19± 0.5
o
C) 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
6ACM 
 
 
% 
6ACM 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
10215.7 
7067.3 
6139.1 
6119.3 
5263.7 
3753.7 
2302.7 
1648.9 
1360.5 
1025.8 
786.4 
410.6 
10055.8 
7116.3 
5908.8 
6272.2 
5204.4 
3695.6 
2302.7 
1851.9 
1360.5 
1058.7 
812.0 
378.5 
10135.8 
7091.8 
6023.9 
6195.8 
5234.1 
3724.6 
2302.7 
1750.4 
1360.5 
1042.2 
799.2 
394.6 
1687.0 
1038.5 
1043.5 
913.6 
667.0 
676.6 
899.3 
753.3 
601.7 
517.3 
291.4 
148.6 
1700.2 
1051.4 
1043.5 
920.0 
669.2 
651.1 
892.9 
756.4 
612.1 
517.3 
293.4 
149.0 
1693.6 
1045.0 
1043.5 
916.8 
668.1 
663.9 
896.1 
754.9 
606.9 
517.3 
292.4 
148.8 
11829.4 
8136.8 
7067.4 
7112.6 
5902.2 
4388.5 
3198.7 
2505.3 
1967.4 
1559.6 
1091.6 
543.4 
94.6 
65.1 
56.5 
56.9 
47.2 
35.1 
25.6 
20.0 
15.7 
12.5 
8.7 
4.3 
18.9 
43.3 
51.8 
50.4 
58.1 
70.2 
81.6 
86.0 
89.1 
91.7 
93.6 
96.8 
670.6 
4363.2 
5432.6 
5387.4 
6597.8 
8111.5 
9301.3 
9994.7 
10532.6 
10940.4 
11408.4 
11956.6 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
6ACM 
 
 
% 
6ACM 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1660.3 
1450.2 
1259.8 
1115.4 
942.9 
746.8 
647.1 
553.6 
452.2 
354.3 
245.3 
135.5 
1659.4 
1444.2 
1269.5 
1136.4 
936.8 
770.3 
653.2 
553.6 
448.3 
360.6 
243.0 
137.0 
1659.8 
1447.2 
1264.6 
1125.9 
939.8 
758.6 
650.1 
553.6 
450.2 
357.4 
244.1 
136.2 
252.7 
187.3 
195.7 
167.4 
148.0 
131.9 
114.0 
89.2 
28.0 
5.9 
4.9 
2.6 
265.9 
182.7 
196.1 
186.2 
164.4 
134.5 
119.4 
101.1 
30.7 
6.7 
5.4 
3.2 
259.3 
185.0 
195.9 
176.8 
156.2 
133.2 
116.7 
95.1 
29.4 
6.3 
5.2 
2.9 
1919.2 
1632.2 
1460.5 
1302.7 
1096.0 
891.8 
766.8 
648.7 
479.6 
363.7 
249.3 
139.1 
15.4 
13.1 
11.7 
10.4 
8.8 
7.1 
6.1 
5.2 
3.8 
2.9 
2.0 
1.1 
86.7 
88.4 
89.9 
91.0 
92.5 
93.9 
94.8 
95.6 
96.4 
97.1 
98.0 
98.9 
10580.8 
10867.8 
11039.5 
11197.3 
11404.0 
11608.2 
11733.2 
11851.3 
12020.4 
12136.3 
12250.7 
12360.9 
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Table 33. Partition/Degradation of 6-ACM in Humus sludge batch tests (19± 0.5
o
C) 
 
 
 
 
Table 34. Total degradation of 6-ACM in Stoke Baldoph effluent batch tests (19 ± 0.5
o
C)
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
6ACM 
 
 
% 
6ACM 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
4228.1 
3906.6 
2915.0 
1809.4 
1433.8 
1267.8 
1035.3 
831.5 
622.3 
434.8 
302.7 
168.8 
4166.1 
3376.7 
2917.2 
1737.6 
1303.6 
1201.0 
1010.1 
831.5 
627.5 
427.5 
302.7 
188.0 
4197.1 
3641.6 
2916.1 
1773.5 
1368.7 
1234.4 
1022.7 
831.5 
624.9 
431.1 
302.7 
178.4 
5.0 
4.4 
2.4 
2.9 
3.0 
1.8 
2.2 
1.7 
1.4 
1.0 
0.8 
0.5 
5.0 
4.4 
2.4 
2.8 
2.6 
1.8 
2.2 
1.7 
1.4 
1.0 
0.8 
0.5 
5.0 
4.4 
2.4 
2.8 
2.8 
1.8 
2.2 
1.7 
1.4 
1.0 
0.8 
0.5 
4202.1 
3646.1 
2918.5 
1776.3 
1371.5 
1236.2 
1024.9 
833.2 
626.3 
432.2 
303.5 
179.0 
33.6 
29.2 
23.3 
14.2 
11.0 
9.9 
8.2 
6.7 
5.0 
3.5 
2.4 
1.4 
66.4 
70.9 
76.7 
85.8 
89.1 
90.1 
91.8 
93.3 
95.0 
96.6 
97.6 
98.6 
8297.9 
8853.9 
9581.5 
10723.7 
11128.5 
11263.8 
11475.1 
11666.8 
11873.7 
12067.8 
12196.5 
12321.0 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
6ACM 
(ug) 
  
 
 
% 
6ACM 
 
  
% 
Removal 
 
 
 Residual 
  
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
134.8 
135.6 
108.5 
88.1 
73.0 
44.4 
36.2 
24.3 
19.2 
12.2 
9.2 
5.2 
132.6 
124.1 
108.4 
88.9 
75.2 
47.2 
35.9 
24.5 
17.1 
12.2 
9.2 
5.2 
133.7 
129.8 
108.5 
88.5 
74.1 
45.8 
36.0 
24.4 
18.1 
12.2 
9.2 
5.2 
1.1 
1.0 
0.9 
0.7 
0.6 
0.4 
0.3 
0.2 
0.1 
0.1 
0.1 
0.0 
98.9 
99.0 
99.1 
99.3 
99.4 
99.6 
99.7 
99.8 
99.9 
99.9 
99.9 
100.0 
12366.3 
12370.2 
12391.5 
12411.5 
12425.9 
12454.2 
12464.0 
12475.6 
12481.9 
12487.8 
12490.8 
12494.8 
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Table 35a. Partition/Degradation of Heroin in primary sludge batch tests (4± 0.5
o
C)
 
 
 
 
 
Table 35b. Partition/Degradation of 6-ACM in primary sludge batch tests (4± 0.5
o
C)
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
HER 
 
 
% 
HER 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1660.7 
1444.6 
1030.3 
1068.7 
908.9 
615.3 
477.3 
277.7 
208.8 
154.3 
110.8 
65.4 
1670.1 
1444.4 
1030.3 
1069.2 
908.2 
601.9 
475.8 
279.4 
207.1 
154.1 
110.8 
67.5 
1665.4 
1444.5 
1030.3 
1068.9 
908.5 
608.6 
476.6 
278.6 
208.0 
154.2 
110.8 
66.4 
2369.3 
2306.3 
1601.9 
1336.1 
1160.7 
797.0 
531.5 
299.1 
236.6 
186.4 
131.2 
91.1 
2396.6 
2280.2 
1622.9 
1354.3 
1150.4 
809.7 
529.2 
303.6 
240.8 
186.4 
134.7 
88.9 
2382.9 
2293.3 
1612.4 
1345.2 
1155.6 
803.3 
530.3 
301.4 
238.7 
186.4 
133.0 
90.0 
4048.3 
3737.7 
2642.7 
2414.1 
2064.1 
1411.9 
1006.9 
579.9 
446.7 
340.6 
243.8 
156.4 
32.4 
29.9 
21.1 
19.3 
16.5 
11.3 
8.1 
4.6 
3.6 
2.7 
2.0 
1.3 
86.7 
88.4 
91.8 
91.4 
92.7 
95.1 
96.2 
97.8 
98.3 
98.8 
99.1 
99.5 
8451.7 
8762.3 
9857.3 
10085.9 
10435.9 
11088.1 
11493.1 
11920.1 
12053.3 
12159.4 
12256.2 
12343.6 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
6ACM 
(ug) 
 
MOR & 
other 
metabolites 
(ug) 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
      15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
625 
575 
504 
437 
408 
360 
312 
242 
225 
154 
110 
57 
650 
575 
504 
437 
408 
345 
312 
242 
225 
154 
110 
57 
650 
575 
504 
437 
408 
360 
312 
242 
225 
154 
110 
57 
       - 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
         - 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
       - 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
650 
575 
504 
437 
408 
360 
312 
242 
225 
154 
110 
57 
7801.7 
8187.3 
9353.3 
9648.9 
10027.9 
10728.1 
11181.1 
11678.1 
11828.3 
12005.4 
12146.2 
12286.6 
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Table 35c. Partition/Degradation of Morphine in primary sludge batch tests (4± 0.5
o
C) 
 
 
 
 
 
Table 36a. Partition/Degradation of Heroin in primary sludge batch tests (19± 0.5
o
C) 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total MOR 
(ug) 
 
 
Other 
metabolites 
(ug) 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
 
2.25 
2.76 
2.31 
1.71 
1.87 
1.5 
1.69 
1.54 
1.35 
1.12 
0.8 
0.51 
2.25 
2.76 
2.31 
1.71 
1.7 
1.5 
1.69 
1.54 
1.35 
1.12 
0.8 
0.51 
2.25 
2.76 
2.31 
1.71 
1.87 
1.5 
1.69 
1.54 
1.35 
1.12 
0.8 
0.51 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
2.25 
2.76 
2.31 
1.71 
1.87 
1.5 
1.69 
1.54 
1.35 
1.12 
0.8 
0.51 
7799.45 
8184.54 
9350.99 
9647.19 
10026.03 
10726.6 
11179.41 
11676.56 
11826.95 
12004.28 
12145.4 
12286.09 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
HER 
 
 
% 
HER 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
479.8 
413.8 
286.3 
272.0 
203.9 
168.1 
140.6 
80.1 
61.1 
34.8 
24.0 
14.7 
480.2 
414.3 
286.3 
280.7 
204.6 
167.3 
140.1 
80.7 
60.8 
34.6 
24.0 
14.6 
480.0 
414.1 
286.3 
276.4.0 
204.2 
167.7 
140.3 
80.4 
61.0 
34.7 
24.0 
14.7 
672.8 
669.4 
478.7 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
681.1 
635.8 
440.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
677.0 
652.6 
459.4 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
1157.0 
1066.7 
745.7 
276.4 
204.2 
167.7 
140.3 
80.4 
61.0 
34.7 
24.0 
14.7 
9.3 
8.5 
6.0 
2.2 
1.6 
1.3 
1.1 
0.6 
0.5 
0.3 
0.2 
0.1 
96.2 
96.7 
97.7 
97.8 
98.4 
98.7 
98.9 
99.4 
99.5 
99.7 
99.8 
99.9 
11343.0 
11433.3 
11754.3 
12223.6 
12295.8 
12332.3 
12359.7 
12419.6 
12439.0 
12465.3 
12476.0 
12485.3 
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Table 36b. Partition/Degradation of 6-ACM in primary sludge batch tests (19± 0.5
o
C)
 
 
 
 
 
 
Table 36c. Partition/Degradation of Morphine in primary sludge batch tests (19± 0.5
o
C)
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
6ACM 
(ug) 
 
MOR & 
Other 
metabolites 
(ug) 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
125 
115 
105 
95 
119 
90 
78 
66 
54 
42 
30 
30 
125 
115 
105 
95 
119 
90 
78 
66 
54 
42 
30 
27 
125 
115 
105 
95 
119 
90 
78 
66 
54 
42 
30 
27 
175 
138 
168 
152 
119 
105 
91 
66 
63 
56 
40 
21 
175 
138 
168 
152 
119 
105 
91 
55 
63 
56 
40 
21 
175 
138 
168 
152 
119 
105 
91 
55 
63 
56 
40 
21 
300 
253 
273 
247 
221 
195 
169 
121 
117 
98 
70 
51 
11043 
11180.3 
11481.3 
11976.6 
12074.8 
12137.3 
12190.7 
12298.6 
12322 
12367.3 
12406 
12434.3 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total MOR 
(ug) 
 
 
Other 
metabolites 
(ug) 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
5 
5.75 
4.83 
3.04 
4.59 
3.45 
3.51 
3.41 
3.78 
2.52 
1.95 
1.2 
5 
5.75 
4.83 
3.04 
4.59 
3.45 
3.51 
3.41 
3.69 
2.52 
1.8 
1.17 
5 
5.75 
4.83 
3.04 
4.59 
3.45 
3.51 
3.41 
3.78 
2.52 
1.85 
1.2 
       - 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
         - 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
       - 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
5 
5.75 
4.83 
3.04 
4.59 
3.45 
3.51 
3.41 
3.78 
2.52 
1.85 
1.2 
11038 
11174.55 
11476.47 
11973.56 
12070.21 
12133.85 
12187.19 
12295.19 
12318.22 
12364.78 
12404.15 
12433.1 
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Table 37a. Total degradation of Heroin in filtered primary sludge batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 37b. Total degradation of 6-ACM in filtered primary sludge batch tests (19 ± 0.5
o
C)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total  
HER 
(ug) 
  
 
 
% 
HER 
 
  
% 
Removal 
 
 
 Residual 
  
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1735.1 
1499.5 
1350.2 
1056.5 
642.0 
592.8 
556.8 
376.1 
267.8 
209.8 
147.0 
92.6 
1725.9 
1466.6 
1343.8 
1064.5 
657.2 
599.7 
556.8 
376.1 
265.6 
210.3 
147.0 
89.3 
1730.5 
1483.0 
1347.0 
1060.5 
649.6 
596.3 
556.8 
376.1 
266.7 
210.1 
147.0 
91.0 
13.8 
11.9 
10.8 
8.5 
5.2 
4.8 
4.5 
3.0 
2.1 
1.7 
1.2 
0.7 
86.2 
88.1 
89.2 
91.5 
94.8 
95.2 
95.5 
97.0 
97.9 
98.3 
98.8 
99.3 
10769.5 
11017.0 
11153.0 
11439.5 
11850.4 
11903.7 
11943.2 
12123.9 
12233.3 
12289.9 
12353.0 
12409.0 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
6ACM (ug) 
  
  
MOR & 
other 
metabolites 
(ug) 
 
Sample 1 
 
Sample 2 
 
 
    15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
 
950 
1058 
1071 
1007 
969 
765 
637 
605 
531 
434 
330 
240 
1075 
1127 
1092 
1007 
986 
795 
663 
638 
531 
441 
330 
240 
1025 
1081 
1071 
1007 
986 
780 
650 
627 
531 
441 
330 
240 
 9744.5 
9936 
10082 
10432.5 
10864.4 
11123.7 
11293.2 
11496.9 
11702.3 
11848.9 
12023 
12169 
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Table 37c. Total degradation of Morphine in filtered primary sludge batch tests (19 ± 0.5
o
C)
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 38a. Partition/Degradation of Heroin in SAF-1 sludge batch tests (19± 0.5
o
C) 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total  
MOR 
 (ug) 
  
  
 
Total 
metabolites  
(ug) 
 
Sample 1 
 
Sample 2 
 
 
    15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
 
25 
46 
63 
38 
68 
60 
52 
44 
45 
49 
30 
21 
25 
69 
63 
38 
68 
60 
52 
44 
45 
49 
30 
21 
25 
69 
63 
38 
68 
60 
52 
44 
45 
49 
30 
21 
 9719.5 
9867 
10019 
10394.5 
10796.4 
11063.7 
11241.2 
11452.9 
11657.3 
11799.9 
11993 
12148 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
HER 
 
 
% 
HER 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
55.4 
46.0 
45.1 
37.0 
35.9 
28.3 
21.4 
17.7 
16.1 
9.4 
7.5 
4.6 
55.4 
46.0 
49.1 
35.6 
31.0 
27.2 
21.8 
17.8 
16.3 
9.0 
6.5 
4.7 
55.4 
46.0 
47.1 
36.3 
33.4 
27.8 
21.6 
17.7 
16.2 
9.2 
7.0 
4.6 
80.1 
72.7 
66.1 
62.4 
37.6 
38.9 
29.2 
17.1 
21.7 
16.3 
6.3 
3.4 
80.0 
72.3 
63.4 
62.4 
38.3 
38.9 
27.9 
17.5 
21.1 
15.5 
6.3 
3.4 
80.0 
72.5 
64.8 
62.4 
38.0 
38.9 
28.6 
17.3 
21.4 
15.9 
6.3 
3.4 
135.4 
118.6 
111.9 
98.7 
71.4 
66.7 
50.1 
35.0 
37.6 
25.1 
13.3 
8.0 
1.1 
0.9 
0.9 
0.8 
0.6 
0.5 
0.4 
0.3 
0.3 
0.2 
0.1 
0.1 
99.6 
99.6 
99.6 
99.7 
99.7 
99.8 
99.8 
99.9 
99.9 
99.9 
99.9 
100.0 
12364.6 
12381.4 
12388.1 
12401.3 
12428.6 
12433.3 
12449.9 
12465.0 
12462.4 
12474.9 
12486.7 
12492.0 
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Table 38b. Partition/Degradation of Morphine in SAF-1 sludge batch tests (19± 0.5
o
C)
 
 
 
 
 
Table 39a. Partition/Degradation of Heroin in MSAF-1 sludge batch tests (19± 0.5
o
C) 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total  
(ug) 
 
 
Other 
metabolites 
(ug) 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
      15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
19.0 
19.1 
11.1 
15.8 
17.0 
13.4 
13.4 
14.0 
11.6 
10.0 
8.0 
5.1 
19.0 
2.1 
11.3 
16.7 
16.0 
13.4 
14.2 
14.3 
11.7 
9.9 
7.8 
5.3 
19.0 
10.6 
11.3 
16.2 
16.5 
13.4 
13.8 
14.2 
11.6 
10.0 
7.9 
5.2 
0.8 
2.1 
2.5 
4.2 
3.9 
3.5 
5.1 
3.4 
4.7 
3.3 
2.2 
0.7 
0.8 
2.3 
2.3 
4.2 
3.6 
3.6 
5.2 
3.3 
4.6 
3.3 
2.2 
0.7 
0.8 
2.3 
2.5 
4.2 
3.7 
3.5 
5.2 
3.4 
4.6 
3.3 
2.2 
0.7 
19.8 
12.9 
13.7 
20.3 
20.2 
16.8 
19.0 
17.5 
16.3 
13.3 
10.1 
5.9 
12344.9 
12368.5 
12374.5 
12381.0 
12408.4 
12416.5 
12430.9 
12447.5 
12446.1 
12461.6 
12476.6 
12486.1 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
HER 
 
 
% 
HER 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
53.3 
45.1 
39.1 
33.5 
28.5 
26.8 
23.9 
18.1 
13.0 
8.7 
6.6 
4.4 
51.1 
45.3 
37.3 
34.0 
28.4 
28.0 
23.5 
17.8 
13.8 
9.1 
6.6 
4.4 
52.2 
45.2 
38.2 
33.8 
28.5 
27.4 
23.7 
17.9 
13.4 
8.9 
6.6 
4.4 
8.3 
9.4 
10.8 
14.6 
11.2 
14.2 
12.3 
8.4 
7.2 
3.9 
2.9 
1.7 
8.1 
9.9 
9.4 
14.5 
11.2 
13.9 
12.5 
8.4 
6.6 
3.9 
2.9 
1.7 
8.2 
9.7 
10.1 
14.6 
11.2 
14.1 
12.4 
8.4 
6.9 
3.9 
2.9 
1.7 
60.4 
54.8 
48.3 
48.3 
39.7 
41.5 
36.1 
26.4 
20.3 
12.7 
9.5 
6.1 
0.5 
0.4 
0.4 
0.4 
0.3 
0.3 
0.3 
0.2 
0.2 
0.1 
0.1 
0.0 
99.6 
99.6 
99.7 
99.7 
99.8 
99.8 
99.8 
99.9 
99.9 
99.9 
99.9 
100.0 
12439.6 
12445.2 
12451.7 
12451.7 
12460.3 
12458.5 
12463.9 
12473.6 
12479.7 
12487.3 
12490.5 
12493.9 
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Table 39b. Partition/Degradation of Morphine in MSAF-1 sludge batch tests (19± 0.5
o
C)
 
 
 
 
 
Table 40a. Partition/Degradation of Heroin in Humus sludge batch tests (19± 0.5
o
C) 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total MOR  
(ug) 
 
 
Other 
metabolites 
(ug) 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
      15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
47.3 
46.5 
34.9 
40.1 
46.4 
30.9 
38.2 
33.6 
28.1 
27.4 
19.6 
13.6 
44.8 
46.7 
34.9 
42.6 
43.5 
31.8 
37.7 
34.8 
28.6 
26.4 
19.6 
13.6 
46.0 
46.5 
34.9 
41.4 
45.1 
31.4 
38.0 
34.2 
28.4 
27.0 
19.6 
13.6 
0.3 
0.2 
0.4 
1.0 
0.9 
2.3 
2.0 
3.5 
4.4 
1.3 
0.9 
0.4 
0.3 
0.2 
0.4 
0.8 
0.9 
2.3 
2.0 
3.5 
4.5 
1.3 
0.9 
0.4 
0.3 
0.2 
0.4 
1.0 
0.9 
2.3 
2.0 
3.5 
4.4 
1.3 
0.9 
0.4 
46.0 
46.7 
35.3 
42.2 
45.9 
33.6 
39.9 
37.6 
32.9 
28.3 
20.5 
14.0 
12393.6 
12398.5 
12416.4 
12409.5 
12414.4 
12424.9 
12424.0 
12436.0 
12446.9 
12459.0 
12470.1 
12479.9 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
HER 
 
 
% 
HER 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1562.8 
1124.7 
918.6 
775.6 
562.2 
354.3 
318.3 
258.4 
131.8 
116.5 
107.3 
60.7 
1514.0 
1105.9 
918.9 
789.2 
566.2 
388.6 
318.3 
275.7 
131.8 
118.5 
107.3 
60.7 
1538.4 
1115.3 
918.7 
782.4 
564.2 
371.5 
318.3 
267.1 
131.8 
117.5 
107.3 
60.7 
721.9 
554.6 
623.3 
488.8 
319.6 
315.2 
267.1 
201.1 
163.1 
98.1 
80.0 
48.7 
721.9 
629.3 
623.3 
502.9 
308.1 
324.5 
269.1 
201.1 
130.7 
97.1 
80.3 
47.4 
721.9 
591.9 
623.3 
495.9 
313.9 
319.8 
268.1 
201.1 
146.9 
97.6 
80.2 
48.0 
2260.3 
1707.2 
1542.1 
1278.3 
878.1 
691.3 
586.4 
468.2 
278.7 
215.1 
187.5 
108.8 
18.1 
13.7 
12.3 
10.2 
7.0 
5.5 
4.7 
3.7 
2.2 
1.7 
1.5 
0.9 
87.7 
91.1 
92.7 
93.7 
95.5 
97.0 
97.5 
97.9 
98.9 
99.1 
99.1 
99.5 
10239.7 
10792.8 
10957.9 
11221.7 
11621.9 
11808.7 
11913.6 
12031.8 
12221.3 
12284.9 
12312.5 
12391.2 
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Table 40b. Partition/Degradation of 6ACM in Humus sludge batch tests (19± 0.5
o
C)
 
 
 
 
 
 
Table 40c. Partition/Degradation of Morphine  in Humus sludge batch tests (19± 0.5
o
C)
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total  
(ug) 
 
 
Other 
metabolites 
(ug) 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
197.5 
173.7 
148.3 
134.7 
131.8 
102.5 
95.7 
69.7 
56.4 
45.3 
34.7 
26.2 
175.8 
185.4 
150.6 
134.5 
131.8 
100.1 
94.1 
70.2 
55.4 
39.1 
34.7 
26.2 
186.8 
179.6 
149.5 
134.5 
131.8 
101.3 
94.9 
70.0 
56.0 
38.7 
34.7 
26.2 
5.0 
30.8 
32.6 
49.4 
9.2 
21.3 
18.5 
13.3 
10.4 
7.6 
3.7 
1.8 
4.8 
31.3 
32.6 
50.5 
9.5 
21.5 
19.0 
13.3 
9.7 
7.4 
3.7 
1.8 
4.8 
31.1 
32.6 
50.0 
9.4 
21.5 
18.7 
13.3 
10.1 
7.5 
3.7 
1.8 
191.5 
210.7 
182.1 
184.5 
141.1 
122.7 
113.6 
83.3 
66.1 
46.2 
38.4 
28.0 
10048.2 
10582.1 
10775.8 
11037.2 
11480.8 
11686.0 
11800.0 
11948.5 
12155.2 
12238.7 
12274.1 
12363.2 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total  
(ug) 
 
 
Other 
metabolites 
(ug) 
 
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
8.0 
8.1 
7.8 
7.0 
6.5 
3.9 
4.0 
4.1 
3.4 
2.8 
1.9 
1.4 
7.8 
7.6 
8.2 
7.0 
6.5 
3.9 
4.9 
3.3 
3.4 
2.8 
1.9 
1.4 
8.0 
7.8 
8.0 
7.0 
6.5 
3.9 
4.6 
3.7 
3.4 
2.8 
1.9 
1.4 
0.0 
0.9 
1.5 
3.4 
1.0 
3.0 
3.5 
2.9 
3.9 
3.4 
2.1 
1.2 
0.0 
1.2 
1.5 
3.8 
1.0 
3.2 
4.2 
2.9 
3.6 
3.4 
1.9 
1.2 
0.0 
1.2 
1.5 
3.6 
1.0 
3.0 
3.8 
2.9 
3.8 
3.4 
2.0 
1.2 
8.0 
8.7 
9.5 
10.6 
7.5 
6.9 
8.3 
6.6 
7.2 
6.2 
3.9 
2.6 
10040.2 
10573.4 
10766.4 
11026.6 
11473.3 
11679.1 
11791.7 
11941.9 
12148.0 
12232.5 
12270.3 
12360.6 
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Table 41a. Total degradation of Heroin in Stoke Bardoph effluent batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 41b. Total degradation of 6-ACM in Stoke Baldoph effluent batch tests (19 ± 0.5
o
C)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total  
HER 
(ug ) 
  
 
 
% 
HER 
 
  
% 
Removal 
 
 
 Residual 
  
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1835.3 
1662.6 
1274.7 
939.4 
847.6 
765.9 
603.7 
516.7 
374.9 
257.0 
175.8 
97.2 
1836.8 
1652.5 
1248.1 
946.9 
833.7 
769.7 
590.9 
496.3 
380.8 
286.2 
175.8 
98.4 
1836.0 
1657.5 
1261.4 
943.2 
840.6 
767.8 
597.3 
506.5 
377.8 
271.6 
175.8 
97.8 
14.7 
13.3 
10.1 
7.5 
6.7 
6.1 
4.8 
4.1 
3.0 
2.2 
1.4 
0.8 
85.3 
86.7 
89.9 
92.5 
93.3 
93.9 
95.2 
95.9 
97.0 
97.8 
98.6 
99.2 
10664.0 
10842.5 
11238.6 
11556.8 
11659.4 
11732.2 
11902.7 
11993.5 
12122.2 
12228.4 
12324.2 
12402.2 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
6ACM (ug) 
  
  
MOR & 
other 
metabolites 
(ug) 
 
Sample 1 
 
Sample 2 
 
 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
975.0 
1058.0 
966.0 
893.0 
901.0 
795.0 
780.0 
671.0 
648.0 
399.0 
305.0 
201.0 
950.0 
1127.0 
966.0 
912.0 
884.0 
780.0 
767.0 
649.0 
702.0 
406.0 
305.0 
195.0 
962.5 
1092.5 
966 
902.5 
892.5 
787.5 
773.5 
660 
675 
402.5 
305 
198 
 9701.5 
9750 
10272.6 
10654.3 
10766.9 
10944.7 
11129.2 
11333.5 
11447.2 
11825.9 
12019.2 
12204.2 
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Table 41c. Total degradation of Morphine in Stoke Baldoph effluent batch tests (19 ± 0.5
o
C)
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 42a. Partition/Degradation of Diazepam in primary sludge batch tests (4± 0.5
o
C) 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total  
MOR 
 (ug) 
  
  
 
Total 
metabolites 
(ug) 
 
Sample 1 
 
Sample 2 
 
 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
50 
69 
63 
38 
68 
60 
52 
55 
45 
35 
25 
18 
50 
69 
63 
38 
85 
60 
52 
55 
45 
35 
25 
18 
50 
69 
63 
38 
77 
60 
52 
55 
45 
35 
25 
18 
 9651.5 
9681 
10209.6 
10616.3 
10689.9 
10884.7 
11077.2 
11278.5 
11402.2 
11790.9 
11994.2 
12186.2 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
DIAZ 
 
 
% 
DIAZ 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
916.6 
835.3 
738.6 
687.2 
294.9 
266.3 
228.6 
192.6 
149.8 
120.5 
76.1 
41.5 
911.9 
829.3 
743.7 
687.2 
294.9 
266.3 
230.8 
193.4 
149.8 
120.6 
79.2 
41.5 
914.2 
832.3 
741.2 
687.2 
294.9 
266.3 
229.7 
193.0 
149.8 
120.6 
77.6 
41.5 
3866.1 
3877.8 
3989.7 
3673.4 
3286.7 
2958.0 
2603.8 
2203.2 
1860.0 
1446.7 
1065.5 
643.5 
3866.1 
3879.4 
3977.0 
3680.8 
3347.6 
2958.0 
2603.8 
2203.2 
1860.0 
1446.7 
1065.5 
643.5 
3866.1 
3878.6 
3983.4 
3677.1 
3317.1 
2958.0 
2603.8 
2203.2 
1860.0 
1446.7 
1065.5 
643.5 
38.2 
37.7 
37.8 
34.9 
28.9 
25.8 
22.7 
19.2 
16.1 
12.5 
9.1 
5.5 
92.7 
93.3 
94.1 
94.5 
97.6 
97.9 
98.2 
98.5 
98.8 
99.0 
99.4 
99.7 
4780.4 
4710.9 
4724.5 
4364.3 
3612.0 
3224.3 
2833.5 
2396.2 
2009.9 
1567.3 
1143.2 
  685.0 
7719.6 
7789.1 
7775.5 
8135.7 
8888.0 
9275.7 
9666.5 
10103.8 
10490.1 
10932.7 
11356.8 
11815.0 
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Table 42b. Partition/Degradation of Nor-dazepam in primary sludge batch tests (4± 0.5
o
C)
 
 
 
 
 
 
Table 43. Partition/Degradation of Diazepam in primary sludge batch tests (19± 0.5
o
C) 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug in10 mL) 
 
 
solid phase (ug in10 mL) 
 
 
 
Total CE 
(ug in10 
mL) 
 
 
Other 
metabolites   
Sample 1 
 
Sample 2 
 
Mean 
 
Sample 1 
 
Sample 2 
 
Mean 
      15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
2 
2 
2 
2 
2 
1 
1 
1 
1 
1 
1 
1 
227 
228 
235 
234 
258 
258 
261 
261 
265 
267 
289 
304 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
DIAZ 
 
 
% 
DIAZ 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
2019.1 
1543.6 
1400.6 
1093.9 
979.7 
655.3 
606.9 
439.4 
306.9 
191.1 
118.8 
37.1 
2012.2 
1550.3 
1401.7 
1093.9 
980.1 
651.9 
588.7 
439.5 
308.5 
190.4 
118.8 
36.9 
2015.7 
1547.0 
1401.2 
1093.9 
979.9 
653.6 
597.8 
439.4 
307.7 
190.8 
118.8 
37.0 
4919.3 
4504.2 
2933.2 
3229.7 
3028.4 
2690.2 
2104.9 
1887.4 
1506.1 
1301.3 
883.8 
508.1 
4919.3 
4504.2 
2933.2 
3229.7 
3028.4 
2690.2 
2104.9 
1887.4 
1506.1 
1301.3 
883.8 
508.1 
4919.3 
4504.2 
2933.2 
3229.7 
3028.4 
2690.2 
2104.9 
1887.4 
1506.1 
1301.3 
883.8 
508.1 
6934.9 
6051.2 
4334.4 
4323.6 
4008.3 
3343.8 
2702.7 
2326.8 
1813.8 
1492.0 
1002.6 
545.1 
55.5 
48.4 
34.7 
34.6 
32.1 
26.8 
21.6 
18.6 
14.5 
11.9 
8.0 
4.4 
83.9 
87.6 
88.8 
91.2 
92.2 
94.8 
95.2 
96.5 
97.5 
98.5 
99.0 
99.7 
5565.1 
6448.8 
8165.6 
8176.4 
8491.7 
9156.2 
9797.3 
10173.2 
10686.2 
11008.0 
11497.4 
11954.9 
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Table 44. Total degradation of Diazepam in filtered primary sludge batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 45. Partition/Degradation of Diazepam in SAF-1sludge batch tests (19± 0.5
o
C) 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
DIAZ 
 (ug) 
  
 
 
% 
DIAZ 
 
  
% 
Removal 
 
 
 Residual 
  
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
11454.1 
9701.1 
9808.8 
7803.9 
6852.8 
5620.6 
4864.4 
4081.6 
3252.1 
2506.8 
1774.3 
1039.5 
11408.3 
9701.1 
9808.8 
7807.9 
6852.8 
5592.6 
4874.7 
4081.1 
3244.4 
2520.3 
1775.0 
1034.3 
11431.2 
9701.1 
9808.8 
7805.9 
6852.8 
5606.6 
4869.5 
4081.3 
3248.2 
2513.5 
1774.7 
1036.9 
91.4 
77.6 
78.5 
62.4 
54.8 
44.9 
39.0 
32.7 
26.0 
20.1 
14.2 
8.3 
8.6 
22.4 
21.5 
37.6 
45.2 
55.1 
61.0 
67.3 
74.0 
79.9 
85.8 
91.7 
1068.8 
2798.9 
2691.2 
4694.1 
5647.2 
6893.4 
7630.5 
8418.7 
9251.8 
9986.5 
10725.3 
11463.1 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
DIAZ 
 
 
% 
DIAZ 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
131.2 
120.7 
106.7 
93.3 
83.3 
70.8 
60.6 
50.0 
37.2 
28.6 
11.8 
6.9 
131.2 
120.7 
106.4 
94.3 
83.3 
71.2 
60.4 
51.0 
36.3 
28.6 
11.8 
6.9 
131.2 
120.7 
106.5 
93.8 
83.3 
71.0 
60.5 
50.5 
36.8 
28.6 
11.8 
6.9 
447.1 
400.3 
349.3 
280.2 
254.8 
209.5 
168.8 
143.3 
111.9 
84.8 
58.4 
33.1 
447.1 
400.3 
349.3 
283.0 
254.8 
208.0 
168.8 
141.3 
113.7 
84.8 
58.4 
33.1 
447.1 
400.3 
349.3 
281.6 
254.8 
208.8 
168.8 
142.3 
112.8 
84.8 
58.4 
33.1 
578.3 
521.0 
455.9 
375.4 
338.2 
279.8 
229.3 
192.8 
149.6 
113.4 
70.2 
40.0 
4.6 
4.2 
3.6 
3.0 
2.7 
2.2 
1.8 
1.5 
1.2 
0.9 
0.6 
0.3 
99.0 
99.0 
99.1 
99.2 
99.3 
99.4 
99.5 
99.6 
99.7 
99.8 
99.9 
99.9 
11921.7 
11979.0 
12044.1 
12124.6 
12161.8 
12220.2 
12270.7 
12307.2 
12350.4 
12386.6 
12429.8 
12460.0 
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Table 46. Partition/Degradation of Diazepam in  MSAF-1sludge batch tests (19± 0.5
o
C) 
 
 
Table 47. Partition/Degradation of Diazepam in HS- sludge batch tests (19± 0.5
o
C) 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
DIAZ 
 
 
% 
DIAZ 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
1811.6 
1368.1 
1251.6 
1080.7 
804.2 
536.9 
525.7 
427.7 
247.5 
147.9 
96.5 
73.0 
1824.8 
1409.7 
1231.6 
1080.7 
829.6 
553.4 
521.4 
444.8 
247.2 
147.9 
96.9 
72.8 
1818.2 
1388.9 
1241.6 
1080.7 
816.9 
545.1 
523.6 
436.2 
247.3 
147.9 
96.7 
72.9 
4640.2 
3924.6 
3702.0 
3010.2 
2466.9 
2280.3 
1817.9 
1511.8 
1196.0 
945.0 
654.1 
382.9 
4623.0 
3924.6 
3745.2 
2993.3 
2474.1 
2333.0 
1811.5 
1511.8 
1196.0 
948.3 
654.5 
384.3 
4631.6 
3924.6 
3723.6 
3001.7 
2470.5 
2306.7 
1814.7 
1511.8 
1196.0 
946.6 
654.3 
383.6 
6449.8 
5313.6 
4965.2 
4082.5 
3287.4 
2851.8 
2338.2 
1948.0 
1443.3 
1094.5 
751.0 
456.5 
51.6 
42.5 
39.7 
32.7 
26.3 
22.8 
18.7 
15.6 
11.5 
8.8 
6.0 
3.7 
85.5 
88.9 
90.1 
91.4 
93.5 
95.6 
95.8 
96.5 
98.0 
98.8 
99.2 
99.4 
6050.2 
7186.4 
7534.8 
8417.5 
9212.6 
9648.2 
10161.8 
10552.0 
11056.7 
11405.5 
11749.0 
12043.5 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
solid phase (ug) 
 
 
 
Total 
DIAZ 
 
 
% 
DIAZ 
 
 
 
% 
removal 
 
  
Residual  
 
Sample 
1 
 
Sample  
2 
  
Mean 
 
Sample  
1 
 
Sample 
2 
 
Mean 
     15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
66.1 
61.9 
61.3 
54.0 
47.4 
43.1 
41.9 
42.3 
31.5 
22.9 
23.2 
20.3 
66.1 
62.0 
61.3 
54.0 
47.2 
43.2 
41.9 
42.3 
31.8 
22.9 
23.2 
20.3 
66.1 
61.9 
61.3 
54.0 
47.3 
43.1 
41.9 
42.3 
31.6 
22.9 
23.2 
20.3 
21.2 
20.3 
19.9 
19.5 
19.3 
19.0 
18.9 
18.9 
19.3 
19.5 
19.4 
18.9 
21.2 
20.3 
19.7 
19.4 
19.3 
18.8 
18.8 
18.7 
19.4 
19.5 
19.5 
19.1 
21.2 
20.3 
19.8 
19.5 
19.3 
18.9 
18.9 
18.8 
19.3 
19.5 
19.5 
19.0 
87.3 
82.3 
81.0 
73.5 
66.6 
62.0 
60.7 
61.1 
50.9 
42.4 
42.6 
39.3 
0.7 
0.7 
0.6 
0.6 
0.5 
0.5 
0.5 
0.5 
0.4 
0.3 
0.3 
0.3 
99.5 
99.5 
99.5 
99.6 
99.6 
99.7 
99.7 
99.7 
99.7 
99.8 
99.8 
99.8 
12412.7 
12417.7 
12419.0 
12426.5 
12433.4 
12438.0 
12439.3 
12438.9 
12449.1 
12457.6 
12457.4 
12460.7 
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Table 48. Total degradation of Diazepam in Stoke Bardolph effluent batch tests (19 ± 0.5
o
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
 
aqueous phase (ug) 
 
 
 
Total 
DIAZ 
(ug) 
  
 
 
% 
DIAZ 
 
  
% 
Removal 
 
 
 Residual 
  
Sample 1 
 
Sample 2 
   15 
 
30 
 
45 
 
60 
 
75 
 
90 
 
105 
 
120 
 
135 
 
150 
 
165 
 
180 
11989.3 
9527.2 
8060.3 
7116.3 
6321.8 
5433.1 
4707.5 
4042.8 
3310.9 
2582.6 
1772.0 
1044.5 
11951.7 
9538.9 
8060.3 
7146.4 
6314.1 
5432.9 
4711.2 
4005.8 
3315.1 
2595.4 
1776.4 
1042.3 
11970.5 
9533.0 
8060.3 
7131.4 
6317.9 
5433.0 
4709.3 
4024.3 
3313.0 
2589.0 
1774.2 
1043.4 
95.8 
76.3 
64.5 
57.1 
50.5 
43.5 
37.7 
32.2 
26.5 
20.7 
14.2 
8.3 
4.2 
23.7 
35.5 
42.9 
49.5 
56.5 
62.3 
67.8 
73.5 
79.3 
85.8 
91.7 
529.5 
2967 
4439.7 
5368.6 
6182.1 
7067 
7790.7 
8475.7 
9187 
9911 
10725.8 
11456.6 
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Appendix 5 – Sewage Treatment Work Process Calculations [292] 
1.1 Primary Settlement Tank 
 
 
Flow to PST 
DWF 63 (=average / 1.25) m3/d 
Average 78 
FFT 360 
Design  recirc. 250.6  (2.9  l/s) 
Temporary Recirc 276.5  (3.2  l/s) 
Dimensions of PST  
No. 1  
Diameter 6 m 
Side Wall Depth 1.7 m 
Floor Slope 60o  
Cone  Depth = Tan60  x pi/180 x 6/2 = 5.2  
Total SA =pi x (6/2)2   = 28.3 m2 
Total Volume = pi x (6/2)2 x 1.7  +(pi x (6/2)2 x 5.2/3 x 
0.7)  = 82.5  (30% of cone  for sludge) 
m3 
 
Hydraulic  loading  rate (m/h) = flow to tanks (m
3
/h) / total  SA (m
2
) Retention time  (h)  = 
flow to tanks (m
3
/h) / total  volume of tanks (m
3
) 
 
1.2 Filter 
 
Flow to filters  
DWF 63 (=average / 1.25) m3/d 
Average 78 
FFT 360 
Design  recirc. 250.6  (2.9  l/s) 
Temporary 
Recirc 
276.5  (3.2  l/s) 
Average BOD 
Conc. 
9.8  (based on crude loads, assuming 25% 
removal in PST) 
mg/l 
Average 
Ammonia Conc. 
5 (based on crude loads, assuming 50% removal 
in PST) 
mg/l 
Dimensions 
No. 1  
Diameter 11.3 m 
Side Wall Depth 1.7 m 
Total SA =pi x (11.3/2)2   = 100 m2 
Total Volume =pi x (20/2)2   x 1.7  = 170* m3 
*Neglects centre column 
 
Wetting  rate (m
3
/m
2
/d) = flow to tanks (m
3
/d) / total  SA (m
2
) 
 
Required Volume  for plastic  media filter calculated using  WEF MOP 8 calc for combined filters  to 
meet  an  effluent quality  of 5 mg/l (on  a MAC and  a 95%ile  basis) 
 1.3 Humus Tank 
 
 
Flow to Humus Tank 
DWF 63 (=average / 1.25) m3/d 
Average 78 
FFT 360 
Design  recirc. 250.6  (2.9  l/s) 
Temporary Recirc 276.5  (3.2  l/s) 
Dimensions of Humus Tank  
No. 1  
Diameter 5 m 
Side Wall Depth 2 m 
Floor Slope 60o  
Cone  Depth = Tan60  x pi/180 x 5/2 = 4.3  
Total SA =pi x (5/2)2   = 19.6 m2 
Total Volume = pi x (6/2)2 x 2 +(pi x (6/2)2 x 4.3/3 x 
0.7)  = 45.8  (30% of cone  for sludge) 
m3 
 
 
Hydraulic  loading  rate (m/h) = flow to tanks (m
3
/h) / total  SA (m
2
) Retention time  (h)  = 
flow to tanks (m
3
/h) / total  volume of tanks (m
3
) 
 
1.4  Reed Beds 
 
 
Reed Beds 
DWF 63 (=average / 1.25) m3/d 
Average 78 
FFT 360 
Design  recirc. 0 
Temporary Recirc 0 
Base  PE 1600 non  residents  
Dimensions of Humus Tank  
No. 2  
Dimensions 24m x 12.5m m 
Side Wall Depth 2 m 
Total Area 600m2 m2 
 
Required area = 1 m2/PE x PE/3 (only on site  for 1/3 time)  = 1 x 1600 / 3 = 530 m2 
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